≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Pneumococcal septicemia

DOID EFO Endpoint Browser PheWeb

PNEUMO_SEPTHICHE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — A40.3
  • Hospital discharge: ICD-9 — 0382
  • Hospital discharge: ICD-8 — 0382
  • Cause of death: ICD-10 — A40.3
  • Cause of death: ICD-9 — 0382
  • Cause of death: ICD-8 — 0382

2 out of 7 registries used, show all original rules.

1352

4. Check minimum number of events

None

1352

5. Include endpoints

None

1352

6. Filter based on genotype QC (FinnGen only)

1290

Control definitions (FinnGen only)

Control exclude
ASTHMA_SEPTICHE_PNEUMONIA

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
A40
Name in latin
Septic(h)aemia pneumococcica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 14540 6399 8046
Only index persons 12041 5409 6632
Unadjusted period prevalence (%)
Whole population 0.21 0.18 0.22
Only index persons 0.23 0.20 0.25
Median age at first event (years)
Whole population 40.52 39.46 41.06
Only index persons 36.59 36.71 36.49

-FinnGen-

Key figures

All Female Male
Number of individuals 1290 596 694
Unadjusted period prevalence (%) 0.27 0.21 0.32
Median age at first event (years) 59.64 55.60 63.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1352
Matched controls
13520
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J18.9
ICD-10 Finland
Pneumonia, unspecified
8.2
307.7
886
2551
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
246.6
307.7
499
32
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
+∞
307.7
1192
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
7.0
203.9
377
706
0382A
ICD-9 Finland
Septicaemia, Pneumococcal septicaemia
+∞
120.7
114
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
114.0
443
1479
A41.9
ICD-10 Finland
Sepsis, unspecified
7.6
104.4
157
229
J01MA14
ATC
moxifloxacin; systemic
4.9
100.8
253
603
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
86.3
856
4847
J86.9
ICD-10 Finland
Pyothorax without fistula
15.9
85.0
74
49
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
76.8
286
904
J01MA12
ATC
levofloxacin; systemic
3.1
69.2
384
1544
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
12.6
66.4
66
55
R50.9
ICD-10 Finland
Fever, unspecified
2.8
50.9
322
1365
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
4.3
50.0
136
339
R81
ICPC
Pneumonia
4.9
48.9
112
243
03820
ICD-8 Finland
Septicaemia, Pneumococcal
+∞
48.2
46
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
46.8
355
1641
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
44.5
239
923
C90.0
ICD-10 Finland
Multiple myeloma
10.1
43.8
50
51
WX872
NOMESCO Finland
Intensive care
4.1
43.3
128
339
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.7
42.3
271
1147
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.0
41.5
213
801
G00.1
ICD-10 Finland
Pneumococcal meningitis
419.9
41.4
41
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
41.3
389
1970
H02AB06
ATC
prednisolone; systemic
2.1
40.9
710
4598
R03BB04
ATC
tiotropium bromide; inhalant
2.9
39.5
208
792
WX892
NOMESCO Finland
Monitored bed care
3.2
37.5
166
572
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
36.5
103
263
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.8
36.4
117
328
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
11.5
36.3
38
34
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.3
34.7
327
1641
A41.8
ICD-10 Finland
Other specified sepsis
5.7
34.0
64
116
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.0
33.9
102
273
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
33.6
215
902
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
33.3
252
1146
C03CA01
ATC
furosemide; systemic
2.0
32.4
485
2905
J01FF01
ATC
clindamycin; systemic
2.1
30.5
408
2336
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
30.2
305
1565
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
29.2
754
5378
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
29.0
98
284
153
Kela drug reimbursment
Lenalidomid
11.3
28.5
30
27
S97
ICPC
Chronic ulcer skin
3.0
27.9
130
459
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
27.7
129
456
TK800
NOMESCO Finland
Hemodialysis
5.3
27.3
56
110
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.9
27.1
61
130
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.3
26.8
106
340
L04AX04
ATC
lenalidomide; oral
10.6
26.3
29
28
A46
ICD-10 Finland
Erysipelas
2.2
25.6
243
1209
XW000
NOMESCO Finland
Bone marrow biopsy
3.6
25.5
89
263
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.8
24.5
77
212
ZX120
NOMESCO Finland
Intravenous
2.5
24.1
159
673
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
23.8
132
512
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.2
23.7
99
328
R03AC02
ATC
salbutamol; inhalant
1.8
23.6
757
5621
ZXD05
NOMESCO Finland
Urgent procedure
1.9
23.6
435
2738
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
23.5
247
1276
R4110
NOMESCO Finland
Physiotherapy
1.9
22.7
404
2508
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.8
22.5
71
196
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
22.3
135
547
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
22.3
117
441
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
22.2
127
500
J01CA04
ATC
amoxicillin; systemic
2.0
21.2
1119
9509
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
50.9
21.2
25
5
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
21.0
248
1335
I50.0
ICD-10 Finland
Congestive heart failure
2.5
20.7
135
567
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
20.6
66
184
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.9
20.6
37
64
WX730
NOMESCO Finland
Conventional respirator
5.6
20.6
39
71
J96.1
ICD-10 Finland
Chronic respiratory failure
4.4
20.5
52
122
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
20.2
76
236
R03DA04
ATC
theophylline; systemic, rectal
2.9
19.9
95
340
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
19.7
165
775
JN4AD
NOMESCO Finland
Body CT examination
2.2
19.7
185
912
H02AB09
ATC
hydrocortisone; systemic
4.1
19.6
54
135
WW200
NOMESCO Finland
Immunization
3.9
19.5
57
149
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.5
18.8
46
105
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
6.2
18.6
32
53
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
18.6
94
347
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
18.5
286
1683
R95
ICPC
Chron obstructive pulmonary disease
3.6
18.4
62
179
J01DB01
ATC
cefalexin; oral
1.9
18.0
1101
9456
4810A
ICD-9 Finland
Pneumococcal pneumonia[PNEUMONIA PNEUMOCOCCICA]
33.4
18.0
23
7
R96
ICPC
Asthma
2.3
18.0
149
696
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
18.0
69
217
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
17.3
58
167
R02
ICPC
Shortness of breath/dyspnoea
2.0
17.2
209
1131
L04AA01
ATC
[U] ciclosporin
6.0
17.0
30
51
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
16.9
239
1362
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.5
16.8
115
493
WX882
NOMESCO Finland
High dependency care
3.2
16.6
67
217
A03
ICPC
Fever
1.9
16.6
262
1547
H02AB07
ATC
prednisone; oral
2.0
16.6
193
1028
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
16.3
115
500
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.2
16.1
65
211
AA1AD
NOMESCO Finland
CT of head and brain
1.7
15.9
403
2722
M04AA01
ATC
allopurinol; systemic
2.0
15.9
201
1102
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.0
15.8
73
256
H02AB04
ATC
methylprednisolone; systemic
2.0
15.8
194
1052
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
15.5
108
467
J15.4
ICD-10 Finland
Pneumonia due to other streptococci
161.8
15.5
16
*
A28
ICPC
Limited function/disability NOS
1.8
15.5
264
1594
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
15.5
423
2912
Z3231
NOMESCO Finland
Registered nurse
1.7
15.4
379
2538
120
Kela drug reimbursment
Hypogammaglobulinaemia
38.5
15.4
19
5
Z3226
NOMESCO Finland
Physiotherapist
1.8
15.3
256
1537
N17.8
ICD-10 Finland
Other acute renal failure
5.4
15.2
30
57
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
5.7
15.1
28
50
A02BC02
ATC
pantoprazole; systemic
1.6
15.0
865
7099
J46
ICD-10 Finland
Status asthmaticus
3.6
14.7
48
136
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
14.7
135
657
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
21.3
14.7
21
10
B18.2
ICD-10 Finland
Chronic viral hepatitis C
5.2
14.6
30
59
L03AA02
ATC
filgrastim; parenteral
3.4
14.6
53
161
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
14.6
379
2569
A07AA02
ATC
nystatin; oral
2.6
14.6
86
344
N02AX02
ATC
tramadol; systemic, rectal
1.6
14.5
548
4067
GBB00
NOMESCO Finland
Tracheostomy
5.5
14.5
28
52
Z72.0
ICD-10 Finland
Tobacco use
3.5
14.5
50
147
N05BA01
ATC
diazepam; systemic, rectal
2.0
14.4
177
959
WW500
NOMESCO Finland
Blood transfusion
2.8
14.4
72
264
L04AA06
ATC
mycophenolic acid; systemic
4.1
14.4
40
101
J45
ICD-10 Finland
Asthma
2.1
14.3
142
713
SPAT1255
SPAT
Intravenous administration of medicine
2.4
14.2
102
448
127
Kela drug reimbursment
Transplant complication
4.3
14.1
36
85
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
43.0
14.1
17
*
WX722
NOMESCO Finland
PEEP
2.7
14.1
79
308
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
13.9
194
1097
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.1
13.9
29
58
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
13.7
159
844
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.0
13.6
29
59
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
13.6
129
636
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.4
13.4
47
140
R05
ICPC
Cough
1.7
13.3
335
2243
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
13.3
70
264
R03AC12
ATC
salmeterol; inhalant
2.7
13.3
73
282
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
13.2
90
385
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
13.2
123
601
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.0
12.9
57
195
C03DA01
ATC
spironolactone; oral
1.9
12.8
178
1004
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
12.8
188
1081
R03BA05
ATC
fluticasone; inhalant
1.7
12.7
244
1517
SPAT1262
SPAT
Handing over of treatment supplies
1.8
12.7
231
1415
SPAT1254
SPAT
Administration of medicine
1.8
12.6
220
1332
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
12.6
162
891
ZXE00
NOMESCO Finland
One hour or less
1.5
12.6
491
3642
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.7
12.5
39
107
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.2
12.5
103
479
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
5.1
12.4
26
52
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.5
12.4
76
310
J20
ICD-10 Finland
Acute bronchitis
2.0
12.3
141
744
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.1
12.3
123
618
C07AB07
ATC
bisoprolol; oral
1.5
12.2
620
4856
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
12.2
339
2323
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.9
12.1
35
91
Z2221
NOMESCO Finland
Medical doctor
1.6
12.1
346
2384
JN4BD
NOMESCO Finland
Extensive body CT
2.0
12.0
141
752
R06.0
ICD-10 Finland
Dyspnoea
1.6
11.9
366
2565
B03XA01
ATC
erythropoietin; parenteral
5.4
11.8
23
43
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.2
11.8
31
75
B01AB05
ATC
enoxaparin; parenteral
1.6
11.8
387
2753
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
11.7
253
1622
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.4
11.6
82
357
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.5
11.6
39
113
J96.0
ICD-10 Finland
Acute respiratory failure
4.2
11.6
30
72
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
11.5
296
1986
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
11.5
87
391
D65
ICD-10 Finland
Disseminated intravascular coagulation [defibrination syndrome]
35.3
11.3
14
*
TK810
NOMESCO Finland
Hemofiltration
9.0
11.3
23
26
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
11.2
477
3582
Z2446
NOMESCO Finland
Social worker
2.1
11.2
107
528
R06AE07
ATC
cetirizine; oral
1.5
11.2
528
4052
J01FA06
ATC
roxithromycin; oral
1.5
11.2
465
3476
B01AA03
ATC
warfarin; systemic
1.7
11.2
258
1683
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.3
11.1
41
126
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.5
11.0
68
278
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
10.9
852
7215
R03BA02
ATC
budesonide; inhalant
1.7
10.8
230
1468
N03AX16
ATC
[U] pregabalin
1.6
10.7
271
1809
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
10.5
316
2197
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
10.3
291
1990
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.3
10.3
38
117
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.6
10.3
58
227
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.3
10.2
81
372
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.7
10.1
52
194
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
14.7
10.0
16
11
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
9.8
621
5006
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.1
9.8
93
458
SPAT1263
SPAT
Sampling
1.5
9.8
522
4074
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
9.8
529
4141
J47
ICD-10 Finland
Bronchiectasis
3.4
9.8
34
101
TGC00
NOMESCO Finland
Bronchial lavation
2.9
9.7
45
159
N02AA05
ATC
oxycodone; systemic
1.6
9.7
241
1598
J01AA02
ATC
doxycycline; systemic
1.5
9.7
932
8120
WX704
NOMESCO Finland
Intubation
2.0
9.6
110
581
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
8.4
9.6
20
24
A04AA01
ATC
ondansetron; systemic, rectal
2.0
9.6
110
582
J01DA01
ATC
[U] cefalexin
1.4
9.5
741
6191
6BA02, ,
NOMESCO Finland
15.1
9.5
15
10
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
9.5
80
376
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
9.5
122
670
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
9.4
167
1012
L04AD01
ATC
ciclosporin; systemic
3.4
9.3
33
99
B34.9
ICD-10 Finland
Viral infection, unspecified
2.7
9.3
50
191
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
9.3
76
353
A12AA04
ATC
calcium carbonate; oral
3.6
9.3
30
85
M10.9
ICD-10 Finland
Gout, unspecified
2.0
9.1
104
548
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
5.1
9.1
19
38
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.8
9.1
20
42
N03AG01
ATC
valproic acid; systemic, rectal
2.1
9.1
82
397
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.1
9.0
37
122
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
9.0
92
467
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.5
9.0
53
213
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
18.7
8.9
13
7
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
8.9
93
475
N07BB01
ATC
disulfiram; oral
2.4
8.9
59
250
N18.0
ICD-10 Finland
End-stage renal disease
4.4
8.9
22
51
A40.0
ICD-10 Finland
Sepsis due to streptococcus, group A
12.6
8.9
15
12
R03DC03
ATC
montelukast; oral
1.6
8.8
196
1262
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
4.1
8.8
24
60
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.0
8.8
37
124
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
8.7
427
3263
A10AB05
ATC
insulin aspart; parenteral
1.9
8.7
107
579
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.0
8.7
38
130
A02BC01
ATC
omeprazole; systemic
1.5
8.7
328
2384
E000001, ,
ATC
1.6
8.6
245
1672
N05AA02
ATC
levomepromazine; systemic
2.5
8.6
55
229
L04AX01
ATC
azathioprine; systemic
2.4
8.6
57
242
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.1
8.6
35
115
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
8.6
363
2697
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
8.5
41
148
J80
ICD-10 Finland
Adult respiratory distress syndrome
9.0
8.5
17
19
L01AA01
ATC
cyclophosphamide; systemic
10.1
8.5
16
16
N05CF01
ATC
zopiclone; oral
1.5
8.5
378
2833
A06AD11
ATC
lactulose; oral
1.6
8.5
190
1225
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
8.5
54
225
V03AE01
ATC
polystyrene sulfonate; oral
3.7
8.5
26
71
C01AA05
ATC
digoxin; systemic
1.9
8.5
111
614
M00.1
ICD-10 Finland
Pneumococcal arthritis and polyarthritis
90.6
8.4
9
*
ZX108
NOMESCO Finland
Inhalation
4.7
8.4
19
41
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
8.4
247
1701
J45.8
ICD-10 Finland
Mixed asthma
2.7
8.3
43
162
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.8
8.2
39
140
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
8.2
105
576
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.4
8.2
20
46
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.6
8.1
45
175
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
8.1
272
1924
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.3
8.1
61
274
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
8.1
123
712
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.0
8.1
22
55
R03BA01
ATC
beclometasone; inhalant
1.7
8.1
160
999
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
6.3
8.0
20
32
UDC00
NOMESCO Finland
Ear microscopy
1.9
8.0
99
537
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
8.0
353
2638
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.3
7.9
59
264
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
4.5
7.9
19
43
WX213
NOMESCO Finland
Lower leg blockade
4.7
7.9
18
39
P15
ICPC
Chronic alcohol abuse
2.6
7.9
46
184
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
7.8
108
608
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
3.7
7.8
24
66
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.8
244
1702
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.9
7.7
22
57
R11
ICD-10 Finland
Nausea and vomiting
1.8
7.7
118
685
N02BE01
ATC
paracetamol; systemic, rectal
1.5
7.7
1131
10401
NH1AD
NOMESCO Finland
Ankle and foot CT
3.0
7.7
33
112
M05BA04
ATC
alendronic acid; oral
1.9
7.7
100
552
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.4
7.7
51
217
I48.1
ICD-10 Finland
Persistent atrial fibrillation
2.2
7.6
61
282
ZX112
NOMESCO Finland
Subcutaneous
2.9
7.6
35
124
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
7.5
234
1627
B03XA02
ATC
darbepoetin alfa; parenteral
2.8
7.5
36
130
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
7.5
438
3437
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.1
7.5
31
103
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.6
7.5
41
159
DC1AD
NOMESCO Finland
Temporalbone CT
4.3
7.5
19
45
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.9
7.4
21
54
E0000UV, ,
ATC
1.4
7.4
510
4112
R03AC13
ATC
formoterol; inhalant
2.1
7.4
66
319
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.0
7.4
20
50
J02AC01
ATC
fluconazole; systemic
1.4
7.3
391
3019
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
7.3
298
2189
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
6.9
7.3
17
25
H02AB02
ATC
dexamethasone; systemic
1.7
7.3
134
820
137
Kela drug reimbursment
Uraemia requiring dialysis
4.2
7.3
19
46
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.9
7.3
21
55
J15.8
ICD-10 Finland
Other bacterial pneumonia
6.3
7.2
18
29
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.9
7.2
33
116
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
2.4
7.2
46
192
207
Kela drug reimbursment
Chronic arrhythmias
1.6
7.2
199
1349
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.0
7.1
31
106
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.9
7.1
33
117
D07AA02
ATC
hydrocortisone; topical
1.6
7.1
182
1210
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
6.6
7.1
17
26
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
7.1
97
544
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
7.1
166
1081
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.8
7.1
21
56
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
4.1
7.1
19
47
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
7.0
112
658
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.0
7.0
70
353
J01MA02
ATC
ciprofloxacin; systemic
1.4
7.0
459
3665
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.8
7.0
34
124
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
7.0
393
3058
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.6
7.0
38
147
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.0
428
3380
J01CF05
ATC
flucloxacillin; systemic
1.8
6.9
97
548
Z94.0
ICD-10 Finland
Kidney transplant status
3.7
6.9
21
57
D09AB01
ATC
zinc bandage without supplements; topical
3.1
6.9
27
87
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.6
6.9
22
62
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.8
506
4116
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
8.3
6.8
14
17
48509
ICD-8 Finland
Bronchopneumonia, unspecified
3.8
6.8
20
53
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
6.8
330
2501
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
16.8
6.7
10
6
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
16.8
6.7
10
6
M46.4
ICD-10 Finland
Discitis, unspecified
7.2
6.7
15
21
N18.8
ICD-10 Finland
Other chronic renal failure
2.7
6.7
34
127
S76
ICPC
Skin infection other
2.0
6.7
72
373
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
6.6
120
731
R10.0
ICD-10 Finland
Acute abdomen
2.5
6.6
40
163
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
6.6
51
232
A10AE04
ATC
insulin glargine; parenteral
1.7
6.6
124
764
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
2.5
6.6
39
158
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.1
6.5
62
307
329
Kela drug reimbursment
Lenalidomide
6.9
6.5
15
22
K65.0
ICD-10 Finland
Acute peritonitis
4.0
6.4
18
46
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.4
371
2893
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
6.4
64
323
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
14.4
6.4
10
7
AA1AA
NOMESCO Finland
Head X-ray examination
3.8
6.4
19
51
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.8
6.4
19
51
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
6.4
118
724
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
6.4
151
987
I50
ICD-10 Finland
Heart failure
2.3
6.3
45
198
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.3
6.3
45
198
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
2.9
6.3
28
97
L04AD02
ATC
tacrolimus; systemic
3.6
6.3
20
56
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.5
6.3
21
61
GBB03
NOMESCO Finland
Percutaneous tracheostomy
+∞
6.3
6
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.0
6.2
26
87
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
26.8
6.2
8
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
26.8
6.2
8
*
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.9
6.2
28
98
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
7.1
6.2
14
20
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
6.2
880
7848
R41.0
ICD-10 Finland
Disorientation, unspecified
2.3
6.2
45
200
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.1
6.2
18
36
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
4.0
6.2
17
43
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
6.2
52
246
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.2
6.2
50
233
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.3
6.2
43
188
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
3.3
6.1
22
67
R03AC03
ATC
terbutaline; inhalant
1.6
6.1
152
1003
N05CD07
ATC
temazepam; oral
1.6
6.1
138
890
N05AB03
ATC
perphenazine; systemic, rectal
2.3
6.1
42
182
I95.9
ICD-10 Finland
Hypotension, unspecified
2.9
6.1
28
99
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.8
6.1
18
48
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.9
6.1
27
94
WX320
NOMESCO Finland
Spinalanesthesy
1.4
6.1
281
2108
7803A
ICD-9 Finland
General symptoms, Convulsions
3.6
6.0
19
53
R03BB01
ATC
ipratropium bromide; inhalant
2.1
6.0
53
255
L01AA03
ATC
melphalan; systemic
10.1
6.0
11
11
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
10.1
6.0
11
11
WX890
NOMESCO Finland
Intesive care monitoring
5.2
6.0
17
33

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Multiple myeloma
C90.0 [45600562]
2.4e+00
2.9e+00
3.5e+00
—
3.2e+00
3.2e+00
3.5e+00
cases:1.30%
controls:0.12%
cases:1.98%
controls:0.11%
cases:1.38%
controls:0.04%
—
—
cases:1.71%
controls:0.07%
cases:2.58%
controls:0.11%
cases:3.37%
controls:0.11%
15
14
1135
11426
23
13
1138
11502
16
5
1145
11510
—
19
8
1094
11485
27
12
1019
11191
28
10
803
9214
Inpatient Hospital
21 [8717]
5.4e-01
6.9e-01
2.2e+00
8.0e+00
3.2e+00
1.4e+00
8.0e-01
cases:45.22%
controls:32.54%
cases:21.96%
controls:12.38%
cases:14.04%
controls:1.82%
cases:65.55%
controls:0.06%
cases:28.84%
controls:1.68%
cases:32.22%
controls:10.95%
cases:44.65%
controls:26.56%
520
3723
630
7717
255
1425
906
10090
163
209
998
11306
761
7
400
11508
321
193
792
11300
337
1227
709
9976
371
2450
460
6774
Emergency Room Visit
ER [9203]
5.6e-01
6.6e-01
2.9e+00
7.4e+00
2.3e+00
1.2e+00
8.2e-01
cases:46.87%
controls:33.56%
cases:22.22%
controls:12.91%
cases:24.03%
controls:1.78%
cases:53.14%
controls:0.07%
cases:13.12%
controls:1.45%
cases:29.73%
controls:11.76%
cases:51.14%
controls:31.59%
539
3839
611
7601
258
1487
903
10028
279
205
882
11310
617
8
544
11507
146
167
967
11326
311
1317
735
9886
425
2914
406
6310
Bacterial pneumonia, unspecified
J15.9 [45557621]
1.3e+00
1.8e+00
4.4e+00
—
4.1e+00
2.6e+00
1.6e+00
cases:2.78%
controls:0.80%
cases:1.98%
controls:0.33%
cases:5.43%
controls:0.07%
—
—
cases:4.04%
controls:0.07%
cases:4.49%
controls:0.36%
cases:5.78%
controls:1.27%
32
92
1118
11348
23
38
1138
11477
63
8
1098
11507
—
45
8
1068
11485
47
40
999
11163
48
117
783
9107
Internal Medicine
11 [38004456]
6.2e-01
7.9e-01
2.7e+00
6.7e+00
2.6e+00
1.3e+00
8.6e-01
cases:36.26%
controls:23.44%
cases:19.21%
controls:9.72%
cases:20.59%
controls:1.63%
cases:52.97%
controls:0.14%
cases:17.34%
controls:1.47%
cases:27.06%
controls:9.19%
cases:39.23%
controls:21.38%
417
2681
733
8759
223
1119
938
10396
239
188
922
11327
615
16
546
11499
193
169
920
11324
283
1030
763
10173
326
1972
505
7252
Pneumonia, unspecified
J18.9 [45601123]
1.3e+00
1.3e+00
4.5e+00
—
4.1e+00
2.3e+00
1.4e+00
cases:11.74%
controls:3.49%
cases:5.77%
controls:1.63%
cases:14.90%
controls:0.19%
—
—
cases:14.20%
controls:0.27%
cases:15.39%
controls:1.79%
cases:17.93%
controls:5.02%
135
399
1015
11041
67
188
1094
11327
173
22
988
11493
—
158
31
955
11462
161
200
885
11003
149
463
682
8761
Infectious Disease
44 [38004484]
1.0e+00
1.4e+00
3.2e+00
—
4.3e+00
3.0e+00
1.9e+00
cases:4.70%
controls:1.70%
cases:2.33%
controls:0.61%
cases:2.07%
controls:0.09%
—
—
cases:6.65%
controls:0.10%
cases:10.33%
controls:0.59%
cases:11.07%
controls:1.75%
54
194
1096
11246
27
70
1134
11445
24
10
1137
11505
—
74
11
1039
11482
108
66
938
11137
92
161
739
9063
Outpatient Hospital
22 [8756]
4.3e-01
6.1e-01
1.9e+00
6.0e+00
2.7e+00
1.2e+00
7.1e-01
cases:34.87%
controls:25.78%
cases:14.90%
controls:8.67%
cases:7.15%
controls:1.11%
cases:26.27%
controls:0.09%
cases:13.30%
controls:1.03%
cases:21.03%
controls:7.48%
cases:33.69%
controls:19.98%
401
2949
749
8491
173
998
988
10517
83
128
1078
11387
305
10
856
11505
148
118
965
11375
220
838
826
10365
280
1843
551
7381
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.6e-01
7.3e-01
1.8e+00
4.5e+00
3.4e+00
1.2e+00
1.0e+00
cases:11.04%
controls:6.06%
cases:7.15%
controls:3.59%
cases:5.00%
controls:0.89%
cases:4.31%
controls:0.05%
cases:17.88%
controls:0.73%
cases:12.05%
controls:4.07%
cases:20.34%
controls:8.47%
127
693
1023
10747
83
413
1078
11102
58
102
1103
11413
50
6
1111
11509
199
84
914
11409
126
456
920
10747
169
781
662
8443
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.7e-01
7.5e-01
1.9e+00
5.3e+00
2.8e+00
1.1e+00
6.3e-01
cases:12.78%
controls:8.37%
cases:9.47%
controls:4.73%
cases:4.74%
controls:0.70%
cases:9.22%
controls:0.05%
cases:10.78%
controls:0.74%
cases:12.14%
controls:4.45%
cases:21.54%
controls:12.75%
147
957
1003
10483
110
545
1051
10970
55
81
1106
11434
107
6
1054
11509
120
85
993
11408
127
499
919
10704
179
1176
652
8048
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.8e-01
5.2e-01
2.3e+00
5.8e+00
2.5e+00
8.4e-01
4.5e-01
cases:15.74%
controls:11.34%
cases:10.16%
controls:6.30%
cases:7.84%
controls:0.85%
cases:15.07%
controls:0.05%
cases:9.79%
controls:0.91%
cases:12.72%
controls:5.93%
cases:26.11%
controls:18.35%
181
1297
969
10143
118
726
1043
10789
91
98
1070
11417
175
6
986
11509
109
105
1004
11388
133
664
913
10539
217
1693
614
7531
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.6e-01
6.8e-01
1.9e+00
5.4e+00
2.7e+00
9.6e-01
5.9e-01
cases:13.91%
controls:9.23%
cases:10.42%
controls:5.54%
cases:5.25%
controls:0.84%
cases:9.04%
controls:0.04%
cases:12.13%
controls:0.94%
cases:13.38%
controls:5.57%
cases:23.71%
controls:14.73%
160
1056
990
10384
121
638
1040
10877
61
97
1100
11418
105
5
1056
11510
135
108
978
11385
140
624
906
10579
197
1359
634
7865
Bacteria identified in Blood by Culture
600-7 [3023368]
8.8e-01
1.1e+00
4.1e+00
—
3.9e+00
1.7e+00
8.2e-01
cases:8.96%
controls:3.91%
cases:6.80%
controls:2.31%
cases:14.04%
controls:0.26%
—
—
cases:13.66%
controls:0.32%
cases:10.99%
controls:2.23%
cases:15.88%
controls:7.65%
103
447
1047
10993
79
266
1082
11249
163
30
998
11485
—
152
37
961
11456
115
250
931
10953
132
706
699
8518
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.1e+00
1.4e+00
2.2e+00
—
3.5e+00
2.4e+00
1.8e+00
cases:3.57%
controls:1.16%
cases:2.33%
controls:0.56%
cases:1.21%
controls:0.14%
—
—
cases:4.22%
controls:0.14%
cases:6.12%
controls:0.58%
cases:8.18%
controls:1.45%
41
133
1109
11307
27
64
1134
11451
14
16
1147
11499
—
47
16
1066
11477
64
65
982
11138
68
134
763
9090
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
7.3e-01
1.5e+00
3.5e+00
—
3.6e+00
1.8e+00
1.3e+00
cases:4.52%
controls:2.24%
cases:3.62%
controls:0.83%
cases:4.74%
controls:0.15%
—
—
cases:3.95%
controls:0.11%
cases:4.02%
controls:0.69%
cases:8.06%
controls:2.43%
52
256
1098
11184
42
96
1119
11419
55
17
1106
11498
—
44
13
1069
11480
42
77
1004
11126
67
224
764
9000
General Practice
1 [38004446]
5.6e-01
6.8e-01
1.6e+00
4.8e+00
3.0e+00
1.0e+00
6.5e-01
cases:22.35%
controls:14.17%
cases:11.46%
controls:6.13%
cases:5.17%
controls:1.09%
cases:7.84%
controls:0.07%
cases:16.08%
controls:0.92%
cases:16.73%
controls:6.59%
cases:29.72%
controls:18.10%
257
1621
893
9819
133
706
1028
10809
60
125
1101
11390
91
8
1070
11507
179
106
934
11387
175
738
871
10465
247
1670
584
7554
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
1.1e+00
2.1e+00
2.8e+00
—
2.6e+00
2.2e+00
1.5e+00
cases:1.48%
controls:0.48%
cases:1.72%
controls:0.22%
cases:0.69%
controls:0.04%
—
—
cases:1.08%
controls:0.08%
cases:2.49%
controls:0.29%
cases:3.61%
controls:0.79%
17
55
1133
11385
20
25
1141
11490
8
5
1153
11510
—
12
9
1101
11484
26
32
1020
11171
30
73
801
9151
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
1.1e+00
2.1e+00
2.8e+00
—
2.6e+00
2.2e+00
1.5e+00
cases:1.48%
controls:0.48%
cases:1.72%
controls:0.22%
cases:0.69%
controls:0.04%
—
—
cases:1.08%
controls:0.08%
cases:2.49%
controls:0.29%
cases:3.49%
controls:0.79%
17
55
1133
11385
20
25
1141
11490
8
5
1153
11510
—
12
9
1101
11484
26
32
1020
11171
29
73
802
9151
Emergency Medicine
93 [38004510]
3.6e-01
4.1e-01
2.4e+00
6.4e+00
1.7e+00
6.9e-01
3.3e-01
cases:17.04%
controls:12.48%
cases:10.94%
controls:7.50%
cases:10.85%
controls:1.04%
cases:20.16%
controls:0.04%
cases:4.94%
controls:0.95%
cases:13.67%
controls:7.36%
cases:27.32%
controls:21.29%
196
1428
954
10012
127
864
1034
10651
126
120
1035
11395
234
5
927
11510
55
109
1058
11384
143
824
903
10379
227
1964
604
7260
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.2e+00
1.3e+00
2.8e+00
1.0e+50
4.4e+00
1.6e+00
8.6e-01
cases:2.87%
controls:0.86%
cases:1.64%
controls:0.43%
cases:1.12%
controls:0.07%
cases:0.43%
controls:0.00%
cases:3.50%
controls:0.04%
cases:2.29%
controls:0.46%
cases:3.49%
controls:1.51%
33
98
1117
11342
19
50
1142
11465
13
8
1148
11507
5
0
1156
11515
39
5
1074
11488
24
51
1022
11152
29
139
802
9085
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
9.5e-01
1.5e+00
3.8e+00
—
3.5e+00
1.6e+00
8.9e-01
cases:4.26%
controls:1.70%
cases:4.65%
controls:1.09%
cases:7.41%
controls:0.18%
—
—
cases:4.31%
controls:0.13%
cases:6.12%
controls:1.28%
cases:9.03%
controls:3.91%
49
194
1101
11246
54
126
1107
11389
86
21
1075
11494
—
48
15
1065
11478
64
143
982
11060
75
361
756
8863
Monocytes/Leukocytes in Blood
26485-3 [3019069]
5.6e-01
6.8e-01
1.6e+00
4.2e+00
3.3e+00
1.1e+00
8.2e-01
cases:14.52%
controls:8.88%
cases:9.82%
controls:5.25%
cases:6.03%
controls:1.26%
cases:4.57%
controls:0.07%
cases:21.11%
controls:1.01%
cases:15.97%
controls:6.00%
cases:25.39%
controls:13.06%
167
1016
983
10424
114
604
1047
10911
70
145
1091
11370
53
8
1108
11507
235
116
878
11377
167
672
879
10531
211
1205
620
8019
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
1.0e+00
2.1e+00
2.8e+00
—
2.7e+00
2.2e+00
1.5e+00
cases:1.30%
controls:0.46%
cases:1.55%
controls:0.20%
cases:0.69%
controls:0.04%
—
—
cases:0.99%
controls:0.07%
cases:2.29%
controls:0.27%
cases:3.25%
controls:0.74%
15
53
1135
11387
18
23
1143
11492
8
5
1153
11510
—
11
8
1102
11485
24
30
1022
11173
27
68
804
9156
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
5.7e-01
6.5e-01
1.6e+00
4.3e+00
3.2e+00
1.1e+00
8.1e-01
cases:14.61%
controls:8.85%
cases:9.56%
controls:5.24%
cases:5.77%
controls:1.26%
cases:4.13%
controls:0.06%
cases:20.75%
controls:1.01%
cases:15.87%
controls:6.00%
cases:25.27%
controls:13.09%
168
1012
982
10428
111
603
1050
10912
67
145
1094
11370
48
7
1113
11508
231
116
882
11377
166
672
880
10531
210
1207
621
8017
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
9.4e-01
1.7e+00
3.4e+00
—
3.6e+00
1.7e+00
8.2e-01
cases:2.96%
controls:1.18%
cases:3.62%
controls:0.69%
cases:4.91%
controls:0.17%
—
—
cases:3.23%
controls:0.10%
cases:4.59%
controls:0.90%
cases:6.38%
controls:2.91%
34
135
1116
11305
42
79
1119
11436
57
19
1104
11496
—
36
11
1077
11482
48
101
998
11102
53
268
778
8956
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
9.9e-01
1.7e+00
3.5e+00
—
3.5e+00
1.7e+00
7.5e-01
cases:2.96%
controls:1.12%
cases:3.79%
controls:0.75%
cases:5.17%
controls:0.17%
—
—
cases:3.32%
controls:0.10%
cases:4.78%
controls:0.92%
cases:6.02%
controls:2.94%
34
128
1116
11312
44
86
1117
11429
60
19
1101
11496
—
37
12
1076
11481
50
103
996
11100
50
271
781
8953
Basophils/Leukocytes in Blood
30180-4 [3022096]
5.7e-01
6.6e-01
1.6e+00
4.1e+00
3.2e+00
1.1e+00
8.0e-01
cases:14.52%
controls:8.79%
cases:9.56%
controls:5.20%
cases:5.68%
controls:1.24%
cases:4.13%
controls:0.07%
cases:20.49%
controls:0.99%
cases:15.77%
controls:6.02%
cases:25.15%
controls:13.06%
167
1006
983
10434
111
599
1050
10916
66
143
1095
11372
48
8
1113
11507
228
114
885
11379
165
674
881
10529
209
1205
622
8019
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.1e-01
6.4e-01
1.6e+00
4.2e+00
3.2e+00
1.0e+00
7.9e-01
cases:14.35%
controls:9.16%
cases:9.65%
controls:5.32%
cases:6.03%
controls:1.28%
cases:4.74%
controls:0.08%
cases:20.84%
controls:1.04%
cases:15.97%
controls:6.24%
cases:25.75%
controls:13.62%
165
1048
985
10392
112
613
1049
10902
70
147
1091
11368
55
9
1106
11506
232
119
881
11374
167
699
879
10504
214
1256
617
7968
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.4e-01
2.5e-01
1.8e+00
5.2e+00
3.0e+00
9.0e-01
4.5e-01
cases:30.87%
controls:25.98%
cases:22.05%
controls:18.00%
cases:19.38%
controls:3.76%
cases:37.98%
controls:0.32%
cases:43.22%
controls:3.61%
cases:36.42%
controls:18.88%
cases:50.42%
controls:39.45%
355
2972
795
8468
256
2073
905
9442
225
433
936
11082
441
37
720
11478
481
415
632
11078
381
2115
665
9088
419
3639
412
5585
Eosinophils [#/volume] in Blood
26449-9 [3013115]
5.3e-01
6.3e-01
1.5e+00
4.3e+00
3.1e+00
1.1e+00
7.6e-01
cases:15.74%
controls:9.92%
cases:10.34%
controls:5.77%
cases:5.77%
controls:1.42%
cases:4.22%
controls:0.06%
cases:21.02%
controls:1.16%
cases:17.02%
controls:6.51%
cases:26.47%
controls:14.38%
181
1135
969
10305
120
664
1041
10851
67
163
1094
11352
49
7
1112
11508
234
133
879
11360
178
729
868
10474
220
1326
611
7898
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.4e-01
6.3e-01
1.6e+00
4.1e+00
3.2e+00
1.0e+00
7.7e-01
cases:14.52%
controls:8.98%
cases:9.39%
controls:5.25%
cases:5.77%
controls:1.23%
cases:4.31%
controls:0.08%
cases:19.77%
controls:0.99%
cases:15.39%
controls:6.03%
cases:24.79%
controls:13.27%
167
1027
983
10413
109
604
1052
10911
67
142
1094
11373
50
9
1111
11506
220
114
893
11379
161
676
885
10527
206
1224
625
8000
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.6e-01
6.6e-01
1.4e+00
4.6e+00
2.9e+00
1.0e+00
7.1e-01
cases:16.96%
controls:11.38%
cases:12.92%
controls:7.13%
cases:7.58%
controls:1.91%
cases:8.35%
controls:0.10%
cases:22.46%
controls:1.58%
cases:18.83%
controls:7.75%
cases:27.92%
controls:16.01%
195
1302
955
10138
150
821
1011
10694
88
220
1073
11295
97
11
1064
11504
250
182
863
11311
197
868
849
10335
232
1477
599
7747
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.2e-01
5.5e-01
1.4e+00
5.3e+00
2.7e+00
9.2e-01
5.6e-01
cases:22.43%
controls:17.42%
cases:17.74%
controls:11.03%
cases:8.44%
controls:2.19%
cases:9.30%
controls:0.05%
cases:23.27%
controls:2.08%
cases:24.47%
controls:11.41%
cases:37.67%
controls:25.73%
258
1993
892
9447
206
1270
955
10245
98
252
1063
11263
108
6
1053
11509
259
239
854
11254
256
1278
790
9925
313
2373
518
6851
pH of Arterial blood
2744-1 [3019977]
9.4e-01
1.4e+00
3.0e+00
—
3.9e+00
1.6e+00
7.8e-01
cases:3.83%
controls:1.53%
cases:3.10%
controls:0.80%
cases:2.76%
controls:0.14%
—
—
cases:5.39%
controls:0.11%
cases:3.25%
controls:0.70%
cases:6.86%
controls:3.25%
44
175
1106
11265
36
92
1125
11423
32
16
1129
11499
—
60
13
1053
11480
34
78
1012
11125
57
300
774
8924
Monocytes [#/volume] in Blood
26484-6 [3001604]
5.5e-01
6.3e-01
1.5e+00
4.0e+00
3.1e+00
1.1e+00
7.6e-01
cases:15.04%
controls:9.27%
cases:9.82%
controls:5.46%
cases:5.60%
controls:1.35%
cases:3.27%
controls:0.06%
cases:18.96%
controls:1.08%
cases:16.54%
controls:6.30%
cases:25.51%
controls:13.80%
173
1060
977
10380
114
629
1047
10886
65
155
1096
11360
38
7
1123
11508
211
124
902
11369
173
706
873
10497
212
1273
619
7951
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
9.0e-01
1.6e+00
2.4e+00
—
3.5e+00
1.9e+00
1.3e+00
cases:3.22%
controls:1.34%
cases:2.24%
controls:0.46%
cases:1.03%
controls:0.10%
—
—
cases:3.77%
controls:0.12%
cases:4.02%
controls:0.62%
cases:6.38%
controls:1.86%
37
153
1113
11287
26
53
1135
11462
12
11
1149
11504
—
42
14
1071
11479
42
69
1004
11134
53
172
778
9052
Basophils [#/volume] in Blood
26444-0 [3006315]
5.5e-01
6.4e-01
1.5e+00
4.0e+00
3.1e+00
1.1e+00
7.5e-01
cases:15.13%
controls:9.34%
cases:9.91%
controls:5.46%
cases:5.60%
controls:1.34%
cases:3.19%
controls:0.06%
cases:18.78%
controls:1.07%
cases:16.44%
controls:6.31%
cases:25.51%
controls:13.95%
174
1068
976
10372
115
629
1046
10886
65
154
1096
11361
37
7
1124
11508
209
123
904
11370
172
707
874
10496
212
1287
619
7937
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
5.2e-01
6.2e-01
1.5e+00
4.1e+00
3.0e+00
1.1e+00
7.3e-01
cases:15.39%
controls:9.79%
cases:10.16%
controls:5.72%
cases:5.77%
controls:1.38%
cases:3.88%
controls:0.07%
cases:19.05%
controls:1.12%
cases:17.21%
controls:6.58%
cases:26.23%
controls:14.64%
177
1120
973
10320
118
659
1043
10856
67
159
1094
11356
45
8
1116
11507
212
129
901
11364
180
737
866
10466
218
1350
613
7874
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
1.1e+00
1.2e+00
2.0e+00
—
3.1e+00
2.4e+00
1.7e+00
cases:2.52%
controls:0.87%
cases:1.38%
controls:0.41%
cases:0.69%
controls:0.10%
—
—
cases:2.52%
controls:0.11%
cases:4.02%
controls:0.37%
cases:5.78%
controls:1.13%
29
100
1121
11340
16
47
1145
11468
8
11
1153
11504
—
28
13
1085
11480
42
42
1004
11161
48
104
783
9120
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
1.9e+00
2.1e+00
2.6e+00
1.0e+50
2.4e+00
2.4e+00
1.5e+00
cases:1.22%
controls:0.18%
cases:1.29%
controls:0.16%
cases:0.78%
controls:0.06%
cases:0.78%
controls:0.00%
cases:0.99%
controls:0.09%
cases:1.53%
controls:0.13%
cases:0.96%
controls:0.22%
14
21
1136
11419
15
18
1146
11497
9
7
1152
11508
9
0
1152
11515
11
10
1102
11483
16
15
1030
11188
8
20
823
9204
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
9.6e-01
1.4e+00
3.0e+00
—
3.8e+00
1.6e+00
8.0e-01
cases:3.83%
controls:1.50%
cases:3.01%
controls:0.78%
cases:2.93%
controls:0.16%
—
—
cases:5.21%
controls:0.12%
cases:3.25%
controls:0.71%
cases:6.86%
controls:3.20%
44
172
1106
11268
35
90
1126
11425
34
18
1127
11497
—
58
14
1055
11479
34
79
1012
11124
57
295
774
8929
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
9.6e-01
1.4e+00
3.0e+00
—
3.8e+00
1.6e+00
8.0e-01
cases:3.83%
controls:1.50%
cases:3.01%
controls:0.79%
cases:2.93%
controls:0.16%
—
—
cases:5.21%
controls:0.12%
cases:3.25%
controls:0.71%
cases:6.86%
controls:3.20%
44
172
1106
11268
35
91
1126
11424
34
18
1127
11497
—
58
14
1055
11479
34
79
1012
11124
57
295
774
8929
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
3.9e-01
3.6e-01
2.3e+00
5.5e+00
2.5e+00
7.5e-01
1.5e-01
cases:10.70%
controls:7.53%
cases:5.34%
controls:3.78%
cases:4.57%
controls:0.47%
cases:9.56%
controls:0.04%
cases:5.84%
controls:0.53%
cases:8.13%
controls:4.01%
cases:13.60%
controls:11.97%
123
861
1027
10579
62
435
1099
11080
53
54
1108
11461
111
5
1050
11510
65
61
1048
11432
85
449
961
10754
113
1104
718
8120
Bacterial infection, unspecified
A49.9 [45590816]
1.2e+00
1.2e+00
3.7e+00
—
2.5e+00
1.8e+00
1.0e+00
cases:3.65%
controls:1.12%
cases:1.38%
controls:0.43%
cases:2.67%
controls:0.07%
—
—
cases:1.17%
controls:0.10%
cases:3.15%
controls:0.54%
cases:4.69%
controls:1.72%
42
128
1108
11312
16
49
1145
11466
31
8
1130
11507
—
13
11
1100
11482
33
61
1013
11142
39
159
792
9065
Bacteria identified in Isolate by Culture
43409-2 [3042936]
8.5e-01
9.1e-01
2.6e+00
1.0e+50
4.2e+00
1.5e+00
1.3e+00
cases:4.70%
controls:2.07%
cases:1.81%
controls:0.74%
cases:1.29%
controls:0.10%
cases:0.78%
controls:0.00%
cases:6.65%
controls:0.10%
cases:3.92%
controls:0.91%
cases:9.75%
controls:2.83%
54
237
1096
11203
21
85
1140
11430
15
11
1146
11504
9
0
1152
11515
74
12
1039
11481
41
102
1005
11101
81
261
750
8963
Oxygen saturation in Arterial blood
2708-6 [3016502]
8.1e-01
1.3e+00
3.0e+00
1.0e+50
3.9e+00
1.6e+00
7.4e-01
cases:2.87%
controls:1.29%
cases:2.50%
controls:0.69%
cases:2.41%
controls:0.12%
cases:6.63%
controls:0.00%
cases:4.58%
controls:0.10%
cases:2.68%
controls:0.57%
cases:6.02%
controls:2.97%
33
148
1117
11292
29
80
1132
11435
28
14
1133
11501
77
0
1084
11515
51
11
1062
11482
28
64
1018
11139
50
274
781
8950
Thorax X-ray examination
GD1AA [2001303617]
6.2e-01
1.1e+00
3.1e+00
1.0e+50
3.3e+00
2.0e+00
1.1e+00
cases:16.09%
controls:9.36%
cases:10.16%
controls:3.69%
cases:9.22%
controls:0.46%
cases:24.46%
controls:0.00%
cases:10.33%
controls:0.44%
cases:19.12%
controls:3.03%
cases:26.11%
controls:10.23%
185
1071
965
10369
118
425
1043
11090
107
53
1054
11462
284
0
877
11515
115
51
998
11442
200
340
846
10863
217
944
614
8280
Base excess in Arterial blood by calculation
1925-7 [3003396]
9.3e-01
1.3e+00
2.8e+00
—
3.8e+00
1.5e+00
8.1e-01
cases:3.74%
controls:1.50%
cases:2.84%
controls:0.79%
cases:2.58%
controls:0.16%
—
—
cases:5.12%
controls:0.12%
cases:3.06%
controls:0.70%
cases:6.98%
controls:3.24%
43
172
1107
11268
33
91
1128
11424
30
18
1131
11497
—
57
14
1056
11479
32
78
1014
11125
58
299
773
8925
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
7.2e-01
1.2e+00
3.1e+00
1.0e+50
4.0e+00
1.5e+00
6.4e-01
cases:2.43%
controls:1.20%
cases:1.98%
controls:0.61%
cases:1.98%
controls:0.10%
cases:6.37%
controls:0.00%
cases:4.04%
controls:0.08%
cases:2.29%
controls:0.50%
cases:5.05%
controls:2.73%
28
137
1122
11303
23
70
1138
11445
23
11
1138
11504
74
0
1087
11515
45
9
1068
11484
24
56
1022
11147
42
252
789
8972
Atrial fibrillation and flutter
I48 [45596206]
5.8e-01
4.5e-01
1.4e+00
5.1e+00
2.0e+00
1.0e+00
5.6e-01
cases:12.00%
controls:7.11%
cases:6.46%
controls:4.21%
cases:3.01%
controls:0.77%
cases:6.46%
controls:0.04%
cases:5.30%
controls:0.72%
cases:10.23%
controls:3.85%
cases:13.48%
controls:8.15%
138
813
1012
10627
75
485
1086
11030
35
89
1126
11426
75
5
1086
11510
59
83
1054
11410
107
431
939
10772
112
752
719
8472
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.1e+00
1.7e+00
2.2e+00
—
2.6e+00
2.0e+00
1.5e+00
cases:3.04%
controls:1.03%
cases:2.07%
controls:0.38%
cases:0.69%
controls:0.08%
—
—
cases:1.53%
controls:0.11%
cases:3.54%
controls:0.47%
cases:6.38%
controls:1.54%
35
118
1115
11322
24
44
1137
11471
8
9
1153
11506
—
17
13
1096
11480
37
53
1009
11150
53
142
778
9082
Chronic obstructive pulmonary disease with acute lower respiratory infection
J44.0 [45601131]
1.9e+00
2.0e+00
1.0e+50
1.0e+50
3.2e+00
2.2e+00
1.7e+00
cases:2.52%
controls:0.38%
cases:2.15%
controls:0.30%
cases:0.86%
controls:0.00%
cases:2.58%
controls:0.00%
cases:1.08%
controls:0.04%
cases:2.87%
controls:0.32%
cases:5.54%
controls:1.01%
29
44
1121
11396
25
34
1136
11481
10
0
1151
11515
30
0
1131
11515
12
5
1101
11488
30
36
1016
11167
46
93
785
9131
Fever, unspecified
R50.9 [45582716]
7.7e-01
1.4e+00
3.3e+00
1.0e+50
2.6e+00
1.9e+00
9.9e-01
cases:3.30%
controls:1.56%
cases:2.15%
controls:0.56%
cases:2.76%
controls:0.10%
cases:3.88%
controls:0.00%
cases:1.44%
controls:0.10%
cases:4.21%
controls:0.62%
cases:5.54%
controls:2.12%
38
178
1112
11262
25
64
1136
11451
32
12
1129
11503
45
0
1116
11515
16
12
1097
11481
44
70
1002
11133
46
196
785
9028
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.7e-01
4.1e-01
2.0e+00
5.4e+00
2.0e+00
8.5e-01
3.3e-01
cases:17.83%
controls:14.27%
cases:11.02%
controls:7.61%
cases:8.35%
controls:1.22%
cases:14.73%
controls:0.08%
cases:8.36%
controls:1.28%
cases:16.63%
controls:7.89%
cases:26.96%
controls:20.95%
205
1632
945
9808
128
876
1033
10639
97
141
1064
11374
171
9
990
11506
93
147
1020
11346
174
884
872
10319
224
1932
607
7292
Hematology
82 [38004501]
1.4e+00
1.5e+00
2.2e+00
—
2.2e+00
1.9e+00
1.6e+00
cases:4.26%
controls:1.13%
cases:3.88%
controls:0.87%
cases:2.41%
controls:0.27%
—
—
cases:2.43%
controls:0.27%
cases:5.35%
controls:0.80%
cases:7.46%
controls:1.57%
49
129
1101
11311
45
100
1116
11415
28
31
1133
11484
—
27
31
1086
11462
56
90
990
11113
62
145
769
9079
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
8.3e-01
9.4e-01
2.5e+00
1.0e+50
4.0e+00
1.6e+00
9.2e-01
cases:5.30%
controls:2.39%
cases:2.93%
controls:1.16%
cases:1.21%
controls:0.10%
cases:0.43%
controls:0.00%
cases:8.00%
controls:0.17%
cases:4.21%
controls:0.85%
cases:7.46%
controls:3.11%
61
273
1089
11167
34
134
1127
11381
14
11
1147
11504
5
0
1156
11515
89
19
1024
11474
44
95
1002
11108
62
287
769
8937
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
5.4e-01
1.0e+00
3.0e+00
—
4.3e+00
1.5e+00
9.3e-01
cases:1.74%
controls:1.02%
cases:1.98%
controls:0.72%
cases:1.03%
controls:0.05%
—
—
cases:5.66%
controls:0.08%
cases:2.29%
controls:0.52%
cases:4.09%
controls:1.65%
20
117
1130
11323
23
83
1138
11432
12
6
1149
11509
—
63
9
1050
11484
24
58
1022
11145
34
152
797
9072
pH of Capillary blood
2745-8 [3009343]
5.4e-01
9.9e-01
3.0e+00
—
4.3e+00
1.5e+00
9.5e-01
cases:1.74%
controls:1.02%
cases:1.89%
controls:0.71%
cases:1.03%
controls:0.05%
—
—
cases:5.30%
controls:0.08%
cases:2.29%
controls:0.50%
cases:4.09%
controls:1.62%
20
117
1130
11323
22
82
1139
11433
12
6
1149
11509
—
59
9
1054
11484
24
56
1022
11147
34
149
797
9075
Chronic viral hepatitis C
B18.2 [45590846]
2.3e+00
2.8e+00
1.0e+50
1.0e+50
1.0e+50
2.6e+00
3.0e+00
cases:0.78%
controls:0.08%
cases:0.86%
controls:0.05%
cases:0.43%
controls:0.00%
cases:0.78%
controls:0.00%
cases:0.45%
controls:0.00%
cases:0.86%
controls:0.06%
cases:1.93%
controls:0.10%
9
9
1141
11431
10
6
1151
11509
5
0
1156
11515
9
0
1152
11515
5
0
1108
11493
9
7
1037
11196
16
9
815
9215
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
1.4e+00
1.9e+00
3.1e+00
1.0e+50
3.1e+00
1.2e+00
4.5e-01
cases:1.48%
controls:0.37%
cases:1.72%
controls:0.26%
cases:1.64%
controls:0.08%
cases:4.82%
controls:0.00%
cases:0.99%
controls:0.04%
cases:1.34%
controls:0.39%
cases:2.29%
controls:1.47%
17
42
1133
11398
20
30
1141
11485
19
9
1142
11506
56
0
1105
11515
11
5
1102
11488
14
44
1032
11159
19
136
812
9088
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.3e-01
4.1e-01
1.3e+00
4.4e+00
2.8e+00
7.5e-01
5.1e-01
cases:11.91%
controls:8.10%
cases:9.13%
controls:6.24%
cases:5.86%
controls:1.64%
cases:8.53%
controls:0.11%
cases:18.96%
controls:1.37%
cases:13.38%
controls:6.77%
cases:19.49%
controls:12.71%
137
927
1013
10513
106
718
1055
10797
68
189
1093
11326
99
13
1062
11502
211
158
902
11335
140
759
906
10444
162
1172
669
8052
Pulmonary Disease
29 [38004472]
8.1e-01
1.2e+00
2.3e+00
—
3.1e+00
2.1e+00
1.2e+00
cases:18.17%
controls:9.01%
cases:12.66%
controls:4.27%
cases:7.75%
controls:0.84%
—
—
cases:18.33%
controls:1.00%
cases:27.53%
controls:4.46%
cases:25.75%
controls:9.76%
209
1031
941
10409
147
492
1014
11023
90
97
1071
11418
—
204
115
909
11378
288
500
758
10703
214
900
617
8324
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
8.3e-01
1.1e+00
2.8e+00
1.0e+50
4.1e+00
1.7e+00
6.3e-01
cases:2.09%
controls:0.92%
cases:1.55%
controls:0.53%
cases:1.29%
controls:0.08%
cases:3.96%
controls:0.00%
cases:2.96%
controls:0.05%
cases:2.29%
controls:0.41%
cases:3.73%
controls:2.02%
24
105
1126
11335
18
61
1143
11454
15
9
1146
11506
46
0
1115
11515
33
6
1080
11487
24
46
1022
11157
31
186
800
9038
Chronic respiratory failure
J96.1 [45557632]
2.1e+00
2.0e+00
—
—
2.3e+00
2.0e+00
2.0e+00
cases:0.96%
controls:0.12%
cases:1.03%
controls:0.14%
—
—
—
—
cases:0.54%
controls:0.05%
cases:1.24%
controls:0.17%
cases:2.29%
controls:0.30%
11
14
1139
11426
12
16
1149
11499
—
—
6
6
1107
11487
13
19
1033
11184
19
28
812
9196
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
1.4e+00
1.4e+00
2.2e+00
1.0e+50
2.1e+00
1.9e+00
1.4e+00
cases:7.57%
controls:2.05%
cases:4.74%
controls:1.16%
cases:2.07%
controls:0.23%
cases:3.36%
controls:0.00%
cases:2.70%
controls:0.33%
cases:7.55%
controls:1.27%
cases:10.95%
controls:2.86%
87
234
1063
11206
55
134
1106
11381
24
27
1137
11488
39
0
1122
11515
30
38
1083
11455
79
142
967
11061
91
264
740
8960
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
9.8e-01
8.9e-01
2.8e+00
—
3.8e+00
1.5e+00
1.4e+00
cases:1.39%
controls:0.52%
cases:0.86%
controls:0.36%
cases:0.69%
controls:0.04%
—
—
cases:1.89%
controls:0.04%
cases:1.15%
controls:0.27%
cases:4.33%
controls:1.14%
16
60
1134
11380
10
41
1151
11474
8
5
1153
11510
—
21
5
1092
11488
12
30
1034
11173
36
105
795
9119
Short blood count panel - Blood
55429-5 [40758558]
4.7e-01
3.9e-01
1.4e+00
4.1e+00
2.9e+00
8.4e-01
6.7e-01
cases:7.48%
controls:4.80%
cases:4.13%
controls:2.84%
cases:2.67%
controls:0.70%
cases:4.13%
controls:0.07%
cases:9.61%
controls:0.57%
cases:6.98%
controls:3.14%
cases:12.27%
controls:6.69%
86
549
1064
10891
48
327
1113
11188
31
81
1130
11434
48
8
1113
11507
107
66
1006
11427
73
352
973
10851
102
617
729
8607
INR in Blood by Coagulation assay
34714-6 [3032080]
4.3e-01
5.0e-01
1.2e+00
4.8e+00
1.8e+00
9.1e-01
6.0e-01
cases:14.61%
controls:10.05%
cases:10.25%
controls:6.50%
cases:6.80%
controls:2.24%
cases:10.34%
controls:0.10%
cases:12.31%
controls:2.33%
cases:14.44%
controls:6.36%
cases:24.19%
controls:14.94%
168
1150
982
10290
119
748
1042
10767
79
258
1082
11257
120
11
1041
11504
137
268
976
11225
151
712
895
10491
201
1378
630
7846
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
1.0e+00
1.6e+00
2.8e+00
—
3.7e+00
9.4e-01
9.0e-01
cases:1.57%
controls:0.56%
cases:1.46%
controls:0.30%
cases:1.55%
controls:0.10%
—
—
cases:2.43%
controls:0.06%
cases:0.86%
controls:0.34%
cases:3.25%
controls:1.34%
18
64
1132
11376
17
35
1144
11480
18
11
1143
11504
—
27
7
1086
11486
9
38
1037
11165
27
124
804
9100
Supplier / Service Provider
OMOP5117446 [33004]
-3.7e-01
1.5e-02
2.9e-01
—
3.9e+00
3.2e+00
3.3e+00
cases:17.74%
controls:23.77%
cases:7.84%
controls:7.73%
cases:0.95%
controls:0.71%
—
—
cases:2.43%
controls:0.05%
cases:8.13%
controls:0.37%
cases:23.23%
controls:1.09%
204
2719
946
8721
91
890
1070
10625
11
82
1150
11433
—
27
6
1086
11487
85
41
961
11162
193
101
638
9123
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.3e-01
2.4e-01
1.6e+00
5.0e+00
2.6e+00
4.9e-01
2.2e-01
cases:32.78%
controls:30.06%
cases:29.54%
controls:24.78%
cases:19.55%
controls:4.87%
cases:36.69%
controls:0.39%
cases:41.24%
controls:4.79%
cases:35.95%
controls:25.65%
cases:51.62%
controls:46.03%
377
3439
773
8001
343
2853
818
8662
227
561
934
10954
426
45
735
11470
459
550
654
10943
376
2874
670
8329
429
4246
402
4978
Monoclonal gammopathy of undetermined significance (MGUS)
D47.2 [45566693]
2.4e+00
2.2e+00
—
—
—
2.7e+00
2.7e+00
cases:0.87%
controls:0.08%
cases:0.60%
controls:0.07%
—
—
—
—
—
—
cases:0.76%
controls:0.05%
cases:1.68%
controls:0.12%
10
9
1140
11431
7
8
1154
11507
—
—
—
8
6
1038
11197
14
11
817
9213
erdosteine; oral
R05CB15 [21603394]
9.3e-01
1.3e+00
1.8e+00
—
3.2e+00
1.5e+00
1.2e+00
cases:5.39%
controls:2.20%
cases:3.62%
controls:1.02%
cases:0.95%
controls:0.16%
—
—
cases:4.04%
controls:0.17%
cases:4.97%
controls:1.15%
cases:11.19%
controls:3.75%
62
252
1088
11188
42
118
1119
11397
11
18
1150
11497
—
45
20
1068
11473
52
129
994
11074
93
346
738
8878
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.2e-01
2.3e-01
1.6e+00
5.0e+00
2.6e+00
4.8e-01
2.1e-01
cases:32.78%
controls:30.21%
cases:29.72%
controls:25.12%
cases:19.64%
controls:4.88%
cases:36.09%
controls:0.39%
cases:41.24%
controls:4.86%
cases:36.14%
controls:26.01%
cases:51.74%
controls:46.39%
377
3456
773
7984
345
2892
816
8623
228
562
933
10953
419
45
742
11470
459
558
654
10935
378
2914
668
8289
430
4279
401
4945
Supine thorax X-ray examination
GD1QA [2001303648]
7.4e-01
9.8e-01
3.2e+00
—
2.9e+00
1.4e+00
6.2e-01
cases:5.13%
controls:2.52%
cases:2.93%
controls:1.12%
cases:3.19%
controls:0.14%
—
—
cases:2.25%
controls:0.12%
cases:4.97%
controls:1.26%
cases:7.22%
controls:4.00%
59
288
1091
11152
34
129
1127
11386
37
16
1124
11499
—
25
14
1088
11479
52
141
994
11062
60
369
771
8855
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.1e+00
1.2e+00
—
—
4.4e+00
2.0e+00
1.1e+00
cases:6.96%
controls:2.45%
cases:3.01%
controls:0.90%
—
—
—
—
cases:9.88%
controls:0.13%
cases:5.83%
controls:0.80%
cases:7.94%
controls:2.92%
80
280
1070
11160
35
104
1126
11411
—
—
110
15
1003
11478
61
90
985
11113
66
269
765
8955
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.0e-01
2.6e-01
1.5e+00
4.8e+00
2.4e+00
5.7e-01
2.8e-01
cases:24.35%
controls:20.80%
cases:22.22%
controls:18.08%
cases:15.50%
controls:3.99%
cases:27.30%
controls:0.30%
cases:30.64%
controls:4.04%
cases:29.35%
controls:18.97%
cases:39.71%
controls:33.33%
280
2380
870
9060
258
2082
903
9433
180
460
981
11055
317
34
844
11481
341
464
772
11029
307
2125
739
9078
330
3074
501
6150
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.1e+00
1.3e+00
2.2e+00
—
2.8e+00
1.3e+00
1.1e+00
cases:3.48%
controls:1.19%
cases:2.07%
controls:0.60%
cases:1.03%
controls:0.11%
—
—
cases:1.44%
controls:0.09%
cases:2.01%
controls:0.54%
cases:6.14%
controls:2.22%
40
136
1110
11304
24
69
1137
11446
12
13
1149
11502
—
16
10
1097
11483
21
60
1025
11143
51
205
780
9019
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
9.9e-01
1.3e+00
3.0e+00
—
3.4e+00
1.1e+00
4.7e-01
cases:2.87%
controls:1.08%
cases:1.89%
controls:0.52%
cases:1.98%
controls:0.10%
—
—
cases:2.79%
controls:0.10%
cases:1.72%
controls:0.57%
cases:3.61%
controls:2.28%
33
124
1117
11316
22
60
1139
11455
23
12
1138
11503
—
31
11
1082
11482
18
64
1028
11139
30
210
801
9014
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
7.1e-01
1.1e+00
2.1e+00
1.0e+50
3.8e+00
1.2e+00
8.6e-01
cases:5.22%
controls:2.64%
cases:3.62%
controls:1.28%
cases:1.81%
controls:0.22%
cases:1.03%
controls:0.00%
cases:6.56%
controls:0.16%
cases:3.63%
controls:1.16%
cases:8.78%
controls:3.92%
60
302
1090
11138
42
147
1119
11368
21
25
1140
11490
12
0
1149
11515
73
18
1040
11475
38
130
1008
11073
73
362
758
8862
Asthma, unspecified
J45.9 [45562456]
1.2e+00
1.4e+00
2.3e+00
—
2.3e+00
1.5e+00
1.1e+00
cases:9.74%
controls:3.27%
cases:5.51%
controls:1.47%
cases:2.15%
controls:0.23%
—
—
cases:3.50%
controls:0.36%
cases:6.60%
controls:1.51%
cases:10.47%
controls:3.90%
112
374
1038
11066
64
169
1097
11346
25
26
1136
11489
—
39
41
1074
11452
69
169
977
11034
87
360
744
8864
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
8.5e-01
9.4e-01
2.2e+00
1.0e+50
3.3e+00
1.3e+00
1.1e+00
cases:3.91%
controls:1.71%
cases:2.84%
controls:1.13%
cases:1.98%
controls:0.23%
cases:0.86%
controls:0.00%
cases:5.03%
controls:0.20%
cases:3.92%
controls:1.05%
cases:8.06%
controls:2.91%
45
196
1105
11244
33
130
1128
11385
23
27
1138
11488
10
0
1151
11515
56
23
1057
11470
41
118
1005
11085
67
268
764
8956
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
1.8e-01
2.8e-01
1.7e+00
5.1e+00
1.8e+00
7.4e-01
3.0e-01
cases:17.65%
controls:15.16%
cases:10.68%
controls:8.28%
cases:6.55%
controls:1.28%
cases:8.96%
controls:0.06%
cases:7.55%
controls:1.31%
cases:16.06%
controls:8.36%
cases:28.16%
controls:22.53%
203
1734
947
9706
124
954
1037
10561
76
147
1085
11368
104
7
1057
11508
84
151
1029
11342
168
937
878
10266
234
2078
597
7146
Essential (primary) hypertension
I10 [45591453]
2.8e-01
2.8e-01
1.3e+00
5.7e+00
1.6e+00
6.9e-01
2.6e-01
cases:24.17%
controls:19.43%
cases:13.18%
controls:10.26%
cases:5.43%
controls:1.48%
cases:13.61%
controls:0.05%
cases:8.18%
controls:1.80%
cases:18.16%
controls:10.02%
cases:30.08%
controls:24.88%
278
2223
872
9217
153
1181
1008
10334
63
170
1098
11345
158
6
1003
11509
91
207
1022
11286
190
1122
856
10081
250
2295
581
6929
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
9.3e-01
9.8e-01
2.1e+00
—
3.2e+00
1.4e+00
1.0e+00
cases:4.43%
controls:1.80%
cases:2.41%
controls:0.92%
cases:1.21%
controls:0.15%
—
—
cases:2.96%
controls:0.12%
cases:3.15%
controls:0.83%
cases:7.82%
controls:3.02%
51
206
1099
11234
28
106
1133
11409
14
17
1147
11498
—
33
14
1080
11479
33
93
1013
11110
65
279
766
8945
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
1.1e+00
1.8e+00
—
—
2.6e+00
2.3e+00
1.8e+00
cases:1.13%
controls:0.37%
cases:1.12%
controls:0.18%
—
—
—
—
cases:0.90%
controls:0.07%
cases:2.10%
controls:0.22%
cases:2.89%
controls:0.50%
13
42
1137
11398
13
21
1148
11494
—
—
10
8
1103
11485
22
25
1024
11178
24
46
807
9178
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
7.5e-01
1.1e+00
2.0e+00
—
3.3e+00
1.3e+00
8.9e-01
cases:4.61%
controls:2.23%
cases:3.96%
controls:1.37%
cases:2.50%
controls:0.35%
—
—
cases:7.01%
controls:0.28%
cases:5.16%
controls:1.52%
cases:8.54%
controls:3.71%
53
255
1097
11185
46
158
1115
11357
29
40
1132
11475
—
78
32
1035
11461
54
170
992
11033
71
342
760
8882
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
8.1e-01
8.9e-01
2.1e+00
1.0e+50
3.4e+00
1.2e+00
7.6e-01
cases:2.26%
controls:1.02%
cases:1.72%
controls:0.71%
cases:1.03%
controls:0.12%
cases:1.03%
controls:0.00%
cases:3.41%
controls:0.11%
cases:2.87%
controls:0.90%
cases:4.33%
controls:2.07%
26
117
1124
11323
20
82
1141
11433
12
14
1149
11501
12
0
1149
11515
38
13
1075
11480
30
101
1016
11102
36
191
795
9033
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
7.2e-01
1.2e+00
2.1e+00
1.0e+50
3.3e+00
1.2e+00
6.8e-01
cases:2.96%
controls:1.46%
cases:3.27%
controls:0.99%
cases:2.24%
controls:0.29%
cases:1.64%
controls:0.00%
cases:5.84%
controls:0.23%
cases:3.54%
controls:1.13%
cases:5.17%
controls:2.68%
34
167
1116
11273
38
114
1123
11401
26
33
1135
11482
19
0
1142
11515
65
26
1048
11467
37
127
1009
11076
43
247
788
8977
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.1e-01
1.6e-01
1.4e+00
5.0e+00
2.4e+00
4.2e-01
1.8e-01
cases:34.43%
controls:32.06%
cases:31.18%
controls:27.87%
cases:20.41%
controls:5.99%
cases:36.43%
controls:0.40%
cases:41.42%
controls:6.13%
cases:38.91%
controls:29.44%
cases:54.27%
controls:49.78%
396
3668
754
7772
362
3209
799
8306
237
690
924
10825
423
46
738
11469
461
704
652
10789
407
3298
639
7905
451
4592
380
4632
Gas panel - Venous blood
24339-4 [3000991]
8.2e-01
1.3e+00
2.3e+00
—
3.4e+00
1.3e+00
5.0e-01
cases:2.78%
controls:1.25%
cases:2.50%
controls:0.71%
cases:1.46%
controls:0.16%
—
—
cases:3.86%
controls:0.13%
cases:2.58%
controls:0.71%
cases:3.61%
controls:2.22%
32
143
1118
11297
29
82
1132
11433
17
18
1144
11497
—
43
15
1070
11478
27
79
1019
11124
30
205
801
9019
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.3e-01
2.8e-01
1.4e+00
4.7e+00
2.2e+00
4.8e-01
2.0e-01
cases:23.04%
controls:20.77%
cases:22.74%
controls:18.25%
cases:14.38%
controls:4.13%
cases:23.60%
controls:0.27%
cases:27.40%
controls:3.94%
cases:28.20%
controls:19.57%
cases:39.11%
controls:34.52%
265
2376
885
9064
264
2101
897
9414
167
476
994
11039
274
31
887
11484
305
453
808
11040
295
2192
751
9011
325
3184
506
6040
CBC panel - Blood by Automated count
58410-2 [40761511]
1.6e-01
1.4e-01
1.4e+00
4.7e+00
2.4e+00
5.2e-01
1.8e-01
cases:32.35%
controls:28.96%
cases:23.60%
controls:21.15%
cases:14.13%
controls:3.82%
cases:23.60%
controls:0.28%
cases:32.43%
controls:4.12%
cases:31.26%
controls:21.24%
cases:47.05%
controls:42.62%
372
3313
778
8127
274
2435
887
9080
164
440
997
11075
274
32
887
11483
361
473
752
11020
327
2380
719
8823
391
3931
440
5293
Leukocytes [#/volume] in Blood
26464-8 [3010813]
9.4e-02
1.1e-01
1.3e+00
4.9e+00
2.3e+00
4.4e-01
1.5e-01
cases:36.43%
controls:34.29%
cases:32.73%
controls:30.40%
cases:21.71%
controls:6.80%
cases:37.73%
controls:0.47%
cases:42.86%
controls:6.78%
cases:41.97%
controls:31.67%
cases:56.56%
controls:52.85%
419
3923
731
7517
380
3500
781
8015
252
783
909
10732
438
54
723
11461
477
779
636
10714
439
3548
607
7655
470
4875
361
4349
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
8.8e-02
1.1e-01
1.3e+00
4.8e+00
2.3e+00
4.5e-01
1.5e-01
cases:36.26%
controls:34.26%
cases:32.82%
controls:30.34%
cases:21.71%
controls:6.78%
cases:37.90%
controls:0.48%
cases:42.86%
controls:6.81%
cases:42.16%
controls:31.63%
cases:56.56%
controls:52.83%
417
3919
733
7521
381
3494
780
8021
252
781
909
10734
440
55
721
11460
477
783
636
10710
441
3544
605
7659
470
4873
361
4351
MCH [Entitic mass]
28539-5 [3035941]
8.6e-02
1.1e-01
1.3e+00
4.8e+00
2.3e+00
4.5e-01
1.5e-01
cases:36.17%
controls:34.20%
cases:32.82%
controls:30.34%
cases:21.71%
controls:6.77%
cases:37.64%
controls:0.48%
cases:42.86%
controls:6.77%
cases:42.07%
controls:31.58%
cases:56.56%
controls:52.78%
416
3913
734
7527
381
3494
780
8021
252
779
909
10736
437
55
724
11460
477
778
636
10715
440
3538
606
7665
470
4868
361
4356
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
1.0e+00
1.5e+00
—
1.0e+50
4.0e+00
1.5e+00
9.8e-01
cases:1.57%
controls:0.57%
cases:1.38%
controls:0.31%
—
—
cases:4.05%
controls:0.00%
cases:2.70%
controls:0.05%
cases:1.34%
controls:0.30%
cases:3.37%
controls:1.29%
18
65
1132
11375
16
36
1145
11479
—
47
0
1114
11515
30
6
1083
11487
14
34
1032
11169
28
119
803
9105
Platelets [#/volume] in Blood
26515-7 [3007461]
9.3e-02
1.1e-01
1.3e+00
4.8e+00
2.3e+00
4.5e-01
1.6e-01
cases:36.26%
controls:34.13%
cases:32.73%
controls:30.31%
cases:21.71%
controls:6.75%
cases:37.64%
controls:0.48%
cases:42.86%
controls:6.77%
cases:41.87%
controls:31.56%
cases:56.56%
controls:52.65%
417
3905
733
7535
380
3490
781
8025
252
777
909
10738
437
55
724
11460
477
778
636
10715
438
3536
608
7667
470
4856
361
4368
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
8.9e-02
1.1e-01
1.3e+00
4.8e+00
2.3e+00
4.5e-01
1.5e-01
cases:36.26%
controls:34.23%
cases:32.82%
controls:30.35%
cases:21.71%
controls:6.78%
cases:37.64%
controls:0.48%
cases:42.86%
controls:6.78%
cases:42.07%
controls:31.63%
cases:56.56%
controls:52.79%
417
3916
733
7524
381
3495
780
8020
252
781
909
10734
437
55
724
11460
477
779
636
10714
440
3543
606
7660
470
4869
361
4355
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
8.5e-02
1.1e-01
1.3e+00
4.8e+00
2.3e+00
4.5e-01
1.5e-01
cases:36.17%
controls:34.24%
cases:32.82%
controls:30.39%
cases:21.71%
controls:6.78%
cases:37.64%
controls:0.48%
cases:42.86%
controls:6.79%
cases:42.07%
controls:31.64%
cases:56.56%
controls:52.82%
416
3917
734
7523
381
3499
780
8016
252
781
909
10734
437
55
724
11460
477
780
636
10713
440
3545
606
7658
470
4872
361
4352
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
8.7e-02
1.1e-01
1.3e+00
4.8e+00
2.3e+00
4.5e-01
1.5e-01
cases:36.26%
controls:34.28%
cases:32.82%
controls:30.40%
cases:21.71%
controls:6.82%
cases:37.90%
controls:0.48%
cases:42.86%
controls:6.81%
cases:42.07%
controls:31.74%
cases:56.56%
controls:52.89%
417
3922
733
7518
381
3501
780
8014
252
785
909
10730
440
55
721
11460
477
783
636
10710
440
3556
606
7647
470
4879
361
4345
Emergency Room and Inpatient Visit
ERIP [262]
6.5e-01
8.8e-01
2.6e+00
1.0e+50
3.3e+00
9.2e-01
5.8e-01
cases:7.91%
controls:4.30%
cases:5.86%
controls:2.53%
cases:4.65%
controls:0.37%
cases:20.50%
controls:0.00%
cases:6.56%
controls:0.25%
cases:7.65%
controls:3.20%
cases:16.13%
controls:9.68%
91
492
1059
10948
68
291
1093
11224
54
43
1107
11472
238
0
923
11515
73
29
1040
11464
80
359
966
10844
134
893
697
8331
pH of Venous blood
2746-6 [3012544]
8.0e-01
1.0e+00
2.3e+00
—
3.3e+00
1.5e+00
2.8e-01
cases:3.13%
controls:1.43%
cases:2.41%
controls:0.88%
cases:1.64%
controls:0.17%
—
—
cases:4.58%
controls:0.18%
cases:3.92%
controls:0.91%
cases:4.09%
controls:3.13%
36
164
1114
11276
28
101
1133
11414
19
19
1142
11496
—
51
21
1062
11472
41
102
1005
11101
34
289
797
8935
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
9.9e-01
1.8e+00
—
—
2.7e+00
1.9e+00
1.4e+00
cases:1.57%
controls:0.59%
cases:1.29%
controls:0.22%
—
—
—
—
cases:0.90%
controls:0.06%
cases:1.82%
controls:0.27%
cases:3.49%
controls:0.88%
18
67
1132
11373
15
25
1146
11490
—
—
10
7
1103
11486
19
30
1027
11173
29
81
802
9143
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
6.7e-01
1.0e+00
2.1e+00
1.0e+50
3.1e+00
1.1e+00
7.8e-01
cases:3.48%
controls:1.81%
cases:2.24%
controls:0.82%
cases:0.86%
controls:0.10%
cases:0.86%
controls:0.00%
cases:1.89%
controls:0.09%
cases:2.49%
controls:0.85%
cases:5.54%
controls:2.62%
40
207
1110
11233
26
94
1135
11421
10
12
1151
11503
10
0
1151
11515
21
10
1092
11483
26
95
1020
11108
46
242
785
8982
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
8.8e-01
9.8e-01
2.2e+00
—
3.4e+00
1.3e+00
6.8e-01
cases:2.35%
controls:0.99%
cases:1.38%
controls:0.52%
cases:1.03%
controls:0.11%
—
—
cases:2.79%
controls:0.10%
cases:1.34%
controls:0.37%
cases:2.53%
controls:1.30%
27
113
1123
11327
16
60
1145
11455
12
13
1149
11502
—
31
11
1082
11482
14
42
1032
11161
21
120
810
9104
Monitored bed care
WX892 [2001310850]
7.4e-01
5.3e-01
3.4e+00
—
2.6e+00
1.5e+00
1.3e+00
cases:1.57%
controls:0.75%
cases:0.60%
controls:0.36%
cases:1.72%
controls:0.06%
—
—
cases:0.72%
controls:0.05%
cases:1.05%
controls:0.23%
cases:3.01%
controls:0.88%
18
86
1132
11354
7
41
1154
11474
20
7
1141
11508
—
8
6
1105
11487
11
26
1035
11177
25
81
806
9143
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
6.5e-01
1.2e+00
2.3e+00
1.0e+50
3.0e+00
2.2e+00
1.2e+00
cases:1.30%
controls:0.68%
cases:0.69%
controls:0.21%
cases:0.60%
controls:0.06%
cases:0.95%
controls:0.00%
cases:0.90%
controls:0.04%
cases:1.34%
controls:0.15%
cases:2.05%
controls:0.61%
15
78
1135
11362
8
24
1153
11491
7
7
1154
11508
11
0
1150
11515
10
5
1103
11488
14
17
1032
11186
17
56
814
9168
Protein electrophoresis panel - 24 hour Urine
81231-3 [21494890]
1.7e+00
2.8e+00
—
—
—
2.4e+00
1.9e+00
cases:0.78%
controls:0.14%
cases:0.69%
controls:0.04%
—
—
—
—
—
—
cases:0.96%
controls:0.09%
cases:1.93%
controls:0.30%
9
16
1141
11424
8
5
1153
11510
—
—
—
10
10
1036
11193
16
28
815
9196
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
1.0e+00
1.7e+00
—
—
2.7e+00
1.9e+00
1.4e+00
cases:1.65%
controls:0.59%
cases:1.29%
controls:0.24%
—
—
—
—
cases:0.90%
controls:0.06%
cases:1.91%
controls:0.29%
cases:3.61%
controls:0.94%
19
68
1131
11372
15
28
1146
11487
—
—
10
7
1103
11486
20
32
1026
11171
30
87
801
9137
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
1.0e+00
1.7e+00
—
—
2.7e+00
1.9e+00
1.4e+00
cases:1.65%
controls:0.59%
cases:1.29%
controls:0.24%
—
—
—
—
cases:0.90%
controls:0.06%
cases:1.91%
controls:0.29%
cases:3.61%
controls:0.94%
19
68
1131
11372
15
28
1146
11487
—
—
10
7
1103
11486
20
32
1026
11171
30
87
801
9137
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
1.0e+00
1.7e+00
—
—
2.7e+00
1.9e+00
1.4e+00
cases:1.65%
controls:0.59%
cases:1.29%
controls:0.24%
—
—
—
—
cases:0.90%
controls:0.06%
cases:1.91%
controls:0.29%
cases:3.61%
controls:0.94%
19
68
1131
11372
15
28
1146
11487
—
—
10
7
1103
11486
20
32
1026
11171
30
87
801
9137
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
9.9e-01
1.6e+00
—
—
2.7e+00
2.0e+00
1.4e+00
cases:1.57%
controls:0.59%
cases:1.21%
controls:0.23%
—
—
—
—
cases:0.90%
controls:0.06%
cases:1.82%
controls:0.26%
cases:3.25%
controls:0.86%
18
67
1132
11373
14
27
1147
11488
—
—
10
7
1103
11486
19
29
1027
11174
27
79
804
9145
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
1.8e+00
1.5e+00
1.8e+00
—
—
1.8e+00
1.7e+00
cases:3.30%
controls:0.55%
cases:2.07%
controls:0.48%
cases:0.60%
controls:0.10%
—
—
—
—
cases:2.20%
controls:0.38%
cases:3.13%
controls:0.56%
38
63
1112
11377
24
55
1137
11460
7
11
1154
11504
—
—
23
43
1023
11160
26
52
805
9172
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
7.4e-01
9.9e-01
2.2e+00
—
3.2e+00
1.5e+00
3.4e-01
cases:2.87%
controls:1.39%
cases:2.33%
controls:0.88%
cases:1.46%
controls:0.17%
—
—
cases:4.22%
controls:0.18%
cases:3.82%
controls:0.89%
cases:4.21%
controls:3.04%
33
159
1117
11281
27
101
1134
11414
17
19
1144
11496
—
47
21
1066
11472
40
100
1006
11103
35
280
796
8944
filgrastim; parenteral
L03AA02 [21603851]
2.1e+00
2.2e+00
—
—
—
2.2e+00
2.1e+00
cases:1.48%
controls:0.17%
cases:0.60%
controls:0.07%
—
—
—
—
—
—
cases:0.86%
controls:0.10%
cases:1.44%
controls:0.18%
17
20
1133
11420
7
8
1154
11507
—
—
—
9
11
1037
11192
12
17
819
9207
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
6.3e-01
1.2e+00
2.4e+00
—
3.4e+00
1.6e+00
1.2e-01
cases:1.57%
controls:0.84%
cases:1.38%
controls:0.43%
cases:0.95%
controls:0.09%
—
—
cases:1.80%
controls:0.06%
cases:2.29%
controls:0.47%
cases:2.29%
controls:2.04%
18
96
1132
11344
16
50
1145
11465
11
10
1150
11505
—
20
7
1093
11486
24
53
1022
11150
19
188
812
9036
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
9.6e-01
1.2e+00
2.0e+00
—
2.9e+00
1.5e+00
4.1e-01
cases:1.91%
controls:0.74%
cases:1.55%
controls:0.50%
cases:0.95%
controls:0.13%
—
—
cases:2.43%
controls:0.13%
cases:2.10%
controls:0.49%
cases:2.17%
controls:1.45%
22
85
1128
11355
18
57
1143
11458
11
15
1150
11500
—
27
15
1086
11478
22
55
1024
11148
18
134
813
9090
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
9.2e-01
1.9e+00
—
—
2.6e+00
1.7e+00
1.5e+00
cases:1.48%
controls:0.59%
cases:1.21%
controls:0.19%
—
—
—
—
cases:0.81%
controls:0.06%
cases:1.53%
controls:0.29%
cases:3.49%
controls:0.83%
17
68
1133
11372
14
22
1147
11493
—
—
9
7
1104
11486
16
32
1030
11171
29
77
802
9147
Base excess in Venous blood by calculation
1927-3 [3002032]
7.0e-01
1.0e+00
2.2e+00
—
3.1e+00
1.4e+00
3.7e-01
cases:2.78%
controls:1.40%
cases:2.33%
controls:0.85%
cases:1.55%
controls:0.17%
—
—
cases:4.22%
controls:0.19%
cases:3.73%
controls:0.90%
cases:4.33%
controls:3.02%
32
160
1118
11280
27
98
1134
11417
18
20
1143
11495
—
47
22
1066
11471
39
101
1007
11102
36
279
795
8945
Blasts/Leukocytes in Blood
26446-5 [3025159]
8.7e-01
8.6e-01
2.0e+00
1.0e+50
3.7e+00
1.1e+00
7.6e-01
cases:2.00%
controls:0.85%
cases:1.55%
controls:0.66%
cases:0.78%
controls:0.10%
cases:0.78%
controls:0.00%
cases:3.14%
controls:0.08%
cases:2.49%
controls:0.82%
cases:3.85%
controls:1.84%
23
97
1127
11343
18
76
1143
11439
9
12
1152
11503
9
0
1152
11515
35
9
1078
11484
26
92
1020
11111
32
170
799
9054
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
6.4e-01
9.6e-01
2.0e+00
1.0e+50
3.5e+00
1.2e+00
7.8e-01
cases:1.83%
controls:0.97%
cases:1.72%
controls:0.67%
cases:0.86%
controls:0.11%
cases:1.03%
controls:0.00%
cases:3.41%
controls:0.10%
cases:2.68%
controls:0.83%
cases:3.97%
controls:1.86%
21
111
1129
11329
20
77
1141
11438
10
13
1151
11502
12
0
1149
11515
38
12
1075
11481
28
93
1018
11110
33
172
798
9052
clindamycin; oral, parenteral
J01FF01 [21602985]
6.7e-01
9.0e-01
—
—
3.8e+00
1.8e+00
1.2e+00
cases:6.61%
controls:3.50%
cases:2.33%
controls:0.96%
—
—
—
—
cases:5.21%
controls:0.12%
cases:5.07%
controls:0.85%
cases:9.63%
controls:3.00%
76
400
1074
11040
27
110
1134
11405
—
—
58
14
1055
11479
53
95
993
11108
80
277
751
8947
Immunofixation for Serum or Plasma
25700-6 [3037756]
1.4e+00
1.9e+00
—
—
—
3.0e+00
2.1e+00
cases:1.30%
controls:0.31%
cases:0.78%
controls:0.11%
—
—
—
—
—
—
cases:2.20%
controls:0.12%
cases:3.49%
controls:0.44%
15
36
1135
11404
9
13
1152
11502
—
—
—
23
13
1023
11190
29
41
802
9183
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
3.4e-02
5.7e-02
1.3e+00
4.6e+00
2.2e+00
3.6e-01
9.2e-03
cases:26.17%
controls:25.52%
cases:21.96%
controls:21.00%
cases:14.81%
controls:4.52%
cases:25.75%
controls:0.36%
cases:29.38%
controls:4.57%
cases:28.68%
controls:21.98%
cases:40.31%
controls:40.09%
301
2919
849
8521
255
2418
906
9097
172
521
989
10994
299
41
862
11474
327
525
786
10968
300
2462
746
8741
335
3698
496
5526
Physiotherapy
R4110 [2001310233]
6.7e-01
8.5e-01
2.5e+00
1.0e+50
2.6e+00
1.0e+00
7.9e-01
cases:8.78%
controls:4.69%
cases:4.39%
controls:1.92%
cases:2.76%
controls:0.23%
cases:8.18%
controls:0.00%
cases:4.22%
controls:0.34%
cases:4.49%
controls:1.69%
cases:10.23%
controls:4.90%
101
537
1049
10903
51
221
1110
11294
32
27
1129
11488
95
0
1066
11515
47
39
1066
11454
47
189
999
11014
85
452
746
8772
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5.4e-01
7.9e-01
2.0e+00
—
3.2e+00
1.0e+00
7.3e-01
cases:7.39%
controls:4.45%
cases:4.74%
controls:2.21%
cases:3.01%
controls:0.40%
—
—
cases:9.07%
controls:0.40%
cases:5.74%
controls:2.11%
cases:11.43%
controls:5.88%
85
509
1065
10931
55
254
1106
11261
35
46
1126
11469
—
101
46
1012
11447
60
236
986
10967
95
542
736
8682
Cathetrisation of vein
TPH04 [2001309597]
8.8e-01
5.9e-01
2.6e+00
1.0e+50
2.2e+00
1.4e+00
1.2e+00
cases:5.91%
controls:2.55%
cases:2.07%
controls:1.16%
cases:1.98%
controls:0.16%
cases:4.31%
controls:0.00%
cases:1.53%
controls:0.17%
cases:3.92%
controls:0.96%
cases:11.31%
controls:3.53%
68
292
1082
11148
24
133
1137
11382
23
18
1138
11497
50
0
1111
11515
17
19
1096
11474
41
108
1005
11095
94
326
737
8898
Physiotherapist
Z3226 [2001311560]
5.6e-01
7.9e-01
3.1e+00
1.0e+50
2.6e+00
1.1e+00
9.6e-01
cases:4.43%
controls:2.59%
cases:1.81%
controls:0.83%
cases:1.64%
controls:0.08%
cases:3.79%
controls:0.00%
cases:1.53%
controls:0.11%
cases:2.10%
controls:0.69%
cases:4.57%
controls:1.81%
51
296
1099
11144
21
95
1140
11420
19
9
1142
11506
44
0
1117
11515
17
13
1096
11480
22
77
1024
11126
38
167
793
9057
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
4.5e-01
1.3e+00
2.8e+00
1.0e+50
4.2e+00
1.1e+00
1.8e-01
cases:1.22%
controls:0.78%
cases:1.38%
controls:0.36%
cases:1.29%
controls:0.08%
cases:3.70%
controls:0.00%
cases:2.70%
controls:0.04%
cases:1.05%
controls:0.37%
cases:2.17%
controls:1.82%
14
89
1136
11351
16
42
1145
11473
15
9
1146
11506
43
0
1118
11515
30
5
1083
11488
11
41
1035
11162
18
168
813
9056
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
4.5e-01
1.4e+00
2.8e+00
1.0e+50
4.1e+00
1.1e+00
2.1e-01
cases:1.22%
controls:0.78%
cases:1.29%
controls:0.33%
cases:1.12%
controls:0.07%
cases:3.70%
controls:0.00%
cases:2.61%
controls:0.04%
cases:0.96%
controls:0.32%
cases:2.17%
controls:1.76%
14
89
1136
11351
15
38
1146
11477
13
8
1148
11507
43
0
1118
11515
29
5
1084
11488
10
36
1036
11167
18
162
813
9062
amoxicillin; oral, parenteral
J01CA04 [21602823]
5.0e-01
8.0e-01
1.4e+00
—
3.8e+00
1.0e+00
7.5e-01
cases:30.09%
controls:20.75%
cases:13.70%
controls:6.63%
cases:2.58%
controls:0.63%
—
—
cases:25.70%
controls:0.79%
cases:16.35%
controls:6.53%
cases:36.10%
controls:21.03%
346
2374
804
9066
159
763
1002
10752
30
73
1131
11442
—
286
91
827
11402
171
731
875
10472
300
1940
531
7284
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
8.8e-01
8.2e-01
2.1e+00
1.0e+50
3.3e+00
1.1e+00
7.9e-01
cases:2.26%
controls:0.95%
cases:1.55%
controls:0.69%
cases:0.95%
controls:0.11%
cases:0.95%
controls:0.00%
cases:3.05%
controls:0.11%
cases:2.58%
controls:0.85%
cases:4.21%
controls:1.96%
26
109
1124
11331
18
79
1143
11436
11
13
1150
11502
11
0
1150
11515
34
13
1079
11480
27
95
1019
11108
35
181
796
9043
Hemodialysis
TK800 [2001305768]
1.1e+00
1.8e+00
1.9e+00
—
2.2e+00
2.3e+00
9.3e-01
cases:0.70%
controls:0.23%
cases:0.95%
controls:0.16%
cases:0.60%
controls:0.09%
—
—
cases:0.99%
controls:0.11%
cases:1.24%
controls:0.12%
cases:0.60%
controls:0.24%
8
26
1142
11414
11
18
1150
11497
7
10
1154
11505
—
11
13
1102
11480
13
14
1033
11189
5
22
826
9202
Office Visit
OMOP4822458 [581477]
5.6e-01
8.5e-01
2.0e+00
—
3.1e+00
1.1e+00
7.1e-01
cases:14.35%
controls:8.74%
cases:7.15%
controls:3.18%
cases:2.93%
controls:0.43%
—
—
cases:7.28%
controls:0.37%
cases:7.93%
controls:2.81%
cases:14.68%
controls:7.79%
165
1000
985
10440
83
366
1078
11149
34
49
1127
11466
—
81
42
1032
11451
83
315
963
10888
122
719
709
8505
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
7.2e-01
9.4e-01
2.1e+00
—
3.1e+00
1.4e+00
8.2e-02
cases:2.52%
controls:1.24%
cases:1.72%
controls:0.68%
cases:1.03%
controls:0.12%
—
—
cases:2.52%
controls:0.12%
cases:2.77%
controls:0.72%
cases:2.89%
controls:2.67%
29
142
1121
11298
20
78
1141
11437
12
14
1149
11501
—
28
14
1085
11479
29
81
1017
11122
24
246
807
8978
Sepsis, unspecified
A41.9 [45585911]
1.6e+00
2.3e+00
—
1.0e+50
—
2.9e+00
1.4e+00
cases:1.22%
controls:0.24%
cases:1.03%
controls:0.10%
—
—
cases:4.57%
controls:0.00%
—
—
cases:1.72%
controls:0.10%
cases:1.20%
controls:0.29%
14
28
1136
11412
12
12
1149
11503
—
53
0
1108
11515
—
18
11
1028
11192
10
27
821
9197
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.2e-01
1.6e-01
1.1e+00
4.5e+00
2.2e+00
4.5e-01
1.9e-01
cases:32.78%
controls:30.10%
cases:26.87%
controls:23.86%
cases:10.94%
controls:3.99%
cases:12.58%
controls:0.17%
cases:28.84%
controls:4.41%
cases:34.13%
controls:24.91%
cases:51.38%
controls:46.74%
377
3444
773
7996
312
2748
849
8767
127
460
1034
11055
146
19
1015
11496
321
507
792
10986
357
2791
689
8412
427
4311
404
4913
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
7.6e-01
1.9e+00
—
—
2.9e+00
2.0e+00
1.3e+00
cases:1.04%
controls:0.49%
cases:0.95%
controls:0.14%
—
—
—
—
cases:0.81%
controls:0.04%
cases:1.34%
controls:0.19%
cases:2.05%
controls:0.56%
12
56
1138
11384
11
16
1150
11499
—
—
9
5
1104
11488
14
21
1032
11182
17
52
814
9172
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
6.2e-01
1.2e+00
2.7e+00
1.0e+50
4.2e+00
1.2e+00
1.6e-01
cases:1.39%
controls:0.75%
cases:1.21%
controls:0.36%
cases:1.21%
controls:0.08%
cases:3.53%
controls:0.00%
cases:2.79%
controls:0.04%
cases:1.15%
controls:0.37%
cases:2.05%
controls:1.75%
16
86
1134
11354
14
42
1147
11473
14
9
1147
11506
41
0
1120
11515
31
5
1082
11488
12
41
1034
11162
17
161
814
9063
High resolution CT examination of lungs
GD1DD [2001303632]
1.3e+00
2.4e+00
—
1.0e+50
—
2.2e+00
2.2e+00
cases:1.65%
controls:0.46%
cases:1.29%
controls:0.11%
—
—
cases:0.69%
controls:0.00%
—
—
cases:1.82%
controls:0.20%
cases:4.09%
controls:0.49%
19
53
1131
11387
15
13
1146
11502
—
8
0
1153
11515
—
19
22
1027
11181
34
45
797
9179
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
5.3e-01
1.0e+00
2.3e+00
—
3.5e+00
1.3e+00
1.7e-01
cases:2.78%
controls:1.66%
cases:2.76%
controls:1.02%
cases:2.15%
controls:0.22%
—
—
cases:4.76%
controls:0.16%
cases:3.63%
controls:1.00%
cases:4.45%
controls:3.77%
32
190
1118
11250
32
117
1129
11398
25
25
1136
11490
—
53
18
1060
11475
38
112
1008
11091
37
348
794
8876
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
7.6e-01
1.1e+00
1.6e+00
—
2.5e+00
1.3e+00
8.1e-01
cases:3.83%
controls:1.83%
cases:3.10%
controls:1.04%
cases:1.12%
controls:0.22%
—
—
cases:2.96%
controls:0.26%
cases:4.78%
controls:1.36%
cases:7.70%
controls:3.57%
44
209
1106
11231
36
120
1125
11395
13
25
1148
11490
—
33
30
1080
11463
50
152
996
11051
64
329
767
8895
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
4.7e-01
4.7e-01
2.3e+00
—
3.0e+00
1.8e+00
8.8e-01
cases:2.61%
controls:1.64%
cases:0.86%
controls:0.54%
cases:0.86%
controls:0.09%
—
—
cases:2.34%
controls:0.11%
cases:2.39%
controls:0.38%
cases:2.77%
controls:1.17%
30
188
1120
11252
10
62
1151
11453
10
10
1151
11505
—
26
13
1087
11480
25
43
1021
11160
23
108
808
9116
Nephrology
39 [38004479]
9.5e-01
1.2e+00
1.7e+00
—
1.8e+00
1.2e+00
1.2e+00
cases:2.61%
controls:1.02%
cases:2.41%
controls:0.74%
cases:1.55%
controls:0.30%
—
—
cases:1.89%
controls:0.30%
cases:2.77%
controls:0.83%
cases:3.73%
controls:1.17%
30
117
1120
11323
28
85
1133
11430
18
34
1143
11481
—
21
35
1092
11458
29
93
1017
11110
31
108
800
9116
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
7.4e-01
1.4e+00
1.8e+00
1.0e+50
2.2e+00
1.2e+00
7.2e-01
cases:2.61%
controls:1.26%
cases:2.15%
controls:0.53%
cases:0.60%
controls:0.10%
cases:1.81%
controls:0.00%
cases:0.99%
controls:0.11%
cases:1.91%
controls:0.61%
cases:3.73%
controls:1.84%
30
144
1120
11296
25
61
1136
11454
7
11
1154
11504
21
0
1140
11515
11
13
1102
11480
20
68
1026
11135
31
170
800
9054
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
7.0e-01
9.8e-01
1.3e+00
—
2.9e+00
1.2e+00
1.0e+00
cases:14.35%
controls:7.71%
cases:5.68%
controls:2.21%
cases:1.03%
controls:0.28%
—
—
cases:3.86%
controls:0.23%
cases:7.17%
controls:2.27%
cases:17.93%
controls:7.47%
165
882
985
10558
66
255
1095
11260
12
32
1149
11483
—
43
26
1070
11467
75
254
971
10949
149
689
682
8535
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
2.8e-01
3.9e-01
1.0e+00
4.1e+00
1.6e+00
8.8e-01
4.1e-01
cases:7.91%
controls:6.08%
cases:4.48%
controls:3.07%
cases:1.46%
controls:0.53%
cases:4.39%
controls:0.08%
cases:2.79%
controls:0.55%
cases:7.84%
controls:3.40%
cases:12.27%
controls:8.48%
91
696
1059
10744
52
353
1109
11162
17
61
1144
11454
51
9
1110
11506
31
63
1082
11430
82
381
964
10822
102
782
729
8442
prednisolone; oral, parenteral
H02AB06 [21602734]
9.3e-01
1.1e+00
1.4e+00
—
2.1e+00
1.4e+00
1.0e+00
cases:23.57%
controls:10.80%
cases:13.52%
controls:4.95%
cases:3.96%
controls:0.97%
—
—
cases:7.10%
controls:0.94%
cases:16.73%
controls:4.63%
cases:27.08%
controls:11.80%
271
1236
879
10204
157
570
1004
10945
46
112
1115
11403
—
79
108
1034
11385
175
519
871
10684
225
1088
606
8136
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
9.0e-01
2.0e+00
—
—
2.7e+00
1.9e+00
1.4e+00
cases:1.22%
controls:0.50%
cases:1.03%
controls:0.15%
—
—
—
—
cases:0.81%
controls:0.05%
cases:1.43%
controls:0.21%
cases:2.29%
controls:0.59%
14
57
1136
11383
12
17
1149
11498
—
—
9
6
1104
11487
15
24
1031
11179
19
54
812
9170
prednisolone
A07EA01 [21600653]
9.3e-01
1.1e+00
1.4e+00
—
2.1e+00
1.4e+00
1.0e+00
cases:23.57%
controls:10.82%
cases:13.61%
controls:4.96%
cases:3.96%
controls:0.97%
—
—
cases:7.10%
controls:0.94%
cases:16.73%
controls:4.66%
cases:27.08%
controls:11.85%
271
1238
879
10202
158
571
1003
10944
46
112
1115
11403
—
79
108
1034
11385
175
522
871
10681
225
1093
606
8131
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
J44.1 [45601132]
1.8e+00
2.3e+00
—
—
—
2.1e+00
1.8e+00
cases:1.74%
controls:0.30%
cases:1.46%
controls:0.16%
—
—
—
—
—
—
cases:1.15%
controls:0.14%
cases:2.89%
controls:0.48%
20
34
1130
11406
17
18
1144
11497
—
—
—
12
16
1034
11187
24
44
807
9180
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
7.6e-01
1.9e+00
—
—
2.7e+00
1.8e+00
1.4e+00
cases:1.04%
controls:0.49%
cases:0.95%
controls:0.15%
—
—
—
—
cases:0.81%
controls:0.05%
cases:1.34%
controls:0.21%
cases:2.17%
controls:0.56%
12
56
1138
11384
11
17
1150
11498
—
—
9
6
1104
11487
14
24
1032
11179
18
52
813
9172
Chron obstructive pulmonary disease
R95 [2002000960]
1.8e+00
1.9e+00
—
—
—
2.8e+00
1.3e+00
cases:1.65%
controls:0.28%
cases:0.86%
controls:0.13%
—
—
—
—
—
—
cases:1.15%
controls:0.07%
cases:1.81%
controls:0.49%
19
32
1131
11408
10
15
1151
11500
—
—
—
12
8
1034
11195
15
45
816
9179
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
7.3e-01
1.1e+00
1.5e+00
—
2.4e+00
1.2e+00
7.6e-01
cases:3.91%
controls:1.93%
cases:3.27%
controls:1.10%
cases:1.12%
controls:0.25%
—
—
cases:3.05%
controls:0.28%
cases:4.88%
controls:1.46%
cases:8.06%
controls:3.95%
45
221
1105
11219
38
127
1123
11388
13
29
1148
11486
—
34
32
1079
11461
51
164
995
11039
67
364
764
8860
Gas panel - Arterial blood
24336-0 [3019060]
9.4e-01
1.1e+00
2.6e+00
—
—
2.1e+00
1.0e+00
cases:2.52%
controls:1.00%
cases:1.46%
controls:0.50%
cases:1.03%
controls:0.08%
—
—
—
—
cases:2.29%
controls:0.29%
cases:4.93%
controls:1.85%
29
114
1121
11326
17
57
1144
11458
12
9
1149
11506
—
—
24
33
1022
11170
41
171
790
9053
Abdominal ultrasound examination
JN3AE [2001305555]
6.0e-01
9.3e-01
2.3e+00
1.0e+50
2.7e+00
1.4e+00
1.4e+00
cases:3.04%
controls:1.69%
cases:1.38%
controls:0.55%
cases:0.52%
controls:0.05%
cases:2.58%
controls:0.00%
cases:0.63%
controls:0.04%
cases:2.01%
controls:0.53%
cases:6.26%
controls:1.66%
35
193
1115
11247
16
63
1145
11452
6
6
1155
11509
30
0
1131
11515
7
5
1106
11488
21
59
1025
11144
52
153
779
9071
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.7e-01
6.4e-01
1.7e+00
—
3.0e+00
1.2e+00
6.4e-01
cases:13.91%
controls:9.16%
cases:10.25%
controls:5.65%
cases:6.12%
controls:1.16%
—
—
cases:18.06%
controls:1.09%
cases:16.44%
controls:5.51%
cases:24.67%
controls:14.68%
160
1048
990
10392
119
651
1042
10864
71
133
1090
11382
—
201
125
912
11368
172
617
874
10586
205
1354
626
7870
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
5.6e-01
1.0e+00
—
—
4.2e+00
1.5e+00
1.0e+00
cases:1.74%
controls:1.01%
cases:1.81%
controls:0.67%
—
—
—
—
cases:4.40%
controls:0.07%
cases:1.82%
controls:0.42%
cases:3.85%
controls:1.45%
20
115
1130
11325
21
77
1140
11438
—
—
49
8
1064
11485
19
47
1027
11156
32
134
799
9090
Laboratory Visit
OMOP4822461 [32036]
9.7e-02
8.0e-02
1.0e+00
4.5e+00
1.8e+00
3.2e-01
1.1e-01
cases:39.74%
controls:37.44%
cases:38.42%
controls:36.53%
cases:26.96%
controls:11.92%
cases:40.40%
controls:0.73%
cases:43.94%
controls:11.71%
cases:46.65%
controls:38.73%
cases:59.93%
controls:57.18%
457
4283
693
7157
446
4207
715
7308
313
1373
848
10142
469
84
692
11431
489
1346
624
10147
488
4339
558
6864
498
5274
333
3950
fenoterol and ipratropium bromide
R03AL01 [43534843]
1.4e+00
1.4e+00
1.8e+00
—
2.3e+00
1.2e+00
1.2e+00
cases:3.39%
controls:0.84%
cases:2.15%
controls:0.53%
cases:0.43%
controls:0.07%
—
—
cases:0.63%
controls:0.06%
cases:1.63%
controls:0.47%
cases:3.13%
controls:0.98%
39
96
1111
11344
25
61
1136
11454
5
8
1156
11507
—
7
7
1106
11486
17
53
1029
11150
26
90
805
9134
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
1.9e-01
3.4e-01
9.7e-01
3.2e+00
1.9e+00
7.2e-01
5.0e-01
cases:19.39%
controls:16.55%
cases:11.97%
controls:8.85%
cases:2.84%
controls:1.09%
cases:1.03%
controls:0.04%
cases:8.00%
controls:1.31%
cases:17.50%
controls:9.35%
cases:33.45%
controls:23.40%
223
1893
927
9547
139
1019
1022
10496
33
126
1128
11389
12
5
1149
11510
89
151
1024
11342
183
1047
863
10156
278
2158
553
7066
Inpatient Visit
IP [9201]
4.1e-01
8.8e-01
1.8e+00
—
2.8e+00
1.1e+00
6.2e-01
cases:9.30%
controls:6.35%
cases:5.43%
controls:2.32%
cases:1.98%
controls:0.32%
—
—
cases:5.03%
controls:0.33%
cases:6.41%
controls:2.33%
cases:14.44%
controls:8.33%
107
726
1043
10714
63
267
1098
11248
23
37
1138
11478
—
56
38
1057
11455
67
261
979
10942
120
768
711
8456
Bone marrow biopsy
XW000 [2001310618]
1.6e+00
2.0e+00
—
—
—
1.8e+00
2.1e+00
cases:2.00%
controls:0.40%
cases:0.95%
controls:0.13%
—
—
—
—
—
—
cases:0.96%
controls:0.15%
cases:2.29%
controls:0.28%
23
46
1127
11394
11
15
1150
11500
—
—
—
10
17
1036
11186
19
26
812
9198
Gas panel - Capillary blood
24337-8 [3022313]
6.4e-01
9.8e-01
—
—
4.3e+00
1.5e+00
8.1e-01
cases:1.48%
controls:0.79%
cases:1.46%
controls:0.56%
—
—
—
—
cases:3.68%
controls:0.05%
cases:1.53%
controls:0.35%
cases:2.65%
controls:1.19%
17
90
1133
11350
17
64
1144
11451
—
—
41
6
1072
11487
16
39
1030
11164
22
110
809
9114
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
5.6e-01
9.1e-01
2.6e+00
—
3.5e+00
1.4e+00
3.5e-01
cases:1.22%
controls:0.70%
cases:0.95%
controls:0.38%
cases:0.60%
controls:0.04%
—
—
cases:2.07%
controls:0.06%
cases:1.63%
controls:0.41%
cases:2.41%
controls:1.70%
14
80
1136
11360
11
44
1150
11471
7
5
1154
11510
—
23
7
1090
11486
17
46
1029
11157
20
157
811
9067
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
7.8e-01
8.5e-01
2.0e+00
1.0e+50
2.5e+00
1.2e+00
1.0e+00
cases:3.48%
controls:1.62%
cases:1.64%
controls:0.70%
cases:0.78%
controls:0.10%
cases:0.78%
controls:0.00%
cases:1.53%
controls:0.12%
cases:2.58%
controls:0.80%
cases:6.38%
controls:2.42%
40
185
1110
11255
19
81
1142
11434
9
12
1152
11503
9
0
1152
11515
17
14
1096
11479
27
90
1019
11113
53
223
778
9001
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.3e-01
7.6e-01
1.9e+00
—
3.0e+00
6.9e-01
7.2e-01
cases:7.48%
controls:5.00%
cases:4.74%
controls:2.28%
cases:1.98%
controls:0.30%
—
—
cases:4.85%
controls:0.24%
cases:4.40%
controls:2.26%
cases:12.88%
controls:6.71%
86
572
1064
10868
55
262
1106
11253
23
35
1138
11480
—
54
28
1059
11465
46
253
1000
10950
107
619
724
8605
Medical doctor
Z2221 [2001311556]
5.5e-01
6.0e-01
3.0e+00
—
2.0e+00
1.0e+00
9.6e-01
cases:9.13%
controls:5.45%
cases:2.93%
controls:1.63%
cases:2.76%
controls:0.14%
—
—
cases:1.98%
controls:0.28%
cases:4.40%
controls:1.62%
cases:8.90%
controls:3.62%
105
624
1045
10816
34
188
1127
11327
32
16
1129
11499
—
22
32
1091
11461
46
182
1000
11021
74
334
757
8890
FEV1/FVC
19926-5 [3011505]
1.3e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:6.09%
controls:1.75%
cases:2.50%
controls:0.41%
—
—
—
—
—
—
cases:3.63%
controls:0.37%
cases:8.06%
controls:1.09%
70
200
1080
11240
29
47
1132
11468
—
—
—
38
41
1008
11162
67
101
764
9123
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.3e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:6.09%
controls:1.75%
cases:2.50%
controls:0.41%
—
—
—
—
—
—
cases:3.63%
controls:0.37%
cases:8.06%
controls:1.09%
70
200
1080
11240
29
47
1132
11468
—
—
—
38
41
1008
11162
67
101
764
9123
FEV1
20150-9 [3024653]
1.3e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:6.09%
controls:1.75%
cases:2.50%
controls:0.41%
—
—
—
—
—
—
cases:3.63%
controls:0.37%
cases:8.06%
controls:1.09%
70
200
1080
11240
29
47
1132
11468
—
—
—
38
41
1008
11162
67
101
764
9123
EKG study
11524-6 [3013512]
1.2e-01
1.6e-01
1.5e+00
4.4e+00
1.6e+00
4.2e-01
2.2e-01
cases:7.30%
controls:6.53%
cases:4.39%
controls:3.77%
cases:1.81%
controls:0.42%
cases:3.53%
controls:0.04%
cases:2.79%
controls:0.57%
cases:5.93%
controls:3.96%
cases:13.00%
controls:10.67%
84
747
1066
10693
51
434
1110
11081
21
48
1140
11467
41
5
1120
11510
31
66
1082
11427
62
444
984
10759
108
984
723
8240
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.6e+00
2.2e+00
—
—
—
2.3e+00
1.5e+00
cases:2.17%
controls:0.45%
cases:1.38%
controls:0.16%
—
—
—
—
—
—
cases:1.63%
controls:0.17%
cases:2.77%
controls:0.65%
25
52
1125
11388
16
18
1145
11497
—
—
—
17
19
1029
11184
23
60
808
9164
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
3.8e-01
8.4e-01
2.2e+00
—
2.9e+00
8.0e-01
7.4e-01
cases:5.22%
controls:3.65%
cases:3.45%
controls:1.52%
cases:1.72%
controls:0.20%
—
—
cases:3.32%
controls:0.18%
cases:3.44%
controls:1.57%
cases:9.63%
controls:4.84%
60
417
1090
11023
40
175
1121
11340
20
23
1141
11492
—
37
21
1076
11472
36
176
1010
11027
80
446
751
8778
X-ray examination of the lungs in one projection
GD1PA [2001303645]
8.3e-01
1.4e+00
3.1e+00
1.0e+50
—
1.1e+00
1.0e+00
cases:2.17%
controls:0.96%
cases:1.81%
controls:0.45%
cases:1.81%
controls:0.09%
cases:3.45%
controls:0.00%
—
—
cases:1.82%
controls:0.59%
cases:4.33%
controls:1.57%
25
110
1125
11330
21
52
1140
11463
21
10
1140
11505
40
0
1121
11515
—
19
66
1027
11137
36
145
795
9079
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
7.2e-01
1.0e+00
1.4e+00
—
2.3e+00
1.2e+00
7.5e-01
cases:4.43%
controls:2.20%
cases:3.36%
controls:1.22%
cases:1.12%
controls:0.27%
—
—
cases:2.96%
controls:0.30%
cases:5.26%
controls:1.62%
cases:8.30%
controls:4.10%
51
252
1099
11188
39
141
1122
11374
13
31
1148
11484
—
33
35
1080
11458
55
182
991
11021
69
378
762
8846
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
—
2.3e+00
—
—
—
2.9e+00
2.2e+00
—
—
cases:0.52%
controls:0.05%
—
—
—
—
—
—
cases:1.24%
controls:0.07%
cases:1.68%
controls:0.18%
—
6
6
1155
11509
—
—
—
13
8
1033
11195
14
17
817
9207
Fever
A03 [2002000144]
4.8e-01
9.5e-01
4.0e+00
1.0e+50
—
1.5e+00
9.5e-01
cases:2.78%
controls:1.75%
cases:1.55%
controls:0.61%
cases:2.24%
controls:0.04%
cases:1.89%
controls:0.00%
—
—
cases:2.39%
controls:0.56%
cases:5.54%
controls:2.21%
32
200
1118
11240
18
70
1143
11445
26
5
1135
11510
22
0
1139
11515
—
25
63
1021
11140
46
204
785
9020
Urgent procedure
ZXD05 [2001311386]
2.9e-01
5.8e-01
2.2e+00
—
3.5e+00
1.0e+00
6.1e-01
cases:6.17%
controls:4.69%
cases:2.33%
controls:1.32%
cases:1.21%
controls:0.14%
—
—
cases:2.79%
controls:0.09%
cases:2.68%
controls:0.96%
cases:6.50%
controls:3.65%
71
536
1079
10904
27
152
1134
11363
14
16
1147
11499
—
31
10
1082
11483
28
107
1018
11096
54
337
777
8887
Nonallergic asthma
J45.1 [45557625]
9.9e-01
1.1e+00
1.3e+00
1.0e+50
2.1e+00
1.5e+00
1.6e+00
cases:2.96%
controls:1.12%
cases:1.46%
controls:0.48%
cases:0.43%
controls:0.12%
cases:1.03%
controls:0.00%
cases:0.90%
controls:0.11%
cases:2.29%
controls:0.51%
cases:4.09%
controls:0.89%
34
128
1116
11312
17
55
1144
11460
5
14
1156
11501
12
0
1149
11515
10
13
1103
11480
24
57
1022
11146
34
82
797
9142
darbepoetin alfa; parenteral
B03XA02 [21601134]
1.7e+00
1.7e+00
—
—
1.8e+00
2.0e+00
1.8e+00
cases:0.78%
controls:0.15%
cases:0.95%
controls:0.17%
—
—
—
—
cases:0.45%
controls:0.08%
cases:1.43%
controls:0.19%
cases:1.56%
controls:0.25%
9
17
1141
11423
11
20
1150
11495
—
—
5
9
1108
11484
15
21
1031
11182
13
23
818
9201
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
9.7e-01
1.2e+00
—
—
2.7e+00
1.3e+00
1.1e+00
cases:2.61%
controls:1.01%
cases:1.38%
controls:0.40%
—
—
—
—
cases:0.99%
controls:0.07%
cases:1.24%
controls:0.35%
cases:3.49%
controls:1.23%
30
115
1120
11325
16
46
1145
11469
—
—
11
8
1102
11485
13
39
1033
11164
29
113
802
9111
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
3.3e-01
9.2e-01
1.9e+00
—
2.6e+00
1.1e+00
7.5e-01
cases:2.96%
controls:2.15%
cases:2.15%
controls:0.87%
cases:0.86%
controls:0.13%
—
—
cases:2.16%
controls:0.17%
cases:2.29%
controls:0.81%
cases:4.45%
controls:2.16%
34
246
1116
11194
25
100
1136
11415
10
15
1151
11500
—
24
19
1089
11474
24
91
1022
11112
37
199
794
9025
moxifloxacin; oral, parenteral
J01MA14 [21603021]
1.0e+00
1.9e+00
—
—
—
2.5e+00
1.7e+00
cases:2.43%
controls:0.88%
cases:1.64%
controls:0.26%
—
—
—
—
—
—
cases:2.96%
controls:0.24%
cases:4.93%
controls:0.92%
28
101
1122
11339
19
30
1142
11485
—
—
—
31
27
1015
11176
41
85
790
9139
FEV1 percent change
69983-5 [42868472]
1.2e+00
1.6e+00
—
—
—
2.3e+00
2.0e+00
cases:5.22%
controls:1.58%
cases:1.81%
controls:0.36%
—
—
—
—
—
—
cases:3.06%
controls:0.32%
cases:6.74%
controls:1.01%
60
181
1090
11259
21
42
1140
11473
—
—
—
32
36
1014
11167
56
93
775
9131
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.2e+00
1.6e+00
—
—
—
2.3e+00
2.0e+00
cases:5.22%
controls:1.58%
cases:1.81%
controls:0.36%
—
—
—
—
—
—
cases:3.06%
controls:0.32%
cases:6.74%
controls:1.01%
60
181
1090
11259
21
42
1140
11473
—
—
—
32
36
1014
11167
56
93
775
9131
FVC percent change Respiratory system
69982-7 [42868471]
1.2e+00
1.6e+00
—
—
—
2.3e+00
2.0e+00
cases:5.22%
controls:1.58%
cases:1.81%
controls:0.36%
—
—
—
—
—
—
cases:3.06%
controls:0.32%
cases:6.74%
controls:1.01%
60
181
1090
11259
21
42
1140
11473
—
—
—
32
36
1014
11167
56
93
775
9131
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.2e+00
1.6e+00
—
—
—
2.3e+00
2.0e+00
cases:5.22%
controls:1.58%
cases:1.81%
controls:0.36%
—
—
—
—
—
—
cases:3.06%
controls:0.32%
cases:6.74%
controls:1.01%
60
181
1090
11259
21
42
1140
11473
—
—
—
32
36
1014
11167
56
93
775
9131
FEV1 --post bronchodilation
20155-8 [3023550]
1.2e+00
1.6e+00
—
—
—
2.3e+00
2.0e+00
cases:5.22%
controls:1.58%
cases:1.81%
controls:0.36%
—
—
—
—
—
—
cases:3.06%
controls:0.32%
cases:6.74%
controls:1.01%
60
181
1090
11259
21
42
1140
11473
—
—
—
32
36
1014
11167
56
93
775
9131
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
9.9e-01
7.3e-01
—
—
4.0e+00
1.9e+00
1.2e+00
cases:1.22%
controls:0.45%
cases:0.43%
controls:0.21%
—
—
—
—
cases:3.14%
controls:0.06%
cases:0.96%
controls:0.14%
cases:2.65%
controls:0.82%
14
52
1136
11388
5
24
1156
11491
—
—
35
7
1078
11486
10
16
1036
11187
22
76
809
9148
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.3e-01
7.0e-01
1.5e+00
—
2.6e+00
1.0e+00
6.7e-01
cases:13.04%
controls:8.09%
cases:9.22%
controls:4.79%
cases:3.96%
controls:0.91%
—
—
cases:10.42%
controls:0.83%
cases:12.43%
controls:4.98%
cases:21.66%
controls:12.41%
150
926
1000
10514
107
551
1054
10964
46
105
1115
11410
—
116
95
997
11398
130
558
916
10645
180
1145
651
8079
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
7.3e-01
5.9e-01
1.4e+00
—
2.6e+00
1.1e+00
6.2e-01
cases:8.26%
controls:4.15%
cases:4.05%
controls:2.29%
cases:1.12%
controls:0.27%
—
—
cases:3.77%
controls:0.30%
cases:6.21%
controls:2.17%
cases:12.15%
controls:6.95%
95
475
1055
10965
47
264
1114
11251
13
31
1148
11484
—
42
35
1071
11458
65
243
981
10960
101
641
730
8583
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
7.7e-01
8.8e-01
—
—
4.2e+00
1.6e+00
1.1e+00
cases:1.57%
controls:0.73%
cases:1.12%
controls:0.47%
—
—
—
—
cases:2.96%
controls:0.04%
cases:1.15%
controls:0.23%
cases:2.65%
controls:0.86%
18
84
1132
11356
13
54
1148
11461
—
—
33
5
1080
11488
12
26
1034
11177
22
79
809
9145
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
6.7e-01
8.9e-01
1.3e+00
—
3.1e+00
1.4e+00
9.0e-01
cases:4.70%
controls:2.47%
cases:2.07%
controls:0.86%
cases:0.52%
controls:0.14%
—
—
cases:2.70%
controls:0.12%
cases:4.59%
controls:1.18%
cases:8.66%
controls:3.71%
54
282
1096
11158
24
99
1137
11416
6
16
1155
11499
—
30
14
1083
11479
48
132
998
11071
72
342
759
8882
CD3 cells [#/volume] in Blood
8122-4 [3011412]
—
2.1e+00
—
—
1.0e+50
2.3e+00
2.5e+00
—
—
cases:0.52%
controls:0.06%
—
—
—
—
cases:0.45%
controls:0.00%
cases:1.24%
controls:0.12%
cases:2.77%
controls:0.23%
—
6
7
1155
11508
—
—
5
0
1108
11493
13
14
1033
11189
23
21
808
9203
salmeterol and fluticasone
R03AK06 [21603280]
1.2e+00
1.3e+00
1.0e+00
—
8.7e-01
1.3e+00
1.3e+00
cases:10.09%
controls:3.40%
cases:8.70%
controls:2.54%
cases:2.41%
controls:0.89%
—
—
cases:2.07%
controls:0.88%
cases:8.80%
controls:2.51%
cases:11.55%
controls:3.39%
116
389
1034
11051
101
292
1060
11223
28
103
1133
11412
—
23
101
1090
11392
92
281
954
10922
96
313
735
8911
tiotropium bromide; inhalant
R03BB04 [21603296]
1.5e+00
1.5e+00
1.3e+00
-1.0e+50
9.0e-01
1.4e+00
1.3e+00
cases:8.87%
controls:2.23%
cases:7.15%
controls:1.75%
cases:2.41%
controls:0.65%
cases:0.00%
controls:0.04%
cases:1.53%
controls:0.63%
cases:7.74%
controls:1.94%
cases:9.51%
controls:2.86%
102
255
1048
11185
83
202
1078
11313
28
75
1133
11440
0
5
1161
11510
17
72
1096
11421
81
217
965
10986
79
264
752
8960
oxycodone; oral, parenteral
N02AA05 [21604260]
6.5e-01
9.4e-01
1.8e+00
—
1.9e+00
1.1e+00
5.6e-01
cases:3.39%
controls:1.79%
cases:2.58%
controls:1.02%
cases:1.64%
controls:0.27%
—
—
cases:1.80%
controls:0.28%
cases:4.11%
controls:1.43%
cases:5.54%
controls:3.24%
39
205
1111
11235
30
118
1131
11397
19
31
1142
11484
—
20
32
1093
11461
43
160
1003
11043
46
299
785
8925
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
8.6e-01
8.2e-01
1.9e+00
—
3.3e+00
1.6e+00
1.1e+00
cases:3.39%
controls:1.46%
cases:1.81%
controls:0.81%
cases:0.52%
controls:0.08%
—
—
cases:2.16%
controls:0.08%
cases:3.06%
controls:0.62%
cases:5.42%
controls:1.88%
39
167
1111
11273
21
93
1140
11422
6
9
1155
11506
—
24
9
1089
11484
32
70
1014
11133
45
173
786
9051
Fungus identified in Specimen by Culture
580-1 [3000494]
8.2e-01
3.6e-01
—
—
3.5e+00
1.4e+00
8.9e-01
cases:3.57%
controls:1.61%
cases:1.03%
controls:0.72%
—
—
—
—
cases:2.34%
controls:0.07%
cases:2.68%
controls:0.68%
cases:6.02%
controls:2.56%
41
184
1109
11256
12
83
1149
11432
—
—
26
8
1087
11485
28
76
1018
11127
50
236
781
8988
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
4.8e-01
8.0e-01
2.4e+00
—
3.1e+00
1.1e+00
-2.7e-01
cases:1.04%
controls:0.65%
cases:0.86%
controls:0.39%
cases:0.69%
controls:0.06%
—
—
cases:1.71%
controls:0.08%
cases:1.43%
controls:0.50%
cases:1.44%
controls:1.88%
12
74
1138
11366
10
45
1151
11470
8
7
1153
11508
—
19
9
1094
11484
15
56
1031
11147
12
173
819
9051
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
-5.3e-03
—
—
1.0e+50
3.5e+00
2.0e+00
1.1e+00
cases:0.78%
controls:0.79%
—
—
—
—
cases:0.52%
controls:0.00%
cases:1.44%
controls:0.04%
cases:1.15%
controls:0.16%
cases:1.81%
controls:0.61%
9
90
1141
11350
—
—
6
0
1155
11515
16
5
1097
11488
12
18
1034
11185
15
56
816
9168
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
4.2e-01
5.6e-01
2.2e+00
—
2.5e+00
9.5e-01
3.1e-01
cases:7.91%
controls:5.32%
cases:4.31%
controls:2.51%
cases:2.50%
controls:0.29%
—
—
cases:3.05%
controls:0.27%
cases:6.21%
controls:2.50%
cases:11.55%
controls:8.75%
91
609
1059
10831
50
289
1111
11226
29
33
1132
11482
—
34
31
1079
11462
65
280
981
10923
96
807
735
8417
Heart failure, unspecified
I50.9 [45576879]
7.4e-01
8.2e-01
1.4e+00
—
1.8e+00
1.1e+00
8.3e-01
cases:4.70%
controls:2.29%
cases:3.10%
controls:1.39%
cases:1.21%
controls:0.31%
—
—
cases:1.80%
controls:0.31%
cases:4.30%
controls:1.54%
cases:8.06%
controls:3.69%
54
262
1096
11178
36
160
1125
11355
14
36
1147
11479
—
20
36
1093
11457
45
173
1001
11030
67
340
764
8884
montelukast; oral
R03DC03 [21603356]
7.8e-01
1.1e+00
1.2e+00
—
1.3e+00
1.2e+00
9.9e-01
cases:5.74%
controls:2.72%
cases:4.57%
controls:1.62%
cases:1.38%
controls:0.40%
—
—
cases:1.26%
controls:0.36%
cases:5.26%
controls:1.63%
cases:7.58%
controls:2.97%
66
311
1084
11129
53
186
1108
11329
16
46
1145
11469
—
14
41
1099
11452
55
183
991
11020
63
274
768
8950
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
7.6e-01
1.1e+00
2.3e+00
—
2.9e+00
1.3e+00
-1.3e-01
cases:1.30%
controls:0.61%
cases:1.03%
controls:0.34%
cases:0.78%
controls:0.08%
—
—
cases:1.26%
controls:0.07%
cases:1.53%
controls:0.41%
cases:1.56%
controls:1.78%
15
70
1135
11370
12
39
1149
11476
9
9
1152
11506
—
14
8
1099
11485
16
46
1030
11157
13
164
818
9060
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
1.2e+00
2.1e+00
—
1.0e+50
1.0e+50
2.7e+00
1.7e+00
cases:0.61%
controls:0.19%
cases:0.52%
controls:0.06%
—
—
cases:0.95%
controls:0.00%
cases:0.45%
controls:0.00%
cases:0.67%
controls:0.04%
cases:0.96%
controls:0.18%
7
22
1143
11418
6
7
1155
11508
—
11
0
1150
11515
5
0
1108
11493
7
5
1039
11198
8
17
823
9207
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
8.0e-01
1.0e+00
—
—
2.4e+00
1.3e+00
9.1e-01
cases:3.48%
controls:1.59%
cases:1.98%
controls:0.71%
—
—
—
—
cases:1.44%
controls:0.13%
cases:2.20%
controls:0.58%
cases:5.05%
controls:2.10%
40
182
1110
11258
23
82
1138
11433
—
—
16
15
1097
11478
23
65
1023
11138
42
194
789
9030
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
4.1e-01
3.6e-01
2.1e+00
—
2.8e+00
9.6e-01
6.1e-01
cases:4.87%
controls:3.29%
cases:2.50%
controls:1.76%
cases:2.15%
controls:0.26%
—
—
cases:4.40%
controls:0.28%
cases:4.30%
controls:1.69%
cases:9.75%
controls:5.56%
56
376
1094
11064
29
203
1132
11312
25
30
1136
11485
—
49
32
1064
11461
45
189
1001
11014
81
513
750
8711
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
3.3e-01
6.4e-01
1.7e+00
—
2.7e+00
8.9e-01
5.9e-01
cases:10.09%
controls:7.45%
cases:6.20%
controls:3.36%
cases:2.33%
controls:0.43%
—
—
cases:5.39%
controls:0.40%
cases:6.88%
controls:2.95%
cases:17.69%
controls:10.61%
116
852
1034
10588
72
387
1089
11128
27
49
1134
11466
—
60
46
1053
11447
72
330
974
10873
147
979
684
8245
Bacteria identified in Sputum by Culture
6460-0 [3023419]
1.8e+00
1.8e+00
—
—
—
2.2e+00
2.5e+00
cases:0.87%
controls:0.14%
cases:0.43%
controls:0.07%
—
—
—
—
—
—
cases:0.76%
controls:0.09%
cases:2.41%
controls:0.21%
10
16
1140
11424
5
8
1156
11507
—
—
—
8
10
1038
11193
20
19
811
9205
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
6.9e-01
1.2e+00
2.2e+00
—
2.8e+00
1.3e+00
-1.5e-01
cases:1.22%
controls:0.61%
cases:1.03%
controls:0.32%
cases:0.69%
controls:0.08%
—
—
cases:1.17%
controls:0.07%
cases:1.53%
controls:0.40%
cases:1.44%
controls:1.68%
14
70
1136
11370
12
37
1149
11478
8
9
1153
11506
—
13
8
1100
11485
16
45
1030
11158
12
155
819
9069
Outpatient Visit
OP [9202]
3.1e-01
4.0e-01
7.1e-01
2.0e+00
1.1e+00
1.1e+00
6.6e-01
cases:78.00%
controls:72.17%
cases:60.47%
controls:50.66%
cases:19.90%
controls:10.85%
cases:4.05%
controls:0.58%
cases:27.76%
controls:10.98%
cases:75.72%
controls:49.99%
cases:87.61%
controls:78.48%
897
8256
253
3184
702
5833
459
5682
231
1249
930
10266
47
67
1114
11448
309
1262
804
10231
792
5600
254
5603
728
7239
103
1985
Standard cardiac ultrasound examination
FM1AE [2001303278]
4.5e-01
5.1e-01
2.5e+00
—
2.6e+00
1.2e+00
4.9e-01
cases:5.30%
controls:3.45%
cases:1.98%
controls:1.20%
cases:1.38%
controls:0.11%
—
—
cases:1.35%
controls:0.10%
cases:3.92%
controls:1.21%
cases:4.93%
controls:3.09%
61
395
1089
11045
23
138
1138
11377
16
13
1145
11502
—
15
12
1098
11481
41
135
1005
11068
41
285
790
8939
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
8.7e-01
9.9e-01
1.6e+00
—
2.2e+00
1.3e+00
8.6e-01
cases:4.78%
controls:2.06%
cases:2.41%
controls:0.91%
cases:0.43%
controls:0.09%
—
—
cases:1.35%
controls:0.15%
cases:2.68%
controls:0.71%
cases:6.02%
controls:2.65%
55
236
1095
11204
28
105
1133
11410
5
10
1156
11505
—
15
17
1098
11476
28
80
1018
11123
50
244
781
8980
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
6.1e-01
5.6e-01
1.6e+00
1.0e+50
2.4e+00
7.3e-01
3.6e-01
cases:9.30%
controls:5.30%
cases:5.51%
controls:3.23%
cases:1.98%
controls:0.39%
cases:2.33%
controls:0.00%
cases:4.58%
controls:0.44%
cases:6.69%
controls:3.35%
cases:13.36%
controls:9.67%
107
606
1043
10834
64
372
1097
11143
23
45
1138
11470
27
0
1134
11515
51
51
1062
11442
70
375
976
10828
111
892
720
8332
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
2.4e-01
6.0e-01
1.8e+00
—
2.6e+00
1.1e+00
8.1e-01
cases:2.26%
controls:1.78%
cases:1.72%
controls:0.96%
cases:0.95%
controls:0.16%
—
—
cases:1.98%
controls:0.16%
cases:2.77%
controls:0.95%
cases:4.81%
controls:2.19%
26
204
1124
11236
20
110
1141
11405
11
18
1150
11497
—
22
18
1091
11475
29
106
1017
11097
40
202
791
9022
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
3.9e-01
6.3e-01
2.2e+00
—
3.5e+00
4.8e-01
5.5e-01
cases:3.83%
controls:2.61%
cases:1.89%
controls:1.02%
cases:1.29%
controls:0.14%
—
—
cases:3.50%
controls:0.11%
cases:1.63%
controls:1.01%
cases:6.50%
controls:3.84%
44
299
1106
11141
22
117
1139
11398
15
16
1146
11499
—
39
13
1074
11480
17
113
1029
11090
54
354
777
8870
Respiratory and circulatory monitoring
WX700 [2001310817]
6.2e-01
8.4e-01
2.7e+00
1.0e+50
—
1.1e+00
1.0e+00
cases:4.26%
controls:2.34%
cases:1.81%
controls:0.79%
cases:1.38%
controls:0.10%
cases:1.29%
controls:0.00%
—
—
cases:1.91%
controls:0.66%
cases:6.74%
controls:2.48%
49
268
1101
11172
21
91
1140
11424
16
11
1145
11504
15
0
1146
11515
—
20
74
1026
11129
56
229
775
8995
Cathetrisation of artery
TPH07 [2001309747]
8.2e-01
9.7e-01
—
1.0e+50
2.6e+00
1.6e+00
1.2e+00
cases:2.61%
controls:1.16%
cases:1.21%
controls:0.46%
—
—
cases:2.41%
controls:0.00%
cases:0.81%
controls:0.06%
cases:1.82%
controls:0.37%
cases:4.09%
controls:1.32%
30
133
1120
11307
14
53
1147
11462
—
28
0
1133
11515
9
7
1104
11486
19
41
1027
11162
34
122
797
9102
Protein [Mass/time] in 24 hour Urine
2889-4 [3020876]
1.1e+00
2.0e+00
—
—
—
2.4e+00
1.8e+00
cases:0.70%
controls:0.23%
cases:0.78%
controls:0.10%
—
—
—
—
—
—
cases:1.05%
controls:0.10%
cases:1.93%
controls:0.33%
8
26
1142
11414
9
12
1152
11503
—
—
—
11
11
1035
11192
16
30
815
9194
More than one and less than three hours
ZXE10 [2001311401]
2.3e-01
5.2e-01
1.8e+00
—
2.3e+00
1.1e+00
8.8e-01
cases:7.30%
controls:5.88%
cases:2.58%
controls:1.55%
cases:0.86%
controls:0.14%
—
—
cases:1.17%
controls:0.11%
cases:3.54%
controls:1.23%
cases:8.06%
controls:3.50%
84
673
1066
10767
30
178
1131
11337
10
16
1151
11499
—
13
13
1100
11480
37
138
1009
11065
67
323
764
8901
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
1.2e+00
2.3e+00
—
1.0e+50
1.0e+50
2.0e+00
1.9e+00
cases:0.70%
controls:0.20%
cases:0.78%
controls:0.08%
—
—
cases:1.55%
controls:0.00%
cases:0.63%
controls:0.00%
cases:0.76%
controls:0.11%
cases:2.05%
controls:0.33%
8
23
1142
11417
9
9
1152
11506
—
18
0
1143
11515
7
0
1106
11493
8
12
1038
11191
17
30
814
9194
Thorax CT examination
GD1AD [2001303618]
1.2e+00
1.6e+00
1.0e+50
1.0e+50
—
2.2e+00
1.0e+00
cases:1.13%
controls:0.33%
cases:0.95%
controls:0.19%
cases:0.86%
controls:0.00%
cases:2.15%
controls:0.00%
—
—
cases:1.72%
controls:0.19%
cases:2.17%
controls:0.77%
13
38
1137
11402
11
22
1150
11493
10
0
1151
11515
25
0
1136
11515
—
18
21
1028
11182
18
71
813
9153
salbutamol; inhalant
R03AC02 [21603256]
7.6e-01
9.2e-01
1.3e+00
—
1.2e+00
9.8e-01
9.1e-01
cases:24.61%
controls:13.28%
cases:16.37%
controls:7.23%
cases:4.65%
controls:1.29%
—
—
cases:4.94%
controls:1.48%
cases:16.92%
controls:7.11%
cases:30.20%
controls:14.85%
283
1519
867
9921
190
833
971
10682
54
149
1107
11366
—
55
170
1058
11323
177
797
869
10406
251
1370
580
7854
Sampling
SPAT1263 [2001700364]
3.3e-01
2.3e-01
8.2e-01
3.3e+00
1.1e+00
7.9e-01
5.9e-01
cases:12.26%
controls:9.09%
cases:5.00%
controls:4.03%
cases:1.64%
controls:0.73%
cases:1.55%
controls:0.06%
cases:2.07%
controls:0.71%
cases:7.93%
controls:3.75%
cases:17.81%
controls:10.77%
141
1040
1009
10400
58
464
1103
11051
19
84
1142
11431
18
7
1143
11508
23
82
1090
11411
83
420
963
10783
148
993
683
8231
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
1.2e+00
1.5e+00
—
1.0e+50
—
1.8e+00
1.5e+00
cases:1.48%
controls:0.45%
cases:0.95%
controls:0.21%
—
—
cases:0.52%
controls:0.00%
—
—
cases:1.43%
controls:0.23%
cases:3.49%
controls:0.80%
17
52
1133
11388
11
24
1150
11491
—
6
0
1155
11515
—
15
26
1031
11177
29
74
802
9150
Bacteria identified in Urine by Culture
630-4 [3026008]
4.1e-01
5.5e-01
2.0e+00
—
2.2e+00
8.4e-01
3.3e-01
cases:7.65%
controls:5.21%
cases:4.91%
controls:2.88%
cases:2.93%
controls:0.40%
—
—
cases:3.32%
controls:0.37%
cases:6.79%
controls:3.05%
cases:11.79%
controls:8.80%
88
596
1062
10844
57
332
1104
11183
34
46
1127
11469
—
37
43
1076
11450
71
342
975
10861
98
812
733
8412
Extensive body CT
JN4BD [2001310899]
7.6e-01
1.0e+00
2.8e+00
1.0e+50
1.9e+00
1.4e+00
7.4e-01
cases:2.70%
controls:1.28%
cases:1.21%
controls:0.43%
cases:0.86%
controls:0.05%
cases:1.29%
controls:0.00%
cases:0.45%
controls:0.07%
cases:1.82%
controls:0.45%
cases:2.53%
controls:1.23%
31
147
1119
11293
14
50
1147
11465
10
6
1151
11509
15
0
1146
11515
5
8
1108
11485
19
50
1027
11153
21
113
810
9111
Psychiatry
26 [38004469]
7.9e-01
8.8e-01
1.0e+00
—
1.4e+00
1.1e+00
8.3e-01
cases:8.35%
controls:3.98%
cases:4.48%
controls:1.91%
cases:1.89%
controls:0.69%
—
—
cases:2.70%
controls:0.70%
cases:5.26%
controls:1.75%
cases:9.39%
controls:4.33%
96
455
1054
10985
52
220
1109
11295
22
80
1139
11435
—
30
81
1083
11412
55
196
991
11007
78
399
753
8825
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
1.1e+00
2.1e+00
—
1.0e+50
1.0e+50
2.0e+00
1.8e+00
cases:1.04%
controls:0.36%
cases:0.95%
controls:0.11%
—
—
cases:1.64%
controls:0.00%
cases:1.26%
controls:0.00%
cases:0.96%
controls:0.12%
cases:3.01%
controls:0.50%
12
41
1138
11399
11
13
1150
11502
—
19
0
1142
11515
14
0
1099
11493
10
14
1036
11189
25
46
806
9178
Protein [Mass] in Urine collected for unspecified duration
32551-4 [3017817]
1.7e+00
1.8e+00
—
—
—
2.6e+00
1.6e+00
cases:0.70%
controls:0.12%
cases:0.43%
controls:0.07%
—
—
—
—
—
—
cases:0.86%
controls:0.06%
cases:1.08%
controls:0.22%
8
14
1142
11426
5
8
1156
11507
—
—
—
9
7
1037
11196
9
20
822
9204
roxithromycin; oral
J01FA06 [21602974]
7.7e-01
1.4e+00
—
—
2.8e+00
6.6e-01
9.8e-01
cases:7.13%
controls:3.44%
cases:2.93%
controls:0.75%
—
—
—
—
cases:1.17%
controls:0.07%
cases:1.43%
controls:0.75%
cases:6.62%
controls:2.58%
82
393
1068
11047
34
86
1127
11429
—
—
13
8
1100
11485
15
84
1031
11119
55
238
776
8986
budesonide; oral, sublingual
A07EA06 [21600658]
1.5e+00
1.7e+00
2.3e+00
—
—
1.5e+00
1.3e+00
cases:1.48%
controls:0.34%
cases:0.78%
controls:0.15%
cases:0.43%
controls:0.04%
—
—
—
—
cases:0.96%
controls:0.21%
cases:1.44%
controls:0.41%
17
39
1133
11401
9
17
1152
11498
5
5
1156
11510
—
—
10
23
1036
11180
12
38
819
9186
Osmolality of Urine
2695-5 [3026782]
3.6e-01
2.0e-01
2.3e+00
—
2.3e+00
7.5e-01
5.8e-01
cases:5.48%
controls:3.88%
cases:2.41%
controls:1.98%
cases:2.76%
controls:0.29%
—
—
cases:2.70%
controls:0.27%
cases:3.82%
controls:1.85%
cases:8.66%
controls:5.05%
63
444
1087
10996
28
228
1133
11287
32
33
1129
11482
—
30
31
1083
11462
40
207
1006
10996
72
466
759
8758
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
2.0e+00
—
—
—
—
2.2e+00
1.7e+00
cases:0.87%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.11%
cases:1.93%
controls:0.36%
10
13
1140
11427
—
—
—
—
10
12
1036
11191
16
33
815
9191
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
1.2e+00
2.0e+00
—
1.0e+50
1.0e+50
2.0e+00
1.9e+00
cases:0.78%
controls:0.24%
cases:0.78%
controls:0.10%
—
—
cases:1.81%
controls:0.00%
cases:0.63%
controls:0.00%
cases:0.96%
controls:0.12%
cases:2.65%
controls:0.42%
9
27
1141
11413
9
12
1152
11503
—
21
0
1140
11515
7
0
1106
11493
10
14
1036
11189
22
39
809
9185
pH of Serum or Plasma
2753-2 [3018418]
3.5e-01
7.1e-01
1.2e+00
—
2.4e+00
1.0e+00
6.0e-01
cases:7.39%
controls:5.32%
cases:5.86%
controls:2.98%
cases:1.64%
controls:0.52%
—
—
cases:5.48%
controls:0.52%
cases:7.65%
controls:2.85%
cases:14.08%
controls:8.27%
85
609
1065
10831
68
343
1093
11172
19
60
1142
11455
—
61
60
1052
11433
80
319
966
10884
117
763
714
8461
Congestive heart failure
I50.0 [45567179]
9.9e-01
1.4e+00
2.0e+00
—
1.5e+00
1.4e+00
5.7e-01
cases:2.35%
controls:0.88%
cases:1.55%
controls:0.38%
cases:0.78%
controls:0.10%
—
—
cases:0.63%
controls:0.14%
cases:2.77%
controls:0.67%
cases:2.53%
controls:1.44%
27
101
1123
11339
18
44
1143
11471
9
12
1152
11503
—
7
16
1106
11477
29
75
1017
11128
21
133
810
9091
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
1.3e+00
1.5e+00
—
1.0e+50
—
2.7e+00
1.9e+00
cases:1.22%
controls:0.35%
cases:0.60%
controls:0.14%
—
—
cases:1.72%
controls:0.00%
—
—
cases:0.67%
controls:0.04%
cases:2.05%
controls:0.31%
14
40
1136
11400
7
16
1154
11499
—
20
0
1141
11515
—
7
5
1039
11198
17
29
814
9195
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
5.4e-01
5.6e-01
1.5e+00
—
1.9e+00
8.5e-01
4.8e-01
cases:10.78%
controls:6.56%
cases:6.46%
controls:3.80%
cases:2.33%
controls:0.50%
—
—
cases:4.04%
controls:0.64%
cases:9.37%
controls:4.21%
cases:17.57%
controls:11.62%
124
751
1026
10689
75
438
1086
11077
27
58
1134
11457
—
45
74
1068
11419
98
472
948
10731
146
1072
685
8152
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
2.3e-01
4.1e-01
2.2e+00
—
2.8e+00
8.1e-01
4.2e-01
cases:4.35%
controls:3.47%
cases:1.89%
controls:1.27%
cases:1.46%
controls:0.17%
—
—
cases:2.34%
controls:0.14%
cases:2.49%
controls:1.12%
cases:7.58%
controls:5.13%
50
397
1100
11043
22
146
1139
11369
17
19
1144
11496
—
26
16
1087
11477
26
125
1020
11078
63
473
768
8751
Acute renal failure, unspecified
N17.9 [45567829]
9.2e-01
1.5e+00
—
1.0e+50
2.9e+00
1.9e+00
1.0e+00
cases:0.78%
controls:0.31%
cases:0.69%
controls:0.16%
—
—
cases:1.98%
controls:0.00%
cases:0.81%
controls:0.04%
cases:1.15%
controls:0.18%
cases:1.68%
controls:0.60%
9
36
1141
11404
8
18
1153
11497
—
23
0
1138
11515
9
5
1104
11488
12
20
1034
11183
14
55
817
9169
Erysipelas
A46 [45561706]
7.6e-01
8.8e-01
1.8e+00
—
2.1e+00
1.1e+00
9.5e-01
cases:4.26%
controls:2.05%
cases:1.98%
controls:0.83%
cases:0.43%
controls:0.07%
—
—
cases:0.72%
controls:0.09%
cases:2.58%
controls:0.86%
cases:6.50%
controls:2.62%
49
234
1101
11206
23
96
1138
11419
5
8
1156
11507
—
8
10
1105
11483
27
96
1019
11107
54
242
777
8982
Otolaryngology
4 [38004449]
2.3e-01
3.7e-01
7.6e-01
2.5e+00
2.0e+00
8.2e-01
5.0e-01
cases:15.04%
controls:12.31%
cases:6.55%
controls:4.60%
cases:1.55%
controls:0.73%
cases:0.60%
controls:0.05%
cases:4.58%
controls:0.62%
cases:9.56%
controls:4.44%
cases:18.77%
controls:12.33%
173
1408
977
10032
76
530
1085
10985
18
84
1143
11431
7
6
1154
11509
51
71
1062
11422
100
497
946
10706
156
1137
675
8087
furosemide; oral, parenteral
C03CA01 [21601518]
7.9e-01
8.4e-01
9.5e-01
—
1.4e+00
1.1e+00
8.1e-01
cases:15.74%
controls:7.79%
cases:14.13%
controls:6.62%
cases:5.34%
controls:2.15%
—
—
cases:7.91%
controls:2.16%
cases:17.69%
controls:6.91%
cases:21.06%
controls:10.57%
181
891
969
10549
164
762
997
10753
62
247
1099
11268
—
88
248
1025
11245
185
774
861
10429
175
975
656
8249
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
3.3e-01
6.8e-01
1.8e+00
—
1.7e+00
7.4e-01
8.8e-01
cases:5.48%
controls:3.99%
cases:3.19%
controls:1.64%
cases:0.86%
controls:0.14%
—
—
cases:1.44%
controls:0.28%
cases:3.54%
controls:1.71%
cases:10.71%
controls:4.75%
63
456
1087
10984
37
189
1124
11326
10
16
1151
11499
—
16
32
1097
11461
37
192
1009
11011
89
438
742
8786
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
1.1e+00
2.0e+00
—
1.0e+50
1.0e+50
2.0e+00
1.8e+00
cases:1.04%
controls:0.36%
cases:0.86%
controls:0.12%
—
—
cases:1.64%
controls:0.00%
cases:1.26%
controls:0.00%
cases:0.96%
controls:0.13%
cases:3.13%
controls:0.51%
12
41
1138
11399
10
14
1151
11501
—
19
0
1142
11515
14
0
1099
11493
10
15
1036
11188
26
47
805
9177
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.3e+00
1.5e+00
—
1.0e+50
—
2.0e+00
9.2e-01
cases:1.57%
controls:0.41%
cases:1.12%
controls:0.25%
—
—
cases:1.72%
controls:0.00%
—
—
cases:1.63%
controls:0.22%
cases:2.41%
controls:0.98%
18
47
1132
11393
13
29
1148
11486
—
20
0
1141
11515
—
17
25
1029
11178
20
90
811
9134
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 [2001309601]
1.5e+00
1.9e+00
—
1.0e+50
—
2.0e+00
2.3e+00
cases:1.04%
controls:0.24%
cases:0.60%
controls:0.09%
—
—
cases:0.52%
controls:0.00%
—
—
cases:0.48%
controls:0.06%
cases:2.05%
controls:0.21%
12
27
1138
11413
7
10
1154
11505
—
6
0
1155
11515
—
5
7
1041
11196
17
19
814
9205
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
1.3e+00
1.8e+00
—
1.0e+50
1.0e+50
1.9e+00
2.0e+00
cases:0.70%
controls:0.19%
cases:0.60%
controls:0.10%
—
—
cases:1.64%
controls:0.00%
cases:0.54%
controls:0.00%
cases:0.67%
controls:0.10%
cases:2.41%
controls:0.35%
8
22
1142
11418
7
11
1154
11504
—
19
0
1142
11515
6
0
1107
11493
7
11
1039
11192
20
32
811
9192
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
6.7e-01
1.1e+00
—
—
4.1e+00
1.6e+00
7.4e-01
cases:0.78%
controls:0.40%
cases:0.86%
controls:0.29%
—
—
—
—
cases:2.61%
controls:0.04%
cases:1.15%
controls:0.23%
cases:1.44%
controls:0.69%
9
46
1141
11394
10
33
1151
11482
—
—
29
5
1084
11488
12
26
1034
11177
12
64
819
9160
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.3e+00
1.5e+00
—
—
—
1.6e+00
1.2e+00
cases:2.96%
controls:0.83%
cases:1.29%
controls:0.28%
—
—
—
—
—
—
cases:1.15%
controls:0.23%
cases:3.61%
controls:1.06%
34
95
1116
11345
15
32
1146
11483
—
—
—
12
26
1034
11177
30
98
801
9126
Acute maxillary sinusitis
J01.0 [45601112]
4.5e-01
6.2e-01
2.3e+00
—
2.7e+00
6.5e-01
6.8e-01
cases:4.09%
controls:2.64%
cases:1.81%
controls:0.98%
cases:0.78%
controls:0.08%
—
—
cases:1.17%
controls:0.08%
cases:1.91%
controls:1.01%
cases:6.02%
controls:3.15%
47
302
1103
11138
21
113
1140
11402
9
9
1152
11506
—
13
9
1100
11484
20
113
1026
11090
50
291
781
8933
salbutamol and ipratropium bromide
R03AL02 [43534844]
1.7e+00
1.7e+00
—
—
—
2.3e+00
1.4e+00
cases:0.70%
controls:0.13%
cases:0.69%
controls:0.12%
—
—
—
—
—
—
cases:0.86%
controls:0.09%
cases:0.84%
controls:0.22%
8
15
1142
11425
8
14
1153
11501
—
—
—
9
10
1037
11193
7
20
824
9204
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
2.8e-01
5.2e-01
2.6e+00
—
1.9e+00
7.2e-01
1.7e-01
cases:10.52%
controls:8.17%
cases:5.51%
controls:3.34%
cases:5.34%
controls:0.43%
—
—
cases:2.43%
controls:0.38%
cases:5.74%
controls:2.88%
cases:16.61%
controls:14.36%
121
935
1029
10505
64
385
1097
11130
62
50
1099
11465
—
27
44
1086
11449
60
323
986
10880
138
1325
693
7899
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
3.3e-01
4.7e-01
7.2e-01
1.9e+00
1.2e+00
5.9e-01
3.9e-01
cases:41.65%
controls:34.00%
cases:27.05%
controls:18.88%
cases:7.41%
controls:3.76%
cases:0.78%
controls:0.11%
cases:12.40%
controls:3.97%
cases:30.88%
controls:19.91%
cases:51.02%
controls:41.24%
479
3890
671
7550
314
2174
847
9341
86
433
1075
11082
9
13
1152
11502
138
456
975
11037
323
2230
723
8973
424
3804
407
5420
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
1.7e+00
1.3e+00
1.0e+50
—
—
2.2e+00
1.7e+00
cases:2.26%
controls:0.43%
cases:0.86%
controls:0.23%
cases:0.43%
controls:0.00%
—
—
—
—
cases:0.67%
controls:0.07%
cases:1.68%
controls:0.30%
26
49
1124
11391
10
26
1151
11489
5
0
1156
11515
—
—
7
8
1039
11195
14
28
817
9196
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
1.8e+00
—
—
—
—
2.1e+00
1.8e+00
cases:0.70%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.10%
cases:1.32%
controls:0.23%
8
13
1142
11427
—
—
—
—
8
11
1038
11192
11
21
820
9203
prednisone
A07EA03 [21600655]
9.5e-01
1.2e+00
—
—
1.7e+00
9.3e-01
8.2e-01
cases:4.35%
controls:1.73%
cases:1.72%
controls:0.52%
—
—
—
—
cases:0.81%
controls:0.15%
cases:1.82%
controls:0.72%
cases:3.73%
controls:1.68%
50
198
1100
11242
20
60
1141
11455
—
—
9
17
1104
11476
19
81
1027
11122
31
155
800
9069
prednisone; oral
H02AB07 [21602735]
9.5e-01
1.2e+00
—
—
1.7e+00
9.3e-01
8.2e-01
cases:4.35%
controls:1.73%
cases:1.72%
controls:0.52%
—
—
—
—
cases:0.81%
controls:0.15%
cases:1.82%
controls:0.72%
cases:3.73%
controls:1.68%
50
198
1100
11242
20
60
1141
11455
—
—
9
17
1104
11476
19
81
1027
11122
31
155
800
9069
methylprednisolone; oral, parenteral
H02AB04 [21602732]
9.2e-01
1.5e+00
—
—
1.8e+00
1.3e+00
6.6e-01
cases:4.26%
controls:1.75%
cases:2.58%
controls:0.59%
—
—
—
—
cases:0.81%
controls:0.13%
cases:2.20%
controls:0.63%
cases:2.89%
controls:1.52%
49
200
1101
11240
30
68
1131
11447
—
—
9
15
1104
11478
23
71
1023
11132
24
140
807
9084
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
4.1e-01
4.1e-01
1.9e+00
—
2.1e+00
6.7e-01
4.0e-01
cases:7.22%
controls:4.89%
cases:4.13%
controls:2.79%
cases:3.62%
controls:0.56%
—
—
cases:3.50%
controls:0.44%
cases:5.54%
controls:2.92%
cases:11.55%
controls:8.04%
83
559
1067
10881
48
321
1113
11194
42
65
1119
11450
—
39
50
1074
11443
58
327
988
10876
96
742
735
8482
Pneumonia
R81 [2002000949]
7.8e-01
—
—
1.0e+50
—
3.4e+00
2.1e+00
cases:0.61%
controls:0.28%
—
—
—
—
cases:0.86%
controls:0.00%
—
—
cases:2.29%
controls:0.08%
cases:2.65%
controls:0.34%
7
32
1143
11408
—
—
10
0
1151
11515
—
24
9
1022
11194
22
31
809
9193
formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]
1.9e+00
1.7e+00
—
—
—
1.8e+00
1.1e+00
cases:0.78%
controls:0.11%
cases:0.78%
controls:0.14%
—
—
—
—
—
—
cases:1.05%
controls:0.18%
cases:1.44%
controls:0.50%
9
13
1141
11427
9
16
1152
11499
—
—
—
11
20
1035
11183
12
46
819
9178
temazepam; oral
N05CD07 [21604642]
6.7e-01
7.3e-01
1.1e+00
—
1.2e+00
1.1e+00
7.2e-01
cases:6.52%
controls:3.44%
cases:4.22%
controls:2.08%
cases:1.38%
controls:0.49%
—
—
cases:1.62%
controls:0.51%
cases:5.93%
controls:2.10%
cases:7.34%
controls:3.70%
75
393
1075
11047
49
240
1112
11275
16
56
1145
11459
—
18
59
1095
11434
62
235
984
10968
61
341
770
8883
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.3e+00
1.6e+00
—
—
—
1.3e+00
1.2e+00
cases:1.74%
controls:0.46%
cases:1.12%
controls:0.23%
—
—
—
—
—
—
cases:1.05%
controls:0.29%
cases:2.77%
controls:0.83%
20
53
1130
11387
13
27
1148
11488
—
—
—
11
33
1035
11170
23
77
808
9147
lenalidomide; oral
L04AX04 [21603930]
—
—
—
—
—
2.4e+00
3.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.05%
cases:1.32%
controls:0.07%
—
—
—
—
—
6
6
1040
11197
11
6
820
9218
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
3.1e-01
2.9e-01
2.0e+00
—
3.3e+00
3.3e-01
2.0e-01
cases:2.35%
controls:1.74%
cases:0.95%
controls:0.71%
cases:0.60%
controls:0.08%
—
—
cases:1.71%
controls:0.06%
cases:0.76%
controls:0.55%
cases:2.89%
controls:2.37%
27
199
1123
11241
11
82
1150
11433
7
9
1154
11506
—
19
7
1094
11486
8
62
1038
11141
24
219
807
9005
Telehealth
OMOP5556618 [722455]
2.1e-01
2.2e-01
6.1e-01
2.8e+00
9.3e-01
6.7e-01
4.3e-01
cases:28.17%
controls:24.04%
cases:12.83%
controls:10.55%
cases:3.70%
controls:2.05%
cases:0.95%
controls:0.06%
cases:4.94%
controls:2.02%
cases:19.02%
controls:10.71%
cases:33.21%
controls:24.41%
324
2750
826
8690
149
1215
1012
10300
43
236
1118
11279
11
7
1150
11508
55
232
1058
11261
199
1200
847
10003
276
2252
555
6972
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
4.1e-01
4.9e-01
1.7e+00
—
2.8e+00
9.4e-01
3.3e-01
cases:5.30%
controls:3.59%
cases:3.27%
controls:2.04%
cases:1.89%
controls:0.36%
—
—
cases:4.94%
controls:0.32%
cases:5.74%
controls:2.31%
cases:7.94%
controls:5.85%
61
411
1089
11029
38
235
1123
11280
22
42
1139
11473
—
55
37
1058
11456
60
259
986
10944
66
540
765
8684
Gout, unspecified
M10.9 [45543454]
1.1e+00
3.3e-01
1.5e+00
—
2.3e+00
1.0e+00
9.4e-01
cases:2.52%
controls:0.89%
cases:0.60%
controls:0.43%
cases:0.43%
controls:0.10%
—
—
cases:0.81%
controls:0.08%
cases:1.53%
controls:0.54%
cases:3.25%
controls:1.29%
29
102
1121
11338
7
50
1154
11465
5
11
1156
11504
—
9
9
1104
11484
16
61
1030
11142
27
119
804
9105
formoterol and beclometasone
R03AK08 [43534839]
1.2e+00
1.3e+00
—
—
—
1.5e+00
1.4e+00
cases:1.48%
controls:0.45%
cases:1.46%
controls:0.41%
—
—
—
—
—
—
cases:1.91%
controls:0.45%
cases:3.37%
controls:0.87%
17
52
1133
11388
17
47
1144
11468
—
—
—
20
50
1026
11153
28
80
803
9144
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
1.5e+00
1.7e+00
—
—
—
2.3e+00
1.6e+00
cases:0.87%
controls:0.19%
cases:0.52%
controls:0.10%
—
—
—
—
—
—
cases:0.76%
controls:0.08%
cases:1.56%
controls:0.34%
10
22
1140
11418
6
11
1155
11504
—
—
—
8
9
1038
11194
13
31
818
9193
Infiltration anesthesia
WX110 [2001310767]
3.0e-01
2.3e-01
3.1e-01
3.1e+00
8.5e-01
5.8e-01
4.6e-01
cases:22.00%
controls:17.28%
cases:8.53%
controls:6.91%
cases:1.29%
controls:0.95%
cases:0.95%
controls:0.04%
cases:2.34%
controls:1.01%
cases:11.47%
controls:6.76%
cases:29.60%
controls:20.93%
253
1977
897
9463
99
796
1062
10719
15
109
1146
11406
11
5
1150
11510
26
116
1087
11377
120
757
926
10446
246
1931
585
7293
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.0e+00
1.7e+00
—
—
—
1.8e+00
1.8e+00
cases:0.78%
controls:0.29%
cases:0.86%
controls:0.17%
—
—
—
—
—
—
cases:1.15%
controls:0.20%
cases:2.89%
controls:0.47%
9
33
1141
11407
10
19
1151
11496
—
—
—
12
22
1034
11181
24
43
807
9181
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
8.9e-01
1.0e+00
—
1.0e+50
3.4e+00
1.9e+00
7.2e-01
cases:1.30%
controls:0.54%
cases:0.95%
controls:0.34%
—
—
cases:2.50%
controls:0.00%
cases:1.53%
controls:0.05%
cases:1.53%
controls:0.24%
cases:2.65%
controls:1.30%
15
62
1135
11378
11
39
1150
11476
—
29
0
1132
11515
17
6
1096
11487
16
27
1030
11176
22
120
809
9104
CD8 cells/Lymphocytes in Specimen
80222-3 [21494814]
—
—
—
—
—
2.7e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.04%
cases:1.08%
controls:0.09%
—
—
—
—
—
7
5
1039
11198
9
8
822
9216
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
3.0e-01
3.7e-01
1.3e+00
—
2.3e+00
1.1e+00
6.4e-01
cases:7.22%
controls:5.44%
cases:4.22%
controls:2.94%
cases:1.46%
controls:0.41%
—
—
cases:4.22%
controls:0.46%
cases:7.84%
controls:2.85%
cases:15.64%
controls:8.94%
83
622
1067
10818
49
339
1112
11176
17
47
1144
11468
—
47
53
1066
11440
82
319
964
10884
130
825
701
8399
enoxaparin; parenteral
B01AB05 [21600976]
6.0e-01
6.7e-01
6.9e-01
—
2.0e+00
1.1e+00
9.0e-01
cases:8.52%
controls:4.89%
cases:3.01%
controls:1.57%
cases:0.60%
controls:0.30%
—
—
cases:1.98%
controls:0.28%
cases:4.21%
controls:1.45%
cases:11.43%
controls:5.01%
98
559
1052
10881
35
181
1126
11334
7
35
1154
11480
—
22
32
1091
11461
44
162
1002
11041
95
462
736
8762
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
7.6e-01
1.3e+00
1.6e+00
—
2.2e+00
1.0e+00
5.4e-01
cases:2.61%
controls:1.24%
cases:1.64%
controls:0.47%
cases:0.43%
controls:0.09%
—
—
cases:0.54%
controls:0.06%
cases:1.82%
controls:0.66%
cases:3.37%
controls:1.99%
30
142
1120
11298
19
54
1142
11461
5
10
1156
11505
—
6
7
1107
11486
19
74
1027
11129
28
184
803
9040
Erythrocyte sedimentation rate above reference range
165468009 [4013526]
1.4e+00
—
—
—
—
2.2e+00
1.6e+00
cases:0.87%
controls:0.22%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.06%
cases:1.08%
controls:0.22%
10
25
1140
11415
—
—
—
—
6
7
1040
11196
9
20
822
9204
General Practice Dentistry
1223G0001X [38003675]
1.0e+00
1.5e+00
—
—
—
1.7e+00
9.6e-01
cases:1.30%
controls:0.47%
cases:0.78%
controls:0.17%
—
—
—
—
—
—
cases:0.96%
controls:0.17%
cases:1.93%
controls:0.75%
15
54
1135
11386
9
20
1152
11495
—
—
—
10
19
1036
11184
16
69
815
9155
Intravenous
ZX120 [2001311495]
8.6e-01
1.2e+00
1.7e+00
1.0e+50
1.6e+00
1.7e+00
1.5e+00
cases:2.70%
controls:1.15%
cases:1.72%
controls:0.52%
cases:0.52%
controls:0.10%
cases:1.21%
controls:0.00%
cases:0.54%
controls:0.10%
cases:2.01%
controls:0.38%
cases:4.57%
controls:1.08%
31
132
1119
11308
20
60
1141
11455
6
11
1155
11504
14
0
1147
11515
6
12
1107
11481
21
43
1025
11160
38
100
793
9124
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
5.8e-01
6.3e-01
1.7e+00
—
2.4e+00
1.1e+00
5.6e-01
cases:2.17%
controls:1.22%
cases:1.55%
controls:0.83%
cases:0.69%
controls:0.13%
—
—
cases:0.99%
controls:0.09%
cases:2.10%
controls:0.73%
cases:3.37%
controls:1.96%
25
140
1125
11300
18
96
1143
11419
8
15
1153
11500
—
11
10
1102
11483
22
82
1024
11121
28
181
803
9043
One hour or less
ZXE00 [2001311394]
5.9e-01
4.7e-01
1.1e+00
—
2.2e+00
1.3e+00
1.1e+00
cases:11.13%
controls:6.47%
cases:3.10%
controls:1.96%
cases:0.78%
controls:0.25%
—
—
cases:1.35%
controls:0.16%
cases:5.54%
controls:1.52%
cases:11.67%
controls:4.39%
128
740
1022
10700
36
226
1125
11289
9
29
1152
11486
—
15
18
1098
11475
58
170
988
11033
97
405
734
8819
Other specified interstitial pulmonary diseases
J84.8 [45548126]
—
—
—
—
—
2.5e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.06%
cases:1.20%
controls:0.09%
—
—
—
—
—
8
7
1038
11196
10
8
821
9216
Dyspnoea
R06.0 [45558449]
5.7e-01
1.1e+00
1.7e+00
1.0e+50
1.0e+00
1.2e+00
6.6e-01
cases:6.09%
controls:3.52%
cases:3.79%
controls:1.31%
cases:1.03%
controls:0.20%
cases:0.95%
controls:0.00%
cases:0.63%
controls:0.23%
cases:4.40%
controls:1.40%
cases:8.66%
controls:4.67%
70
403
1080
11037
44
151
1117
11364
12
23
1149
11492
11
0
1150
11515
7
26
1106
11467
46
157
1000
11046
72
431
759
8793
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
8.7e-01
1.1e+00
—
1.0e+50
3.4e+00
1.8e+00
7.2e-01
cases:1.30%
controls:0.55%
cases:0.95%
controls:0.33%
—
—
cases:2.67%
controls:0.00%
cases:1.53%
controls:0.05%
cases:1.53%
controls:0.27%
cases:2.65%
controls:1.31%
15
63
1135
11377
11
38
1150
11477
—
31
0
1130
11515
17
6
1096
11487
16
30
1030
11173
22
121
809
9103
dexamethasone; oral, parenteral
H02AB02 [21602730]
7.0e-01
1.2e+00
2.2e+00
—
1.6e+00
1.0e+00
5.6e-01
cases:4.17%
controls:2.12%
cases:3.10%
controls:0.97%
cases:0.95%
controls:0.10%
—
—
cases:0.45%
controls:0.09%
cases:2.77%
controls:1.00%
cases:5.05%
controls:2.94%
48
243
1102
11197
36
112
1125
11403
11
12
1150
11503
—
5
10
1108
11483
29
112
1017
11091
42
271
789
8953
CD19 cells/cells in Blood
8117-4 [3016228]
—
—
—
—
—
2.7e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.04%
cases:1.08%
controls:0.10%
—
—
—
—
—
7
5
1039
11198
9
9
822
9215
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
6.9e-01
9.4e-01
1.8e+00
—
—
1.0e+00
6.7e-01
cases:5.83%
controls:3.02%
cases:3.10%
controls:1.23%
cases:0.86%
controls:0.14%
—
—
—
—
cases:2.96%
controls:1.12%
cases:6.38%
controls:3.37%
67
345
1083
11095
36
142
1125
11373
10
16
1151
11499
—
—
31
125
1015
11078
53
311
778
8913
IgG subclass 3 [Mass/volume] in Serum
2468-7 [3024139]
—
—
—
—
—
2.6e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.07%
cases:1.44%
controls:0.12%
—
—
—
—
—
10
8
1036
11195
12
11
819
9213
IgG subclass 2 [Mass/volume] in Serum
2467-9 [3028192]
—
—
—
—
—
2.6e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.07%
cases:1.44%
controls:0.12%
—
—
—
—
—
10
8
1036
11195
12
11
819
9213
IgG subclass 1 [Mass/volume] in Serum
2466-1 [3027135]
—
—
—
—
—
2.6e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.96%
controls:0.07%
cases:1.44%
controls:0.12%
—
—
—
—
—
10
8
1036
11195
12
11
819
9213
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
4.4e-01
5.8e-01
1.1e+00
—
1.9e+00
6.4e-01
4.5e-01
cases:8.87%
controls:5.89%
cases:5.51%
controls:3.15%
cases:1.46%
controls:0.50%
—
—
cases:3.32%
controls:0.51%
cases:5.93%
controls:3.22%
cases:12.39%
controls:8.26%
102
674
1048
10766
64
363
1097
11152
17
57
1144
11458
—
37
59
1076
11434
62
361
984
10842
103
762
728
8462
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
3.2e-01
5.2e-01
1.6e+00
—
3.0e+00
1.2e+00
8.6e-01
cases:2.78%
controls:2.04%
cases:1.38%
controls:0.83%
cases:0.43%
controls:0.09%
—
—
cases:0.90%
controls:0.04%
cases:2.20%
controls:0.68%
cases:5.78%
controls:2.54%
32
233
1118
11207
16
95
1145
11420
5
10
1156
11505
—
10
5
1103
11488
23
76
1023
11127
48
234
783
8990
Gastroenterology
10 [38004455]
6.1e-01
4.1e-01
1.4e+00
—
1.4e+00
9.3e-01
7.3e-01
cases:8.35%
controls:4.74%
cases:3.19%
controls:2.14%
cases:1.03%
controls:0.25%
—
—
cases:1.26%
controls:0.32%
cases:4.97%
controls:2.03%
cases:11.07%
controls:5.65%
96
542
1054
10898
37
246
1124
11269
12
29
1149
11486
—
14
37
1099
11456
52
227
994
10976
92
521
739
8703
ECG with 12 standard connections
XF400 [2001303368]
5.4e-01
4.6e-01
2.8e+00
—
—
1.1e+00
1.1e+00
cases:3.39%
controls:2.01%
cases:0.86%
controls:0.55%
cases:1.46%
controls:0.09%
—
—
—
—
cases:1.63%
controls:0.54%
cases:4.45%
controls:1.55%
39
230
1111
11210
10
63
1151
11452
17
10
1144
11505
—
—
17
60
1029
11143
37
143
794
9081

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
797
3440
4.21
148.23
7.2
4.4
—
—
—
0
0
301
962
3.74
79.76
5.6
2.9
11.78
10.74
g/l
1.88
281
892
93
109
9.09
73.84
1.4
1.2
—
—
—
0
0
714
4089
2.58
63.26
10.7
6.6
—
—
—
0
0
352
1418
3.00
62.53
12.6
8.9
7.41
7.42
ph
0.23
208
782
348
1430
2.93
59.30
12.7
8.8
5.11
5.13
kpa
0.09
330
1373
348
1431
2.93
59.21
12.7
8.8
10.26
12.26
kpa
15.71
330
1376
342
1410
2.91
57.76
12.5
8.8
1.19
0.92
mmol/l
0.45
289
1163
230
771
3.39
55.28
3.2
1.8
1.33
1.38
g/l
0.09
213
715
384
1763
2.65
52.01
2.7
2.1
—
—
—
0
0
374
1714
2.63
50.67
11.6
7.0
1.08
1.06
mmol/l
0.66
357
1598
302
1277
2.76
47.71
12.6
9.3
93.20
95.50
%
4.54
289
1238
838
5631
2.28
45.97
11.8
6.8
8.53
8.92
%
2.91
806
5301
849
5772
2.27
44.75
11.5
6.7
25.05
27.61
%
6.44
822
5504
832
5619
2.25
44.44
11.7
6.7
2.48
2.88
%
5.27
800
5286
829
5621
2.23
43.42
11.9
6.8
0.59
0.67
%
4.11
796
5286
275
1168
2.70
42.66
14.0
9.7
118.28
120.99
g/l
1.24
267
1141
70
112
6.54
42.22
2.5
2.9
1381.77
1253.70
e6/l
0.33
53
94
827
5682
2.17
40.80
11.3
6.6
59.94
57.28
%
5.95
808
5439
162
525
3.37
40.57
2.4
2.0
3.51
1.95
ug/l
1.12
147
468
267
1165
2.61
38.95
13.9
8.5
11.55
9.94
mmol/l
2.66
259
1119
879
6249
2.16
38.83
11.9
6.8
0.19
0.19
e9/l
0.10
773
5446
385
2018
2.27
37.17
6.6
4.0
0.81
0.82
mmol/l
0.70
364
1910
868
6199
2.12
37.09
11.4
6.6
2.15
1.92
e9/l
0.89
773
5453
430
2362
2.20
36.97
2.0
2.0
—
—
—
0
0
99
246
4.26
36.35
2.1
1.7
—
—
—
0
0
919
6734
2.14
36.31
17.3
9.8
4.76
4.12
e9/l
8.82
805
5838
849
6054
2.08
35.88
11.4
6.5
0.64
0.59
e9/l
7.61
736
5182
195
756
2.85
35.66
14.4
10.7
24.06
24.31
mmol/l
0.39
189
743
849
6066
2.07
35.53
11.4
6.5
0.04
0.04
e9/l
0.43
736
5198
851
6100
2.07
35.11
10.5
6.8
11.18
12.04
umol/l
1.05
824
5826
258
1165
2.50
34.72
12.9
8.7
1.64
1.36
mmol/l
1.32
252
1143
289
1380
2.39
34.37
7.7
4.9
7.38
7.38
ph
0.11
189
831
768
5334
2.02
34.25
15.3
7.4
1.20
1.21
mmol/l
3.89
723
4950
234
1015
2.58
34.24
6.3
2.9
66.69
66.40
g/l
0.15
208
936
302
1473
2.35
34.20
4.9
3.0
1.90
1.76
%
1.40
273
1332
349
1811
2.25
34.13
3.6
2.8
19.93
22.86
%
3.66
328
1695
81
181
4.70
33.99
1.8
1.6
—
—
—
0
0
81
181
4.70
33.99
1.8
1.6
—
—
—
0
0
81
181
4.70
33.99
1.8
1.6
—
—
—
0
0
81
181
4.70
33.99
1.8
1.6
—
—
—
0
0
285
1377
2.36
32.86
7.5
4.8
5.88
5.82
kpa
0.42
275
1340
365
1958
2.18
32.69
3.7
2.7
2.19
2.30
g/l
3.17
339
1813
80
184
4.56
32.39
3.8
3.9
2.13
1.38
%
0.49
75
169
54
87
6.42
32.31
2.4
3.1
683.09
599.17
e6/l
0.23
33
66
276
1329
2.35
32.00
7.5
4.9
1.70
1.77
mmol/l
0.09
244
1124
159
589
2.93
31.47
2.2
2.0
1.71
1.49
g/l
1.72
137
527
816
5914
1.96
30.75
16.6
7.9
1.20
1.21
mmol/l
4.42
727
5142
766
5437
1.94
30.70
19.3
16.0
1.32
1.28
inr
0.94
671
4559
176
699
2.75
30.54
15.3
12.0
15.06
15.81
%
2.66
168
671
191
794
2.64
30.28
6.5
2.6
—
—
—
0
0
249
1178
2.37
29.89
15.5
9.8
—
—
—
0
0
288
1463
2.23
29.16
2.7
1.7
—
—
—
0
0
371
2098
2.06
28.37
3.8
2.8
10.71
13.06
umol/l
9.11
347
1951
730
5182
1.89
28.36
9.9
5.6
33.07
35.57
g/l
19.82
691
4880
50
87
5.93
27.71
2.8
3.2
220.79
198.77
e6/l
0.17
34
71
238
1141
2.32
27.55
5.1
2.9
71.06
68.71
e9/l
0.41
176
846
58
118
5.09
27.16
1.5
1.3
10.05
6.62
g/l
1.69
35
87
58
118
5.09
27.16
1.4
1.3
—
—
—
0
0
58
118
5.09
27.16
1.5
1.3
0.40
0.43
g/l
0.21
38
87
58
118
5.09
27.16
1.5
1.3
2.33
2.86
g/l
1.11
38
87
116
402
3.06
25.72
8.0
3.5
174.88
38.09
mg/l
0.73
96
347
900
6956
1.88
25.47
11.0
5.6
6.94
6.69
mmol/l
2.21
864
6583
115
401
3.04
25.22
8.0
3.5
70.92
65.05
mg/l
0.13
95
344
204
949
2.35
25.18
9.8
4.6
5.11
5.14
kpa
0.18
194
915
70
178
4.09
24.88
3.8
2.9
—
—
—
0
0
53
108
5.07
24.77
2.4
2.8
36.73
37.33
%
0.09
53
108
58
129
4.65
24.46
1.5
1.3
—
—
—
0
0
235
1181
2.20
24.06
3.3
2.7
0.19
0.21
g/l
2.28
212
1099
106
363
3.08
23.97
7.9
3.3
4.57
3.73
ratio
0.16
67
208
198
929
2.33
23.90
9.9
4.7
7.42
7.41
ph
1.04
175
788
69
179
4.01
23.87
1.4
1.4
33.62
32.16
g/l
0.36
60
162
170
747
2.46
23.77
11.0
7.6
24.69
24.49
mmol/l
0.24
159
710
63
154
4.24
23.59
1.3
1.3
1403.72
1649.19
e6/l
0.24
40
106
119
444
2.84
23.09
5.9
2.5
2.81
2.97
g/l
0.88
104
405
123
471
2.77
22.72
6.2
2.5
4.17
4.15
g/l
0.07
108
432
123
471
2.77
22.72
6.2
2.5
4.17
3.65
g/l
0.80
108
432
123
471
2.77
22.72
6.2
2.5
7.49
7.30
g/l
0.58
108
432
522
3510
1.79
22.57
3.8
3.2
—
—
—
0
0
495
3278
1.80
22.52
2.9
2.4
3.12
2.84
mg/l
1.38
436
2819
71
199
3.71
22.03
2.0
1.8
0.60
0.83
g/l
1.02
53
161
508
3435
1.77
21.23
4.3
3.5
0.61
0.43
e6/l
0.91
380
2550
66
184
3.72
20.64
9.9
6.6
11.49
11.92
mg/l
0.33
60
168
941
7608
1.78
20.36
6.5
4.7
256.92
1703.05
e6/l
1.74
12
130
381
2395
1.82
20.18
3.6
3.1
503.21
549.63
mosm/kgh2o
4.22
342
2111
200
1009
2.15
20.06
5.7
4.6
0.91
0.65
%
0.49
113
322
101
372
2.85
20.04
3.3
1.4
0.23
0.24
g/l
0.30
94
354
125
514
2.58
20.02
8.8
6.1
0.76
0.87
%
2.64
117
483
555
3908
1.71
19.69
4.7
3.5
49.57
33.21
u/l
0.75
519
3703
563
3982
1.71
19.63
4.7
3.6
43.74
95.94
e6/l
1.44
435
3071
207
1067
2.11
19.62
5.8
4.7
0.78
0.93
%
0.50
119
345
507
3487
1.73
19.57
7.9
4.3
7.40
7.40
ph
0.16
395
2518
704
5300
1.68
19.31
18.6
11.9
0.00
0.00
e9/l
0.18
574
4318
53
133
4.11
19.18
1.3
1.3
111762.31
124798.71
e6/l
0.07
29
76
223
1194
2.04
19.05
6.5
4.3
4.73
4.59
kpa
0.42
213
1162
106
413
2.70
18.90
5.9
2.5
12.54
10.43
g/l
1.31
90
372
131
567
2.45
18.81
8.5
5.7
1.71
1.57
%
0.98
122
535
30
46
6.65
18.79
2.6
4.2
0.25
0.35
e9/l
—
10
20
1033
8672
1.81
18.64
14.1
8.3
89.96
80.79
u/l
4.72
997
8243
618
4528
1.67
18.55
5.4
4.2
47.27
117.68
e6/l
2.49
453
3214
386
2495
1.77
18.33
2.3
1.5
2.49
2.40
g/l
0.32
277
1527
74
240
3.20
18.33
9.1
9.3
104.08
105.19
mmol/l
0.81
65
216
74
240
3.20
18.33
9.1
9.3
11.95
11.37
mmol/l
0.72
65
216
86
305
2.94
18.28
3.0
3.4
35.27
34.54
umol/l
0.11
77
274
26
35
7.55
18.27
2.2
1.9
30.31
30.57
%
0.02
26
35
53
138
3.96
18.26
2.8
2.6
1.91
1.51
g/24h
0.22
34
84
319
1960
1.82
17.92
1.9
1.7
—
—
—
0
0
81
283
2.98
17.68
6.7
4.0
—
—
—
0
0
441
2993
1.70
17.42
8.3
4.5
83.56
87.59
%
2.97
427
2942
196
1035
2.05
17.30
6.3
5.1
0.01
0.12
%
1.88
102
277
244
1397
1.91
17.05
4.5
3.2
8.48
8.17
umol/l
0.09
205
1234
159
782
2.17
16.90
6.9
4.0
120.90
127.97
g/l
3.60
154
763
192
1017
2.03
16.78
6.0
4.8
0.10
0.12
%
0.21
102
294
510
3627
1.65
16.69
3.6
2.7
56.78
61.68
u/l
0.80
482
3369
45
111
4.16
16.68
4.1
2.2
—
—
—
0
0
252
1469
1.88
16.63
3.7
3.1
5.85
5.06
e9/l
0.34
218
1285
51
139
3.77
16.50
1.4
1.4
6.00
6.21
mmol/l
0.22
45
133
350
2265
1.74
16.26
6.1
4.0
334.22
465.65
ng/l
0.61
297
1757
50
136
3.78
16.22
1.3
1.4
—
—
—
0
0
247
1446
1.87
16.04
1.7
1.5
—
—
—
0
0
501
3576
1.64
16.00
4.5
3.4
2485.49
1508.75
ng/l
3.56
436
3096
49
133
3.79
15.95
4.1
4.1
—
—
—
0
0
88
347
2.64
15.32
9.3
7.8
1.33
1.34
mmol/l
0.04
77
299
174
924
2.01
15.04
5.1
3.1
328.57
219.96
ng/l
1.76
161
852
312
1999
1.73
14.85
2.1
1.8
1191.85
1181.42
nmol/l
0.06
242
1538
313
2019
1.72
14.50
3.7
3.3
3.66
1.82
e6/l
1.53
152
1023
301
1924
1.73
14.40
5.0
2.4
30.56
29.54
s
1.60
295
1872
491
3563
1.59
14.25
10.2
6.4
—
—
—
0
0
239
1440
1.80
14.00
1.9
1.6
—
—
—
0
0
324
2145
1.67
13.50
3.8
3.2
1.94
0.99
e6/l
1.63
167
1157
397
2767
1.62
13.49
3.9
2.8
7.76
5.36
e6/l
1.78
367
2526
173
954
1.93
13.36
1.4
1.5
—
—
—
0
0
68
253
2.78
13.27
7.0
4.7
2.83
2.71
mmol/l
0.11
46
166
77
306
2.61
13.21
3.6
2.4
123.23
129.46
g/l
1.58
62
246
34
81
4.28
13.21
3.3
3.1
43.18
39.38
%
0.46
17
37
52
167
3.20
13.13
3.7
2.8
—
—
—
0
0
45
133
3.47
12.96
1.3
1.6
—
—
—
0
0
132
674
2.06
12.66
11.6
4.9
—
—
—
0
0
697
5591
1.51
12.25
4.5
3.2
178.23
128.61
ug/l
2.60
645
5218
30
70
4.36
11.98
1.4
1.3
7.35
7.39
ph
0.42
19
51
96
442
2.26
11.96
1.3
1.2
—
—
—
0
0
148
805
1.94
11.87
1.7
1.3
186.27
250.98
u/ml
0.45
135
745
165
934
1.87
11.72
6.6
4.7
104.46
89.10
ng/l
0.96
144
825
66
259
2.63
11.64
4.4
2.9
15.24
16.16
%
1.71
66
253
100
477
2.18
11.43
3.3
1.7
12.25
7.72
iu/ml
0.44
31
105
42
132
3.25
11.02
4.6
2.4
0.58
0.50
mmol/l
0.04
42
127
61
239
2.63
10.80
1.4
1.6
55.98
66.62
mmol/l
1.28
47
204
29
72
4.09
10.71
2.3
1.6
—
—
—
0
0
243
1579
1.66
10.64
1.6
1.4
571.25
475.20
titre
0.34
64
333
25
56
4.53
10.51
2.3
1.8
—
—
—
0
0
193
1190
1.73
10.26
2.9
2.1
363.21
378.55
nmol/l
0.33
180
1110
74
328
2.33
10.09
1.3
1.1
—
—
—
0
0
559
4417
1.45
9.85
5.6
4.0
39.00
69.27
ng/l
1.24
428
3177
914
7951
1.46
9.40
6.5
4.6
—
3.63
—
0
12
72
331
2.24
9.04
1.2
1.3
95.00
86.87
titre
—
6
32
510
4009
1.44
9.03
5.3
3.5
2.33
2.35
mmol/l
2.41
468
3642
61
262
2.39
8.96
2.0
1.6
148.57
142.62
au/ml
0.09
14
79
32
97
3.35
8.93
1.3
1.2
18.56
13.15
u/l
0.95
27
88
180
1132
1.68
8.86
3.1
2.5
38.06
77.33
u/l
0.44
142
947
399
3005
1.47
8.83
5.0
3.0
372.15
350.77
umol/l
3.23
365
2650
518
4108
1.42
8.64
4.5
3.6
6.68
7.87
mmol/l
7.86
438
3524
1202
11153
1.70
8.59
36.7
16.6
41.35
25.16
mg/l
28.15
1111
9211
656
5431
1.40
8.51
4.3
2.9
—
—
estimate
—
0
0
440
3396
1.44
8.49
2.1
1.7
19.26
19.82
nmol/l
0.36
376
2897
60
263
2.34
8.43
4.3
3.2
57.96
57.92
%
0.01
60
263
19
41
4.69
8.36
1.6
1.3
—
—
—
0
0
37
128
2.94
8.32
1.9
1.7
64.79
61.32
%
0.19
24
85
350
2596
1.47
8.30
2.8
1.9
2.67
1.34
mg/l
2.63
291
1999
66
304
2.23
8.27
1.8
1.7
40183.35
13799.40
e6/l
1.47
49
220
62
281
2.26
8.08
2.0
1.5
—
—
—
0
0
48
198
2.48
7.72
3.0
2.0
1.54
1.62
mmol/l
0.30
48
192
89
475
1.94
7.57
4.9
3.0
21.46
21.09
s
0.32
81
435
47
197
2.44
7.32
4.3
3.4
4.83
4.28
e9/l
0.67
47
197
480
3840
1.39
7.30
4.1
2.6
—
—
—
0
0
616
5143
1.36
7.14
2.6
2.2
94.55
94.78
pmol/l
0.04
373
2776
43
176
2.49
7.05
1.2
1.1
1.56
1.50
g/l
0.59
38
158
66
325
2.08
7.03
4.7
3.4
4.49
1.90
index
0.45
37
181
44
185
2.42
6.83
3.5
1.9
0.91
0.88
%
0.14
36
133
46
198
2.37
6.78
1.1
1.1
—
—
—
0
0
461
3710
1.37
6.62
4.3
3.6
100.10
53.88
mg/l
1.82
327
2503
64
321
2.04
6.51
1.5
1.2
7.45
12.04
u/ml
0.32
20
45
171
1146
1.56
6.46
2.1
1.4
—
—
—
0
0
467
3780
1.36
6.42
5.2
4.3
17.74
9.33
mg/mmol
2.23
322
2474
61
305
2.05
6.27
1.1
1.2
—
—
—
0
0
719
6222
1.33
6.25
5.5
3.9
6.02
0.25
estimate
0.47
166
1256
338
2610
1.39
6.18
8.4
4.8
—
—
—
0
0
589
4970
1.33
6.02
5.0
3.5
6.35
6.24
ph
1.47
322
2758
17
44
3.90
5.99
5.1
3.7
—
—
—
0
0
707
6127
1.32
5.97
5.6
3.9
0.00
0.00
estimate
0.50
175
1324
64
333
1.97
5.91
1.5
1.2
26.65
14.45
u/ml
0.31
12
12
60
306
2.01
5.86
2.8
2.2
10.71
12.10
mg/l
0.67
55
282
62
320
1.98
5.86
1.5
1.2
2.31
2.34
u/ml
0.01
15
28
27
96
2.85
5.85
1.9
1.5
25.75
27.39
%
0.08
19
63
28
102
2.78
5.81
1.8
1.6
1.44
1.15
promille
0.43
23
85
440
3575
1.34
5.77
2.7
2.2
296.64
248.13
u/l
0.26
411
3395
18
50
3.64
5.77
1.5
1.4
1.00
1.43
%
—
5
7
712
6199
1.31
5.71
5.6
3.9
6.46
5.05
estimate
0.08
176
1339
1025
9405
1.37
5.71
41.1
20.5
14.16
13.62
%
22.97
1012
9296
99
601
1.70
5.58
1.4
1.2
—
—
—
0
0
845
7551
1.32
5.53
5.2
3.5
75.05
48.60
u/l
5.49
796
7121
81
467
1.78
5.47
2.8
2.5
8232.12
5245.61
u/l
0.26
31
199
601
5142
1.30
5.36
3.2
2.6
75.54
75.97
nmol/l
0.14
547
4645
74
421
1.80
5.23
12.4
7.7
1.60
1.51
mg/l
0.37
66
384
23
80
2.91
5.20
2.0
2.9
16.20
16.30
%
0.06
23
80
135
909
1.54
5.01
6.3
4.0
1.22
1.22
mmol/l
0.03
119
779
19
61
3.14
4.92
1.2
1.6
—
—
—
0
0
19
62
3.09
4.80
2.8
2.7
1.89
1.89
umol/l
0.01
19
56
42
203
2.10
4.78
1.2
1.1
—
—
—
0
0
11
17
6.51
4.77
1.1
1.2
—
—
—
0
0
13
25
5.24
4.77
1.5
1.4
—
—
—
0
0
62
345
1.84
4.74
1.5
1.5
278.82
278.18
ug/g
0.01
34
209
397
3258
1.31
4.68
3.8
3.1
0.40
0.04
—
10
70
140
967
1.50
4.62
5.7
3.8
—
—
—
0
0
23
86
2.70
4.59
1.1
1.0
—
—
—
0
0
80
486
1.69
4.54
4.5
4.1
462.38
297.84
mg/l
0.78
47
231
303
2405
1.33
4.50
2.1
1.7
43478721.43
17557305.60
pmol/l
0.25
253
2022
340
4141
0.76
4.49
3.2
3.1
—
—
—
0
0
29
124
2.37
4.43
1.2
1.2
—
—
—
0
0
57
316
1.84
4.42
6.8
4.4
3.96
3.92
mmol/l
0.23
57
311
141
986
1.48
4.38
2.9
2.5
6.48
7.40
ug/l
0.33
115
882
29
125
2.35
4.36
1.0
1.1
—
—
—
0
0
31
138
2.28
4.33
1.1
1.2
—
—
—
0
0
12
24
5.03
4.32
1.6
1.8
—
—
—
0
0
31
139
2.26
4.27
1.3
1.1
—
—
—
0
0
22
84
2.65
4.24
1.8
2.6
7.74
8.10
mmol/l
0.18
22
84
55
308
1.82
4.15
4.2
3.1
1.64
1.55
mmol/l
0.32
50
302
47
252
1.90
4.06
2.4
3.4
0.86
0.85
nmol/l
0.10
39
206
15
47
3.22
4.06
1.8
2.2
895.00
959.10
e6/l
—
9
39
53
298
1.81
3.96
1.7
1.4
208.73
241.37
u/ml
0.44
30
154
79
498
1.62
3.92
1.5
1.4
—
—
—
0
0
70
430
1.66
3.85
1.5
1.2
0.45
1.50
u/ml
—
6
20
173
1291
1.39
3.79
1.8
1.8
—
—
—
0
0
12
29
4.17
3.70
8.2
7.2
5.90
5.23
kpa
0.37
12
29
15
50
3.02
3.69
3.0
1.8
—
—
—
0
0
14
40
3.53
3.61
3.0
1.8
40.61
40.14
g/l
0.08
14
40
30
143
2.12
3.60
1.6
1.4
—
—
—
0
0
29
139
2.11
3.45
1.6
1.2
—
—
—
0
0
19
76
2.52
3.38
1.1
1.0
—
—
—
0
0
76
1138
0.65
3.38
1.6
1.9
3.65
3.54
ratio
0.36
59
875
13
42
3.12
3.37
1.0
1.0
—
—
—
0
0
30
150
2.02
3.21
1.4
1.5
283.88
280.98
mosm/kgh2o
0.28
25
112
22
97
2.29
3.20
2.0
1.4
4.66
1.85
u/ml
0.44
14
54
22
97
2.29
3.20
1.1
1.1
—
—
—
0
0
27
132
2.07
3.08
1.5
1.9
—
—
—
0
0
13
41
3.19
3.06
2.6
2.5
0.62
0.61
mmol/l
0.20
13
41
16
62
2.60
3.05
57.3
32.9
115.19
134.54
ug/l
0.44
16
54
79
531
1.52
3.04
2.3
1.7
0.27
0.30
mg/l
0.18
41
256
53
839
0.62
3.04
1.4
1.7
3.21
3.43
mmol/l
0.88
36
589
1177
11296
1.32
3.02
41.5
19.9
3.97
3.98
mmol/l
0.53
1158
11050
12
36
3.35
3.02
2.1
1.9
—
—
—
0
0
1176
11286
1.32
3.01
41.1
19.7
138.76
139.60
mmol/l
21.25
1161
11061
27
134
2.04
2.97
1.0
1.1
—
—
—
0
0
391
3358
1.23
2.96
5.2
3.4
0.01
0.05
estimate
0.57
143
1048
70
463
1.54
2.91
3.2
3.5
90.03
3371.48
u/ml
0.89
55
398
280
2326
1.26
2.86
3.7
3.0
2.48
2.45
mmol/l
2.38
242
2088
44
261
1.71
2.82
3.9
2.4
—
—
—
0
0
11
33
3.35
2.81
1.0
1.1
—
—
—
0
0
73
493
1.51
2.77
1.4
1.2
—
—
—
0
0
154
1192
1.33
2.71
3.8
4.3
13.94
23.20
ug/l
0.44
127
989
12
41
2.94
2.62
1.2
1.1
—
—
—
0
0
80
561
1.45
2.54
4.5
3.8
1.02
1.02
ratio
0.06
72
522
24
122
1.98
2.51
1.3
1.3
1.43
1.56
nmol/l
0.18
18
109
11
37
2.99
2.49
1.2
1.3
2.00
63.48
ug/l
—
5
16
41
248
1.67
2.48
1.4
1.9
—
—
—
0
0
9
26
3.48
2.48
2.1
2.3
1.67
2.88
%
—
9
26
7
16
4.39
2.47
1.0
1.8
—
—
—
0
0
8
21
3.83
2.46
1.4
1.5
—
—
—
0
0
1019
10648
0.83
2.36
5.1
4.9
1.38
1.43
mmol/l
2.88
952
9882
50
324
1.56
2.32
1.2
1.2
—
—
—
0
0
15
65
2.32
2.32
1.7
2.5
496.00
500.43
min
—
8
47
23
119
1.95
2.31
4.1
3.5
11.56
12.23
index
0.18
16
79
18
85
2.13
2.29
1.7
2.5
633.78
627.54
ml
—
9
56
6
13
4.63
2.27
1.3
1.0
—
—
—
0
0
30
171
1.77
2.26
1.2
1.2
6.12
5.00
u/ml
0.18
17
75
188
1533
1.26
2.25
1.4
1.3
—
—
—
0
0
8
24
3.35
2.18
1.0
1.0
—
—
—
0
0
8
24
3.35
2.18
2.4
3.4
14.40
15.83
ml/dl
—
8
19
16
74
2.18
2.15
2.3
1.8
10.80
20.22
umol/l
2.57
16
66
10
36
2.79
2.14
8.0
7.8
63.62
63.97
mg/mmol
—
10
31
123
959
1.31
2.10
1.6
1.4
—
—
—
0
0
80
590
1.38
1.98
2.9
2.2
0.00
1.35
estimate
0.50
22
186
5
11
4.56
1.94
1.4
1.0
—
—
—
0
0
5
11
4.56
1.94
1.4
1.0
—
—
—
0
0
75
550
1.38
1.92
2.9
2.0
—
—
—
0
0
1032
10717
0.84
1.90
5.2
5.0
4.41
4.52
mmol/l
2.67
972
10016
137
1101
1.27
1.87
2.7
2.1
0.00
0.02
estimate
0.78
25
233
388
3457
1.17
1.87
6.2
3.9
0.01
0.01
estimate
0.00
151
1223
27
159
1.71
1.86
2.1
1.6
23.59
32.18
ng/l
0.54
27
159
42
277
1.53
1.86
1.5
1.9
391.00
41.91
e6/l
1.11
31
207
509
4634
1.16
1.85
5.9
3.8
0.03
0.03
estimate
0.12
157
1106
21
115
1.84
1.83
1.5
1.3
33047.13
193325.11
e6/l
1.08
15
79
18
94
1.93
1.80
1.1
1.1
231.08
42.81
mg/l
0.71
13
77
8
29
2.77
1.79
2.4
1.9
—
—
—
0
0
57
404
1.43
1.79
1.6
1.7
24.73
10.74
u/ml
0.34
14
87
42
280
1.52
1.78
1.5
1.9
1574.19
562.96
e6/l
0.41
32
218
13
60
2.18
1.78
2.2
2.0
—
—
—
0
0
15
74
2.04
1.75
1.7
1.2
174.67
139.21
nmol/l
0.58
15
74
78
586
1.35
1.75
2.9
2.0
—
—
—
0
0
19
334
0.56
1.74
18.5
10.0
—
—
—
0
0
78
587
1.35
1.73
2.9
2.0
—
—
—
0
0
8
30
2.68
1.72
2.1
1.9
—
—
—
0
0
18
96
1.89
1.71
1.7
1.5
—
—
—
0
0
42
283
1.50
1.71
4.7
5.0
—
—
—
0
0
14
68
2.07
1.70
3.2
2.8
—
—
—
0
0
15
75
2.01
1.70
1.3
1.2
0.52
0.53
ratio
—
8
45
78
591
1.34
1.66
2.9
2.0
—
—
—
0
0
8
31
2.59
1.66
1.5
1.9
—
—
—
0
0
14
69
2.04
1.65
1.3
1.7
112.79
101.12
ng/l
0.09
14
69
11
49
2.26
1.63
1.1
1.1
384.93
182.57
iu/ml
0.36
11
49
471
4296
1.15
1.63
2.2
2.2
—
—
—
0
0
5
14
3.58
1.61
1.2
7.6
—
—
—
0
0
17
91
1.88
1.61
3.2
2.3
1.40
1.70
u/field
—
10
50
977
10151
0.86
1.60
4.5
4.2
1.35
1.28
mmol/l
2.41
906
9348
41
280
1.48
1.58
1.5
1.8
3.56
3.77
mmol/l
0.37
34
264
6
20
3.01
1.58
10.3
6.3
1.98
2.83
mg/l
—
6
15
11
50
2.21
1.57
1.6
1.2
136.64
506.48
u/l
0.99
11
44
1174
11429
1.21
1.56
29.8
14.8
—
—
—
0
0
22
130
1.70
1.53
1.4
2.4
—
—
—
0
0
125
1028
1.24
1.45
4.3
2.6
0.68
0.45
e6/l
0.61
120
980
27
172
1.58
1.43
4.4
3.2
7.22
9.37
umol/l
0.36
20
131
31
455
0.67
1.38
1.4
1.6
—
—
—
0
0
126
1048
1.22
1.33
8.2
4.4
7.39
7.35
ph
3.65
103
779
19
114
1.68
1.28
2.4
2.2
—
—
—
0
0
44
319
1.39
1.28
1.5
1.8
1097.92
498.27
mg/l
2.13
39
301
74
582
1.29
1.27
2.9
1.9
—
—
—
0
0
419
3849
1.13
1.26
4.6
3.7
—
0.81
—
0
16
381
3481
1.13
1.25
1.5
1.5
—
—
—
0
0
1199
11741
1.19
1.22
41.3
21.3
85.67
79.36
umol/l
3.42
1186
11606
5
19
2.64
1.21
1.8
6.5
8.62
8.22
mmol/l
—
5
19
52
393
1.34
1.19
1.2
1.3
171.32
235.29
miu/ml
0.52
16
185
15
86
1.75
1.19
1.1
1.1
—
—
—
0
0
62
482
1.30
1.17
2.6
2.7
—
—
—
0
0
171
1483
1.18
1.17
1.3
1.3
—
—
—
0
0
80
644
1.26
1.16
3.1
3.5
4.63
4.59
pmol/l
0.11
72
573
56
431
1.31
1.14
2.0
1.6
302.91
304.56
mu/l
0.01
45
396
7
30
2.34
1.12
1.1
1.4
5.99
8.05
mmol/l
—
7
30
811
7771
1.11
1.10
5.2
4.2
—
6313.94
—
0
16
5
21
2.39
1.09
3.0
1.4
—
—
—
0
0
14
81
1.74
1.09
1.1
1.0
—
—
—
0
0
1058
10852
0.88
1.08
5.8
5.6
2.54
2.64
mmol/l
3.34
985
10089
62
776
0.79
1.04
1.2
1.2
148.71
131.15
u/ml
0.10
21
293
5
22
2.28
1.03
2.2
3.8
—
—
—
0
0
14
83
1.69
1.01
1.4
1.3
—
—
—
0
0
227
2522
0.88
1.00
2.7
3.3
0.68
0.77
ug/l
1.05
149
1645
11
61
1.81
0.98
1.1
1.0
1474.64
1497.72
miu/ml
0.03
11
61
21
141
1.50
0.95
2.1
1.8
—
—
—
0
0
15
93
1.62
0.94
1.1
1.1
—
—
—
0
0
6
28
2.15
0.91
1.7
1.6
—
—
—
0
0
99
1161
0.84
0.91
2.8
2.3
11.62
13.09
nmol/l
1.21
84
1049
15
94
1.60
0.90
3.0
3.4
29.16
29.06
mg/l
—
9
71
6
29
2.07
0.89
2.5
2.0
18.27
16.30
umol/l
—
6
29
8
42
1.91
0.88
2.5
2.4
137.07
96.25
ug/l
—
8
42
26
357
0.72
0.87
1.1
1.1
1.43
1.50
g/l
0.94
26
357
69
569
1.22
0.86
1.7
1.6
948.44
965.28
mu/l
0.06
58
492
304
2803
1.11
0.85
1.4
1.4
3.32
1.55
u/ml
0.57
69
756
102
875
1.18
0.84
3.2
2.6
5.97
6.12
ph
1.02
74
603
22
155
1.43
0.81
1.1
1.2
—
—
—
0
0
66
547
1.22
0.79
2.8
2.4
—
—
—
0
0
32
417
0.76
0.78
2.2
1.8
34.47
40.74
nmol/l
1.49
32
398
14
90
1.56
0.78
1.2
1.1
97.14
106.49
pmol/l
0.29
14
90
5
97
0.51
0.78
2.2
5.2
—
37.84
—
0
31
58
477
1.23
0.76
1.6
1.5
22.40
21.35
iu/l
0.09
47
398
5
24
2.09
0.74
1.8
1.9
—
—
—
0
0
41
513
0.79
0.74
1.0
1.1
—
—
—
0
0
17
242
0.70
0.73
1.5
1.6
—
—
—
0
0
29
378
0.76
0.72
1.4
1.2
0.92
0.90
g/l
0.21
29
378
21
287
0.73
0.71
1.0
1.2
—
—
—
0
0
32
247
1.30
0.71
4.1
3.7
44.22
28.24
mg/l
1.16
27
181
50
410
1.23
0.69
1.6
1.6
10.29
7.93
u/l
0.74
39
325
5
27
1.85
0.68
1.4
3.4
3786.20
5.55
ug/l
—
5
27
11
69
1.60
0.68
3.7
2.6
20.27
28.83
umol/l
2.26
11
64
16
227
0.70
0.68
1.2
1.3
—
—
—
0
0
24
318
0.75
0.68
1.4
1.6
115.69
63.71
ug/l
0.39
19
278
23
170
1.36
0.67
1.2
1.5
0.42
0.31
nmol/l
0.22
17
136
17
237
0.71
0.66
1.5
1.5
—
—
—
0
0
5
28
1.79
0.66
1.0
1.5
54.80
96.82
nmol/24h
—
5
28
16
111
1.45
0.66
1.6
2.3
—
—
—
0
0
40
324
1.24
0.63
2.2
1.9
—
—
—
0
0
28
218
1.29
0.60
1.1
1.1
—
—
—
0
0
437
4581
0.93
0.59
2.0
2.0
1.39
1.34
mmol/l
0.53
381
3887
22
166
1.33
0.58
1.3
1.2
—
—
—
0
0
17
231
0.73
0.58
1.4
1.5
1.29
1.27
mm
—
9
173
203
1876
1.10
0.57
1.3
1.3
16.87
11.02
u/ml
0.36
55
718
1028
10462
0.93
0.56
5.5
5.0
6.11
5.94
mmol/l
2.78
941
9588
1177
11619
1.10
0.56
20.2
12.0
27.70
26.32
u/l
1.26
1150
11299
9
60
1.50
0.54
3.9
2.9
1604.44
2005.19
ml
—
9
53
142
1551
0.91
0.51
2.6
2.5
181.70
124.47
ug/g
1.03
109
1243
64
734
0.87
0.51
1.2
1.2
—
—
—
0
0
1003
10204
0.93
0.51
7.6
6.4
40.87
39.28
mmol/mol
4.83
939
9542
214
1998
1.08
0.50
1.4
1.3
45.80
30.81
iu/ml
0.69
73
604
7
45
1.56
0.49
1.7
2.9
—
—
—
0
0
21
163
1.29
0.48
1.0
1.2
—
—
—
0
0
7
46
1.52
0.48
1.1
1.1
—
—
—
0
0
27
219
1.24
0.45
1.1
1.1
—
—
—
0
0
17
220
0.77
0.45
1.4
1.7
—
—
—
0
0
7
50
1.40
0.45
1.4
1.6
0.37
0.51
e9/l
—
7
50
33
274
1.21
0.45
2.6
2.5
169.36
90.84
ug/min
0.57
22
165
5
32
1.56
0.42
1.2
1.3
25.80
27.13
s
—
5
32
8
57
1.41
0.42
1.3
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
1.98
—
0
16
0
17
0.00
0.40
0.0
1.0
—
0.22
—
0
5
8
61
1.31
0.39
1.3
1.2
—
—
—
0
0
1223
12133
1.08
0.36
49.8
25.0
7.87
6.81
e9/l
16.32
1204
11870
16
127
1.26
0.33
1.2
1.3
—
—
nmol/l
—
0
0
6
47
1.28
0.32
2.0
1.5
0.00
0.06
estimate
—
6
47
29
248
1.17
0.32
1.3
1.3
—
—
—
0
0
7
52
1.35
0.31
1.6
1.6
1.67
4.90
nmol/l
—
7
42
1039
10272
1.05
0.31
5.5
5.1
1.97
1.93
mu/l
0.38
955
9495
24
282
0.85
0.30
1.3
1.1
5.65
2.20
u/ml
0.53
18
163
127
1347
0.94
0.27
1.6
1.6
—
—
—
0
0
1220
12124
1.06
0.26
50.0
25.0
251.80
247.36
e9/l
1.21
1204
11892
21
246
0.85
0.26
1.0
1.1
0.72
1.26
u/ml
0.47
13
126
1220
12127
1.06
0.25
49.7
24.9
91.30
90.84
fl
2.48
1211
12000
103
968
1.07
0.24
1.1
1.2
—
—
—
0
0
16
133
1.21
0.24
1.8
2.6
—
—
—
0
0
949
9386
1.04
0.24
43.5
21.1
330.65
332.92
g/l
10.23
942
9323
1220
12130
1.06
0.24
51.5
25.6
38.45
40.35
%
26.05
1209
11994
1220
12130
1.06
0.24
49.7
24.9
30.26
30.29
pg
0.21
1211
12001
1220
12130
1.06
0.24
49.8
24.9
4.29
4.50
e12/l
31.04
1202
11870
5
40
1.25
0.22
1.8
3.2
—
—
—
0
0
1220
12134
1.06
0.22
50.4
25.2
128.28
135.36
g/l
40.59
1210
12004
26
294
0.88
0.21
1.9
2.0
4.07
4.14
iu/l
—
10
113
5
42
1.19
0.21
9.2
6.2
13.00
8.31
%
—
5
42
5
42
1.19
0.21
4.6
3.1
46.60
46.00
%
—
5
42
0
11
0.00
0.21
0.0
1.1
—
0.13
—
0
5
0
10
0.00
0.21
0.0
1.0
—
0.05
—
0
5
0
10
0.00
0.21
0.0
2.1
—
0.56
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
0.12
—
0
6
38
417
0.91
0.20
1.1
1.1
—
—
—
0
0
15
127
1.18
0.19
1.1
1.2
0.20
0.18
nmol/l
—
10
100
869
8607
1.03
0.17
4.5
4.2
14.74
14.83
pmol/l
0.47
791
7875
6
79
0.76
0.15
1.7
1.3
159.92
167.70
pmol/l
—
6
79
18
203
0.89
0.15
1.3
1.4
430.06
291.12
pmol/l
0.18
18
198
117
1216
0.96
0.15
1.5
1.7
—
—
—
0
0
6
56
1.07
0.08
1.7
1.4
5.83
6.19
mmol/l
—
6
56
6
57
1.05
0.08
1.2
1.0
—
—
—
0
0
10
88
1.14
0.08
1.4
1.2
—
—
—
0
0
6
74
0.81
0.07
3.3
1.5
88.67
82.19
umol/l
—
6
74
45
468
0.96
0.07
4.0
3.0
37.21
92.82
u/ml
1.23
45
450
18
167
1.08
0.07
1.2
1.2
—
—
—
0
0
24
252
0.95
0.05
1.0
1.1
4.00
7.52
u/ml
0.71
17
153
19
200
0.95
0.03
1.0
1.1
4.68
5.28
u/ml
0.05
12
111
129
1274
1.01
0.03
1.4
1.4
—
—
—
0
0
15
158
0.95
0.02
1.1
1.1
10.54
2.16
eliau/ml
—
5
65
421
4226
0.99
0.02
5.1
5.7
2.65
2.59
ug/l
0.04
372
3797
19
183
1.04
0.01
1.0
1.1
1.03
6.70
u/ml
—
10
93
279
2783
1.00
0.00
6.6
3.9
1.02
1.02
kg/l
0.45
210
1849
52
519
1.00
0.00
2.1
1.9
—
—
—
0
0
13
133
0.98
0.00
1.0
1.1
—
—
—
0
0
16
157
1.02
0.00
1.1
1.4
4.04
3.22
ug/l
0.49
11
139
10
105
0.95
0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
78.14
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
554.57
—
0
7
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
1.08
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint PNEUMO_SEPTHICHE and mortality.

Females

Parameter HR [95% CI] p-value
PNEUMO_SEPTHICHE 2.811 [2.33, 3.39] < 0.001
Birth year 0.992 [0.98, 1.0] 0.068

During the follow-up period (1.1.1998 — 31.12.2019), 996 out of 4840 females with PNEUMO_SEPTHICHE died.

Males

Parameter HR [95% CI] p-value
PNEUMO_SEPTHICHE 3.457 [2.88, 4.14] < 0.001
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1385 out of 5934 males with PNEUMO_SEPTHICHE died.

Mortality risk

Mortality risk for people of age

years, who have PNEUMO_SEPTHICHE.

N-year risk Females Males
1 0.271% 0.64%
5 1.424% 3.663%
10 3.592% 8.811%
15 7.108% 16.967%
20 12.402% 26.779%

Relationships between endpoints

↥

Index endpoint: PNEUMO_SEPTHICHE – Pneumococcal septicemia

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data